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Cells	  interact	  with	  neighboring	  cells	  and	  the	  extracellular	  matrix	  forming	  cell-­‐cell	  and	  
cell-­‐matrix	   contacts,	   which	   are	   mainly	   mediated	   by	   cadherins	   and	   integrins,	  
respectively.	   These	   processes	   are	   dynamic	   and	   spatially	   and	   temporally	   tightly	  
regulated	  during	  many	  biological	  events	  including	  embryogenesis,	  wound	  healing	  and	  
cancer	  development.	  Dynamic	  control	  of	   cell	   interactions	   is	  a	  key	   to	  understanding	  
many	   underlying	   cellular	   processes,	   to	   achieving	   the	   bottom-­‐up	   assembly	   of	   single	  
cells	  into	  tissues	  and	  to	  developing	  medical	  implants.	  The	  challenge	  lies	  in	  controlling	  
specific	   cell-­‐cell	   and	   cell-­‐material	   interactions	   both	   dynamically	   and	   reversibly	  with	  
high	  spatiotemporal	  control	  in	  a	  non-­‐invasive	  way	  over	  a	  long	  period	  of	  time.	  The	  aim	  
of	   this	   thesis	   is	   to	   generate	   platforms	  where	   these	   cell	   interactions	   are	   controlled	  
spatially,	   temporally,	   dynamically	   and	   reversibly	   using	   visible	   light	   responsive	  
proteins	  from	  plants.	  	  
	  
The	   recent	   developments	   in	   the	   field	   of	   optogenetics	   provide	   powerful	   tools	   to	  
overcome	   above-­‐mentioned	   challenges	   and	   they	   have	   been	   employed	   to	   control	  
many	   intracellular	   signaling	   pathways.	   Among	   others	   cryptochromes	   and	  
phytochromes	   were	   used	   in	   this	   study.	   Cryptochrome	   2	   (CRY2)	   is	   a	   blue	   light	  
photoreceptor	   and	   it	   heterodimerizes	   with	   CIBN	   upon	   blue	   light	   irradiation.	   This	  
interaction	  can	  be	  reversed	  to	  the	  ground	  state	  passively	  in	  the	  dark.	  Phytochrome	  B	  
(PhyB)	   is	   a	   red	   and	   far-­‐red	   light	   sensing	  protein	   and	  upon	   red	   light	   illuminations	   it	  
interacts	  and	  forms	  heterodimers	  with	  PIF6.	  This	  heterodimerization	  can	  be	  reversed	  
under	  far-­‐red	  light	  or	  passively	  in	  the	  dark.	  	  
	  
To	   control	   cell-­‐cell	   interactions	   with	   light,	   the	   blue	   light	   dependent	   heterodimers,	  
CRY2	   or	   CIBN	  were	   expressed	   on	   the	   surfaces	   of	   the	   cells,	  which	   do	   not	   form	   any	  
native	  cell-­‐cell	  contacts.	  In	  equally	  mixed	  cultures	  of	  CRY2	  and	  CIBN	  expressing	  cells,	  
these	  cells	  form	  cell-­‐cell	  interactions	  upon	  blue	  light	  illumination,	  which	  provides	  high	  
high	  spatial	  and	  temporal	  control.	  These	  photoswitchable	  interactions	  are	  reversible	  
in	   the	   dark,	   and	   can	   be	   repeatedly	   and	   dynamically	   switched	   on	   and	   off.	   These	  
genetically	   encoded	   interactions	   can	   be	   sustained	   over	   a	   long	   time	   as	   they	   are	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genetically	  encoded	  and	  they	  respond	  to	  nontoxic	  low	  intensity	  blue	  light.	  
	  
Towards	   controlling	   cell-­‐material	   contacts	   of	   multiple	   cell	   types,	   one	   of	   the	  
heterodimerization	   partners	   (CIBN	   or	   PIF6)	  was	   immobilized	   on	   non-­‐adhesive	   glass	  
surfaces.	  By	  expressing	  CRY2	  or	  PhyB	  on	  the	  cell	  surfaces,	  their	  adhesion	  to	  CIBN	  and	  
PIF6	  functionalized	  substrates	  can	  be	  triggered	  under	  nontoxic	  low	  intensity	  blue	  and	  
red	   light	   illumination,	   respectively.	   CRY2/CIBN	   and	   PhyB/PIF6	   interactions	   are	  
orthogonal	   to	   each	   other	   since	   they	   respond	   to	   only	   blue	   and	   red/far-­‐red	   light,	  
respectively.	   This	   orthogonality	   provides	  wavelength	   selective	   adhesion	   of	   one	   cell	  
type	  to	  its	  complementary	  substrate	  in	  the	  presence	  of	  the	  other	  cell	  type.	  The	  ability	  
of	   PhyB/PIF6	   system	   to	   far-­‐red	   light	   also	   makes	   orthogonal	   reversion	   of	   these	  
adhesions	  possible	  while	  the	  other	  cell	  type	  (CRY2)	  remains	  adhered	  to	  its	  substrate.	  
These	  photoswitchable	  cell-­‐material	   interactions	  are	  reversible	   in	  the	  dark	  or	  under	  
far-­‐red	  light,	  and	  can	  be	  repeatedly	  and	  dynamically	  switched	  on	  and	  off.	  	  
	  
Overall,	   this	   optogenetic	   approach	   to	   control	   cell	   interactions	   reflects	   the	   dynamic	  
and	   reversible	   nature	   of	   cell-­‐cell	   and	   cell-­‐material	   interactions	   and	   provides	   the	  
desired	  spatiotemporal	  control	  in	  a	  noninvasive	  manner.	  These	  blue	  and	  red/far-­‐red	  
light	   responsive	   proteins	   are	   genetically	   encodable;	   hence,	   they	   can	   be	   sustained	  
over	  a	  long	  time.	  Finally,	  photoswitchable	  cell	  interactions	  will	  provide	  a	  new	  way	  of	  
studying	   them	   and	   assembling	   cells	   into	   multicellular	   structures	   in	   the	   context	   of	  
bottom-­‐up	  tissue	  engineering.	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Zusammenfassung	  
Zellen	  interagieren	  mit	  benachbarten	  Zellen	  und	  der	  extrazelluläre	  Matrix	  in	  dem	  sie	  
Zell-­‐Zell-­‐	   und	   Zell-­‐Matrix-­‐Kontakte	   bilden,	   welche	   hauptsächlich	   durch	   Cadherine	  
oder	   Integrine	   vermittelt	   werden.	   Diese	   Prozesse	   sind	   dynamisch	   und	   sowohl	  
räumlich	   als	   auch	   zeitlich	   während	   vieler	   biologischer	   Ereignisse	   einschließlich	  
Embryogenese,	   Wundheilung	   und	   der	   Entwicklung	   von	   Krebs.	   Die	   dynamische	  
Kontrolle	   von	   Zellinteraktionen	   ist	   ein	   Schlüssel	   zum	   Verständnis	   vieler	  
zugrundeliegender	   zellulärer	   Prozesse,	   zur	   Herstellung	   der	   Bottom-­‐up-­‐Anordnung	  
einzelner	   Zellen	   in	   Gewebe	   und	   zur	   Entwicklung	   medizinischer	   Implantate.	   Die	  
Herausforderung	  besteht	  darin,	   spezifische	  Zell-­‐Zell-­‐	  und	  Zell-­‐Material-­‐Interaktionen	  
sowohl	   dynamisch	   als	   auch	   reversibel	   mit	   hoher	   raumzeitlicher	   Kontrolle	   auf	  
nichtinvasive	  Weise	  über	  einen	   langen	  Zeitraum	  hinweg	   zu	   steuern.	  Das	   Ziel	   dieser	  
Arbeit	   ist	  es,	  Plattformen	  zu	  konzipieren,	   in	  denen	  diese	  Zellinteraktionen	  räumlich,	  
zeitlich,	   dynamisch	   und	   reversibel	   unter	   Verwendung	   von	   auf	   sichtbares	   Licht	  
reagierenden	  Proteinen	  aus	  Pflanzen	  gesteuert	  werden.	  
	  
Die	   jüngsten	  Entwicklungen	  auf	  dem	  Gebiet	  der	  Optogenetik	  bieten	   leistungsfähige	  
Komponenten,	   welche	   bereits	   zur	   Kontrolle	   von	   intrazellulären	   Signalwegen	  
angewedet	  wurden,	  um	  die	  oben	  genannten	  Herausforderungen	  zu	  überwinden.	   In	  
dieser	   Studie	   wurden	   unter	   anderem	   Cryptochrome	   und	   Phytochrome	   verwendet.	  
Cryptochrom	  2	  (CRY2)	  ist	  ein	  Blaulicht-­‐Photorezeptor	  und	  heterodimerisiert	  mit	  CIBN	  
unter	   blauem	   Licht.	   Diese	   Wechselwirkung	   kehrt	   im	   Dunkeln	   passiv	   in	   den	  
Grundzustand	   zurück.	   Phytochrom	   B	   (PhyB)	   ist	   ein	   rotes	   und	   infrarotes	   Licht	  
sensitives	   Protein	   und	   bildet	   unter	   Bestrahlung	   Heterodimere	   mit	   PIF6.	   Diese	  
Heterodimerisierung	  kann	  unter	  	  infrarotem	  Licht	  oder	  passiv	  im	  Dunkeln	  umgekehrt	  
werden.	  
	  
Um	   die	   Zell-­‐Zell-­‐Wechselwirkungen	   mit	   Licht	   zu	   steuern,	   wurden	   die	   Blaulicht-­‐
abhängigen	   Heterodimere	   CRY2	   oder	   CIBN	   auf	   den	   Oberflächen	   der	   Zellen	  
exprimiert,	  die	  keine	  nativen	  Zell-­‐Zell-­‐Kontakte	  bilden.	  In	  gleichermaßen	  gemischten	  
Kulturen	   von	   CRY2-­‐	   und	   CIBN-­‐exprimierenden	   Zellen	   bilden	   diese	   Zellen	   bei	   der	  
Beleuchtung	   mit	   blauem	   Licht	   Zell-­‐Zell	   Kontakte.	   Diese	   photoschaltbaren	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Wechselwirkungen	  sind	  im	  Dunkeln	  reversibel	  und	  können	  mehrmals	  und	  dynamisch	  
ein-­‐	   und	   ausgeschaltet	   werden.	   Durch	   die	   genetische	   kodierung	   der	   vermittelnden	  
Proteine,	  können	  die	  Interaktionen	  über	  eine	  lange	  Zeit	  aufrechterhalten	  werden,	  da	  
sie	  zudem	  auf	  nichttoxisches	  blaues	  Licht	  mit	  niedriger	  Intensität	  reagieren.	  
	  
Zur	   Steuerung	   von	   Zell-­‐Material-­‐Kontakten	   mehrerer	   Zelltypen,	   wurde	   einer	   der	  
jeweiligen	   Heterodimerisierungspartner	   (CIBN	   oder	   PIF6)	   auf	   nicht-­‐adhäsiven	  
Glasoberflächen	   immobilisiert.	   Durch	   die	   Expression	   von	   CRY2	   oder	   PhyB	   auf	   den	  
Zelloberflächen	   kann	   deren	  Adhäsion	   an	   CIBN-­‐	   und	   PIF6-­‐funktionalisierte	   Substrate	  
unter	   nichttoxischer	   Beleuchtung	   mit	   niedriger	   Intensität	   von	   blauem	   bzw.	   rotem	  
Licht	   ausgelöst	   werden.	   CRY2	   /	   CIBN-­‐	   und	   PhyB	   /	   PIF6-­‐Wechselwirkungen	   sind	  
orthogonal	   zueinander,	   da	   sie	   nur	   auf	   blaues	   bzw.	   rotes	   bzw.	   infrarotes	   Licht	  
ansprechen.	  Diese	  Orthogonalität	   sbefähigt	   zu	  eine	  wellenlängenselektive	  Adhäsion	  
eines	   Zelltyps	   an	   sein	   komplementäres	   Substrat	   in	  Gegenwart	   des	   anderen	   Zelltyp.	  
Die	   Fähigkeit	   des	   PhyB	   /	   PIF6-­‐Systems	   zu	   weit	   rotem	   Licht	   macht	   auch	   eine	  
orthogonale	   Reversion	   dieser	   Adhäsionen	   möglich,	   während	   der	   andere	   Zelltyp	  
(CRY2)	   an	   seinem	   Substrat	   haften	   bleibt.Diese	   photoschaltbaren	   Zell-­‐Material-­‐
Wechselwirkungen	   sind	   im	  Dunkeln	   oder	   im	   fernen	  Rotlicht	   reversibel	   und	   können	  
wiederholt	  und	  dynamisch	  ein-­‐	  und	  ausgeschaltet	  werden.	  
	  
Insgesamt	  spiegelt	  dieser	  optogenetische	  Ansatz	  zur	  Kontrolle	  von	  Zellinteraktionen	  
die	   dynamische	   und	   reversible	   Natur	   der	   Zell-­‐Zell-­‐	   und	   Zell-­‐Material-­‐
Wechselwirkungen	   wider	   und	   liefert	   die	   gewünschte	   raumzeitliche	   Kontrolle	   auf	  
nichtinvasive	   Weise.	   Die	   verwendeten	   blau	   und	   rot	   /	   weit-­‐rot	   lichtempfindlichen	  
Proteine	   sind	   genetisch	   codierbar;	   Daher	   können	   die	   durch	   sie	   vermittelten	  
Interaktionen	   über	   eine	   lange	   Zeit	   aufrechterhalten	   werden.	   Schließlich	   werden	  
photoschaltbare	   Zellinteraktionen	   eine	   neue	  Möglichkeit	   bieten,	   diese	   zu	   studieren	  
und	  Zellen	  im	  Rahmen	  des	  Bottom-­‐Up-­‐Tissue	  Engineering	  zu	  mehrzelligen	  Strukturen	  
zusammenzufügen.	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List	  of	  abbreviations	  
	  
A	   	   	   	  	   absorbance	  
APC	   	   	   	   adenomatous	  polyposis	  coli	  
BSA	   	   	   	   bovine	  serum	  albumin	  
CAMs	   	   	   	   cell	  adhesion	  molecules	  
cAMP	   	   	   	   cyclic	  adenosine	  monophosphate	  
Cas9	   	   	   	   CRISPR-­‐associated	  protein	  9	  
CCE	  	   	   	   	   cryptochrome	  C-­‐terminal	  extension	  domain	  
CFP	   	   	   	   cyan	  fluorescent	  protein	  
CIBN	   N-­‐truncated	  Cry-­‐interacting	  basic	  helix-­‐loop-­‐helix	  
protein	  1	  
CKI	   	   	   	   casein	  kinase	  1	  
COP1	   constitutive	  photomorphogenesis	  protein1	  
Cph1	   cyanobacterial	  phytochrome	  1	  
CRISPR	   clustered	  regularly	  interspaced	  short	  palindromic	  
repeats	  
CRY2	   	   	   	   cryptochrome	  2	  
CSANs	   	   	   	   chemically	  self-­‐assembled	  nanorings	  
Da	   	   	   	   dalton	  
DAH	   	   	   	   differential	  adhesion	  hypothesis	  
DAPI	   	   	   	   4',6-­‐diamidino-­‐2-­‐phenylindole	  
DHFR	   dihydrofolate	  reductase	  
DH-­‐PH	   Dbl	  homology-­‐pleckstrin	  
Dil	   1,1’-­‐dioctadecyl-­‐3,3,3’,3’-­‐	  	  tetramethylindocarbocyanin	  
perchlorate	  
DiO	   	   	   	   3,3’-­‐dioctadecyloxacarbocyanine	  perchlorate	  
DITH	   	   	   	   differential	  interfacial	  tension	  hypothesis	  
DMEM	  	   	   	   Dulbecco's	  Modified	  Eagle	  Medium	   	  
DMSO	   	   	   	   dimethylsulfoxide	  
DNA	   	   	   	   deoxyribonucleic	  acid	  
dNTP	   	   	   	   deoxynucleoside	  triphosphates	  
	  vii	  
DpnI	   	   	   	   deoxyribonuclease	  I	  
DTT	   	   	   	   dithiothreitol	  
EC	  	   	   	   	   extracellular	  
E.	  coli	   	   	   	   Escherichia	  coli	  
ECM	   	   	   	   extracellular	  matrix	  
EDTA	   	   	   	   ethylenediaminetetraacetic	  acid	  
EGF	   	   	   	   epidermal	  growth	  factor	  
EMT	   	   	   	   epithelial	  to	  mesenchymal	  transition	  
ERK	   	   	   	   extracellular	  signal	  regulated	  kinase	  
FAD	   	   	   	   flavine	  adenine	  dinucleoide	  
FAK	   	   	   	   focal	  adhesion	  kinase	  
FBS	   	   	   	   fetal	  bovine	  serum	  
FDA	   	   	   	   Food	  and	  Drug	  Administration	  	  
FGF	   	   	   	   fibroblast	  growth	  factor	  
FGFR	   	   	   	   fibroblast	  growth	  factor	  receptor	  
FITC	   	   	   	   fluorescein	  isothiocyanate	  
FKF	   	   	   	   Kelch	  repeat	  F-­‐box	  protein	  
FMN	   	   	   	   flavin	  mononucleotide	  
FRET	   	   	   	   Förster	  resonance	  energy	  transfer	  
GEF	   	   	   	   Guanosine	  nucleotide	  exchange	  factor	  
GFP	   	   	   	   green	  fluorescent	  protein	  
GSK3β	   	   	   	   glycogen	  synthase	  3β	  	  
GTP	   	   	   	   guanosine	  triphosphate	  
HEK	   	   	   	   human	  embryonic	  kidney	  
His6	   	   	   	   histidine	  tag	  
HPLC	   	   	   	   high	  performance	  liquid	  chromatography	  
Hz	   	   	   	   Hertz	  
Ig	   	   	   	   immunoglobulin	  
ILK	   	   	   	   integrin	  linked	  kinase	  
IPTG	   	   	   	   isopropyl	  β-­‐D-­‐1-­‐thiogalactopyranoside	  
LACE	   	   	   	   light	  activated	  CRISPR-­‐Cas9	  effector	  
LB	  medium	   	   	   Luria-­‐Bertani	  medium	  
	  viii	  
LEF	   	   	   	   lymphoid	  enhancer	  factor	  
LOV	   	   	   	   light-­‐oxygen-­‐voltage	  
LRP6	   	   	   	   lipoprotein	  receptor	  related	  protein	  6	  
MAPK	   	   	   	   mitogen	  activated	  protein	  kinase	  
MET	   	   	   	   mesenchymal	  to	  epithelial	  transition	  
MOPS	   	   	   	   3-­‐(N-­‐morpholino)propanesulfonic	  acid	  
MTX	   methotrexate	  	  
MTT	   3-­‐(4,5-­‐Dimethylthiazol-­‐2-­‐yl)-­‐2,5-­‐Diphenyltetrazolium	  
Bromide	  
NIR	   	   	   	   near	  infrared	  
NTA	   	   	   	   nitrilotriacetic	  acid	  
PAS	   	   	   	   Per-­‐ARNT-­‐Sim	  domain	  
PBS	   	   	   	   phosphate	  buffer	  saline	  
PCB	   	   	   	   phycocyanobilin	  
PCR	   	   	   	   polymerase	  chain	  reaction	  
PDGF	   	   	   	   platelet	  derived	  growth	  factor	  
PDGFR	  	   	   	   platelet	  derived	  growth	  factor	  receptor	  
PDMS	   	   	   	   (poly)-­‐dimethylsiloxane	  
PEG-­‐N3	  	   	   	   polyethyleneglycol-­‐azide	  
PFA	   	   	   	   para-­‐formaldehyde	  
PIF6	   	   	   	   phytochrome	  interacting	  factor	  6	  
PhyB	   	   	   	   phytochrome	  B	  
PHR	   	   	   	   photolyase	  region	  
PKB	   	   	   	   protein	  kinase	  B	  
PM	   	   	   	   plasma	  membrane	  
PMSF	   	   	   	   phenylmethylsulfonyl	  fluoride	  
POI	   	   	   	   protein	  of	  interest	  
P/S	   	   	   	   penicillin/streptomycin	  
QCM-­‐D	   	   	   quartz	  crystal	  microbalance	  with	  dissipation	  
rpm	   	   	   	   round	  per	  minute	  
RT	   	   	   	   room	  temperature	  
RTK	   	   	   	   receptor	  tyrosine	  kinase	  
	  ix	  
SAM	   	   	   	   self-­‐assembled	  monolayers	  
SDS-­‐PAGE	   sodium	  dodecyl	  sulfide-­‐polyacrylamide	  gel	  	  	  	  
electrophoresis	  
ssDNA	   	   	   	   single	  stranded	  DNA	  
TAE	  buffer	   	   	   tris-­‐acetate-­‐EDTA	  buffer	  
TBS-­‐T	   	   	   	   tris	  buffer	  saline	  with	  tween	  20	  
TCF	   	   	   	   T	  cell	  factor	  
TGF	   	   	   	   transforming	  growth	  factor	  
TM	   	   	   	   transmembrane	  
TRIS	   	   	   	   tris(hydroxymethyl)aminomethane	  
TRITC	   	   	   	   tetramethylrhodamine	  
UCNPs	  	   	   	   upconversion	  nanoparticles	  
UV	   	   	   	   ultraviolet	  
Vis	   	   	   	   visible	  light	  
VVD	   	   	   	   vivid	  






















List	  of	  figures	  
	  
Figure	  1.1	  Schematic	  representation	  of	  homophilic	  cadherin	  interaction	   	   	  	  	  	  	  1	  
Figure	  1.2	  Cell	  sorting	  following	  DAH	  	   	   	   	   	   	   	  	  	  	  	  2	  
Figure	  1.3	  β-­‐catenin/Wnt	  signaling	  pathway	  	   	   	   	   	   	  	  	  	  	  4	  
Figure	  1.4	  Epithelial	  to	  mesenchymal	  and	  mesenchymal	  to	  epithelial	  transitions	  	   	  	  	  	  	  5	  
Figure	  1.5	  Integrin	  structure	   	   	   	   	   	   	   	   	  	  	  	  	  8	  
Figure	  1.6	  Integrin	  signaling	   	   	   	   	   	   	   	   	  	  	  	  	  9	  
Figure	  1.7	  Bi-­‐directional	  integrin	  signaling	   	   	   	   	   	  	  	   	  	  	  10	  
Figure	  1.8	  Top-­‐down	  vs	  bottom-­‐up	  tissue	  engineering	   	   	   	   	  	  	  11	  
Figure	  1.9	  Self-­‐organization	  and	  self-­‐assembling	  processes	  in	  bottom-­‐up	  tissue	  	  	  	  	  
	   	  	  	  	  	  	  	  engineering	   	   	   	   	   	   	   	  	  	  	  	  	   	  	  	  13	  
Figure	  1.10	  Engineering	  cell	  surface	  to	  induce	  cell-­‐cell	  interactions	  	   	   	  	  	  16	  
Figure	  1.11	  Light	  controlled	  cell-­‐cell	  interactions	   	   	   	   	   	  	  	  19	  
Figure	  1.12	  Cell	  capture	  strategies	  from	  co-­‐culture	  of	  cells	   	   	   	   	  	  	  21	  
Figure	  1.13	  Light	  controlled	  cell-­‐material	  interactions	   	   	   	   	  	  	  23	  
Figure	  1.14	  Chimeric	  photoreceptors	  as	  optogenetic	  tools	   	   	   	   	  	  	  27	  
Figure	  2.1	  Schematic	  representation	  of	  blue	  light	  induced	  cell-­‐cell	  contacts	   	  	  	  35	  
Figure	  2.2	  Generation	  of	  MDA-­‐CRY2	  and	  MDA-­‐CIBN	  stable	  cell	  lines	   	   	  	  	  36	  
Figure	  2.3	  Immunostaining	  for	  c-­‐myc	  epitope	  to	  show	  the	  expression	  of	  CRY2	  and	  	  	  	  	  	  	  	  	  
	   	  	  	  	  	  	  	  CIBN	  on	  the	  cell	  surface	   	   	   	   	   	   	   	  	  	  38	  
Figure	  2.4	  Blue	  light	  induced	  cell-­‐cell	  interactions	   	   	   	  	  	   	  	   	  	  	  40	  
Figure	  2.5	  Cell	  number	  optimization	  for	  blue	  light	   	   	   	   	   	  	  	  41	  
Figure	  2.6	  Cell	  viability	  under	  blue	  light	  illumination	  	   	   	   	   	  	  	  42	  
Figure	  2.7	  Quantification	  of	  cell-­‐cell	  interactions	  between	  MDA-­‐CRY2-­‐mCherry	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  and	  MDA-­‐CIBN-­‐GFP	  cells	  in	  dark	  and	  under	  blue	  light	   	   	  	  	  	   	  	  	  44	  
Figure	  2.8	  Reversible	  control	  of	  cell-­‐cell	  interactions	   	   	   	   	  	  	  46	  
Figure	  2.9	  Layer-­‐by-­‐layer	  tissue	  formation	  under	  blue	  light	  illumination	   	   	  	  	  49	  
Figure	  2.10 Schematic	  representation	  of	  orthogonal	  and	  reversible	  control	  of	  	  
	   	  	  	  	  	  	  	  cell-­‐material	  interactions	  	   	   	   	   	   	   	  	  	  51	  
Figure	  2.11	  Characterization	  of	  stable	  cell	  lines	  and	  purified	  proteins	   	   	  	  	  52	  
Figure	  2.12	  Frequency	  vs	  time	  plots	  from	  QCM-­‐D	  measurements	  to	  show	  protein	  	  
	  xi	  
	   	  	  	  	  	  	  	  immobilization	  through	  His6-­‐Ni2+-­‐NTA	  coordination	  	   	   	   	  	  	  53	  
Figure	  2.13	  Quantification	  of	  light	  controlled	  cell-­‐material	  interactions	  	   	   	  	  	  55	  
Figure	  2.14	  Spreading	  area	  of	  CRY2	  and	  PhyB	  expressing	  cells	  	   	   	   	  	  	  56	  
Figure	  2.15	  Confocal	  images	  for	  comparison	  of	  morphology	  of	  CRY2	  and	  PhyB	  	  
	   	  	  	  	  	  	  	  expressing	  cells	  on	  protein	  and	  glass	  substrates	  	   	   	   	  	  	  57	  
Figure	  2.16	  Adhesion	  and	  reversion	  kinetics	   	   	   	   	   	   	  	  	  59	  
Figure	  2.17 Orthogonal	  blue	  and	  red	  light	  switchable	  cell	  adhesions	  	  	   	   	  	  	  61	  
	  
	  
List	  of	  tables	  
	  
Table	  4.1	  List	  of	  gene	  specific	  primers	  	   	   	   	   	   	   	  	  	  72	  
Table	  4.2	  Restriction	  enzymes	  and	  digestion	  conditions	  	   	   	   	   	  	  	  73	  
	  
	  




	   Acknowledgements	  	   	   	   	   	   	   	   	   	  	  	  	  	  	  i	  
	   Abstract	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	   	   	   	   	   	   	   	  	  	  	  	  ii	  
	   Zusammenfassung	  	  	   	   	   	   	   	   	   	   	  	  	  	  iv	  
	   List	  of	  abbreviations	  	  	  	  	  	  	  	  	  	  	  	   	   	   	   	   	   	   	  	  	  	  vi	  
	   List	  of	  figures	   	   	   	   	   	   	   	   	   	  	  	  	  	  x	  	  	  	  	  	  




1.1	  Cell	  –	  cell	  interactions	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  	  
1.2	  Cell	  –	  extracellular	  matrix	  (ECM)	  interactions	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	  	  
1.3	  Tissue	  engineering	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	  
	   	  	  	  	  	  	  	  1.3.1	  	  	  	  Top-­‐down	  tissue	  engineering	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	  
	   	  	  	  	  	  	  	  1.3.2	  	  	  	  Bottom-­‐up	  tissue	  engineering	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  12	  
1.4	  Controlling	  cell	  interactions	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  15	  
	  	  	  	  	  	  	  1.4.1	  	  	  	  Controlling	  cell-­‐cell	  interactions	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  15	  
	   	  	  	  	  	  	  	  1.4.1.1	  Light	  controlled	  cell-­‐cell	  interactions	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  18	  
	  	  	  	  	  	  	  1.4.2	  	  	  	  Independently	  controlling	  multiple	  cell-­‐material	  interactions	  	  	  	  	  	  	  20	  
	   	  	  	  	  	  	  	  1.4.2.1	  Light	  controlled	  cell-­‐material	  interactions	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  22	  
1.5	  Non-­‐neuronal	  optogenetics	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  25	  
	  	  	  	  	  	  	  1.5.1	  	  	  	  Cryptochromes	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  28	  
	  	  	  	  	  	  	  1.5.2	  	  	  	  Phytochromes	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  31	  
2. Results	  and	  Discussion	  
2.1 Blue	  light	  induced	  reversible	  cell-­‐cell	  interactions	   	   	   	  	  	  35	  
2.1.1 Generation	  and	  characterization	  of	  stable	  cell	  lines	   	   	  	  	  36	  
2.1.2 Blue	  light	  induced	  heterophilic	  cell-­‐cell	  interactions	   	   	  	  	  39	  
2.1.3 Reversible	  control	  of	  blue	  light	  dependent	  cell-­‐cell	  interactions	  	  	  45	  
2.1.4 Layer-­‐by-­‐layer	  tissue	  formation	  by	  blue	  light	  illumination	   	  	  	  48	  
2.2 Blue	  and	  red	  light	  controlled	  cell-­‐substrate	  interactions	   	   	  	  	  50	  
2.2.1 Cell	  lines,	  protein	  purification	  and	  characterization	   	   	  	  	  51	  
2.2.2 Blue	  and	  red	  light	  induced	  cell	  adhesion	   	   	   	   	  	  	  54	  
	  xiii	  
2.2.3 Cell	  spreading	  by	  photoswitchable	  interactions	   	   	   	  	  	  55	  
2.2.4 Adhesion	  and	  reversion	  kinetics	   	   	   	   	   	  	  	  58	  
2.2.5 Orthogonal	  switching	  of	  cell	  adhesion	   	   	   	   	  	  	  59	  
3. Summary	  and	  Outlook	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  62	  
4. Materials	  &	  Methods	  	  	  	  	  	  	  	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  65	  
4.1 Equipment	  list	  	  	  	   	   	   	   	  	  	  	  	  	  	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  65	  
4.2 Cloning	  	   	   	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  70	  
4.2.1 Vector	  design	  	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  70	  
4.2.2 Polymerase	  chain	  reaction	  (PCR)	   	   	   	   	   	  	  	  71	  
4.2.3 Restriction	  enzyme	  digestion	  and	  ligation	  	  	  	  	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  73	  
4.2.4 Transformation	  into	  E.	  coli	  by	  electroporation	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  74	  
4.3 Cell	  culture	   	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  74	  
4.3.1 Culturing	  medium	  	   	   	   	   	   	   	  	  	  74	  
4.3.2 Generation	  of	  stable	  cell	  lines	   	   	   	   	   	  	  	  74	  
4.3.3 Fixation,	  actin	  and	  nuclear	  staining	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  75	  
4.3.4 Immunostaining	   	   	   	   	   	   	   	  	  	  75	  
4.4 Isolation	  of	  phycocyanobilin	  (PCB)	   	   	   	   	   	  	  	  76	  
4.5 Protein	  purification	  and	  characterization	   	   	   	   	  	  	  77	  
4.5.1 Protein	  expression	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  77	  
4.5.2 Affinity	  chromatography	   	   	   	   	   	  	  	   	  	  	  77	  
4.5.3 Size	  exclusion	  chromatography	   	   	   	   	   	  	  	  78	  
4.5.4 SDS-­‐PAGE	   	   	   	   	   	   	   	   	  	  	  78	  
4.6 Surface	  functionalization	  and	  protein	  immobilization	   	   	   	  	  	  79	  
4.7 Quartz	  crystal	  microbalance	  with	  dissipation	  monitoring	  (QCM-­‐D)	  	  	  	  	  	  	  	  	  	  	  79	  
4.8 Blue	  light	  induced	  cell-­‐cell	  contacts	   	   	   	   	   	  	  	  80	  
4.8.1 Cell-­‐cell	  contact	  formation	  and	  quantification	   	   	   	  	  	  80	  
4.8.2 Reversible	  cell-­‐cell	  contacts	   	   	   	   	   	  	  	  81	  
4.8.3 Layer-­‐by-­‐	  layer	  tissue	  formation	   	   	   	   	   	  	  	  81	  
4.9 	  Blue	  and	  red	  light	  induced	  cell-­‐material	  interactions	   	   	   	  	  	  81	  
4.9.1 Blue	  and	  red	  light	  induced	  cell	  adhesion	   	   	   	   	  	  	  81	  
4.9.2 Cell	  spreading	  by	  photoswitchable	  interactions	   	   	   	  	  	  82	  
4.9.3 Adhesion	  and	  reversion	  kinetics	   	   	   	   	   	  	  	  82	  
	  xiv	  
4.9.4 Orthogonal	  switching	  of	  cell	  adhesion	   	   	   	   	  	  	  83	  
4.10	  Cell	  viability	  assay	  	   	   	   	   	   	   	   	  	  	  83	  
4.11	  Confocal	  imaging	  	   	   	   	   	   	   	  	  	   	  	  	  83	  
5. Bibliography	   	   	   	   	   	   	   	  	  	  	  	   	  	  	  85	  
6. Appendix	   	   	   	   	   	   	   	   	   	  	  	  94	  
6.1 DNA	  and	  aminoacid	  sequences	  of	  cloned	  constructs	   	   	   	  	  	  94	  
6.1.1 pDisplay-­‐CRY2-­‐mCherry	   	   	   	   	   	   	  	  	  94	  
6.1.2 pDisplay-­‐CIBN-­‐GFP	   	   	   	   	   	   	  	  	  96	  
6.1.3 pDisplay-­‐PhyB-­‐YFP	   	   	   	   	   	   	  	  	  98	  
6.1.4 pDisplay-­‐PIF6-­‐CFP	  	   	   	   	   	   	   	  101	  
6.1.5 pET21b-­‐CIBN-­‐GFP	  	   	   	   	   	   	   	  102	  
6.1.6 pET21b-­‐PIF6-­‐CFP	   	   	   	   	   	   	  	   	  103	  
























1.	  Introduction	  	  
1.1	  Cell-­‐cell	  interactions	  
	  
Cadherins,	  a	  class	  of	  transmembrane	  glycoproteins,	  are	  calcium	  (Ca2+)	  dependent	  cell	  
adhesion	  molecules	  (CAMs)	  and	  they	  are	  the	  main	  mediators	  of	  cell-­‐cell	  adhesions.1-­‐3	  
The	   classical	   cadherins	   (E-­‐,	   N-­‐,	   P-­‐cadherins)	   consist	   of	   an	   N-­‐terminal	   extracellular	  
domain	   with	   five	   tandem	   repeats,	   a	   single-­‐pass	   transmembrane	   domain	   and	   a	   C-­‐
terminal	   cytoplasmic	   domain	   (Figure	   1.1).4	   The	   extracellular	   domain	   of	   cadherins	  
contains	  Ca2+-­‐	  binding	  pockets	  and	  the	  first	  N-­‐terminal	  EC	  domain	  (EC1)	  is	  responsible	  
for	  trans-­‐	  interaction	  of	  cadherins	  of	  two	  neighboring	  cells.2,4	  The	  cytosolic	  domain	  is	  
widely	   conserved	   in	   classical	   cadherins	   and	   interacts	  with	   cytosolic	   proteins,	   called	  
catenins.	   The	   cadherin-­‐catenin	   interaction	   is	   crucial	   for	   cadherins	   to	   interact	   with	  
other	   cadherins	   on	   the	   neighboring	   cells	   and	   to	   stabilize	   these	   cadherin-­‐cadherin	  
interactions.4	   There	   are	   three	   major	   cytoplasmic	   binding	   partners	   of	   classical	  
cadherins:	  α-­‐catenin,	  β-­‐catenin	  or	  γ-­‐catenin	  and	  plakoglobin/p120.2	  β-­‐catenin	  (and	  in	  
some	  cases	  also	  γ-­‐catenin)	  directly	  interacts	  with	  the	  cytoplasmic	  domain	  of	  classical	  
cadherins,	  and	  then	  α-­‐catenin	  binds	  to	  β-­‐catenin.	  α-­‐catenin	  has	  actin	  binding	  activity;	  
hence,	   it	   links	   the	   cadherin/β-­‐catenin	   complex	   to	   the	   actin	   cytoskeleton	   (Figure	  
1.1).2-­‐4	  	  
	  
Figure	  1.1	  Schematic	  representation	  of	  homophilic	  cadherin	  interaction.	  Classical	  cadherins	  mediate	  
calcium-­‐dependent	   intercellular	   adhesion.	   They	   consist	   of	   an	   extracellular	   (EC)	   domain	   with	   five	  
tandem	  repeats,	  a	  transmembrane	  (TM)	  domain	  and	  a	  cytoplasmic	  domain	  (in	  red).	  The	  cytoplasmic	  
domain	   interacts	  with	  p120-­‐catenin	  and	  β-­‐catenin.	  β-­‐catenin	  binds	   to	  α-­‐catenin,	  which	  establishes	  a	  
direct	  link	  between	  the	  cadherin-­‐catenin	  complex	  and	  the	  actin	  cytoskeleton.	  PM:	  plasma	  membrane.	  
Adapted	  from	  Gall	  et	  al.5	  
	  2	  
Cadherin	  mediated	  cell-­‐cell	  adhesion	  is	  crucial	  in	  embryonic	  development	  and	  tissue	  
organization.4	  Different	  cell	  types	  in	  a	  tissue	  express	  different	  cadherins	  and	  cadherin	  
subtype-­‐specific	   binding	   leads	   to	   formation	   and	   segregation	   of	   tissues	   during	  
embryogenesis.6	   The	   spreading	   of	   the	   embryonic	   layers	   over	   each	   other	   and	   cell	  
sorting	   was	   shown	   to	   be	   dependent	   on	   homophilic	   or	   heterophilic	   cadherin	  
interactions	   and	   formulated	   for	   the	   first	   time	  by	  Malcolm	  Steinberg	   in	   1963	   in	   the	  
Differential	   Adhesion	   Hypothesis	   (DAH).6-­‐8	   The	   DAH	   states	   that	   in	   a	   population	   of	  
different	   types	   of	   cells,	   the	   final	   configuration	  will	   favor	  minimal	   interfacial	   energy	  
and	  maximum	  cell-­‐cell	  binding	  strength.6,7	  Cell-­‐cell	  interactions	  rearrange	  due	  to	  the	  
repeated	   exchange	  of	   the	  weaker	   cohesive	   interactions	   for	   the	   stronger	   ones.	   This	  
cell	  sorting	  behavior	  was	  shown	  experimentally	  by	  Duguay	  et	  al.	  with	  L-­‐cells	  in	  3D	  cell	  
culture	  model	   (Figure	   1.2).6	   In	   that	  study,	   two	  populations	  of	  L-­‐cells	  expressing	   the	  
same	  amount	  of	  N-­‐cadherin	  were	  mixed	  in	  equal	  proportions,	  the	  final	  configuration	  
was	   a	   homogeneous	   mixture	   of	   these	   cells	   (Figure	   1.2A).	   When	   the	   N-­‐cadherin	  
expression	  was	  reduced	  to	  half	  in	  one	  of	  the	  sub-­‐population,	  segregation	  took	  place;	  
i.e,	  more	   adhesive	   cells	   (cells	  with	   high	  N-­‐cadherin	   expression)	  were	   enveloped	  by	  
the	   less	   adhesive	   cells	   (cells	  with	   low	  N-­‐cadherin	   expression)	   (Figure	   1.2B).	   Finally,	  
they	  showed	  that	  in	  a	  mixture	  of	  B-­‐	  and	  R-­‐cadherin	  expressing	  cells,	  two	  segregated	  




Figure	  1.2	  Cell	  sorting	  following	  DAH.	  Duguay	  et	  al.6	  showed	  cell	  sorting	  under	  equilibrium	  conditions	  
of	  mixtures	  of	   red	  and	  green	   labeled	  cells	  having	  different	  number	  and	  kind	  of	  cadherins.	  Scale	  bar:	  
100	  μm.	  A)	  Red	  and	  green	  cells	  express	  the	  same	  amount	  of	  N-­‐cadherin;	  thus,	  they	  stay	  intermixed.	  B)	  
Red	  cells	  express	  50%	  more	  N-­‐cadherin,	  which	   led	  to	  stronger	   interaction	  between	  them.	  Thus,	  they	  
locate	   to	   the	   center	   of	   the	   assembly	   and	   are	   enveloped	  by	   green	   cells	  with	  weaker	   interactions.	  C)	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Green	   cells	   express	   B-­‐cadherin	   and	   red	   cells	   express	   R-­‐cadherin.	   Since	   there	   is	   a	   weak	   interaction	  
between	  these	  cadherins,	  the	  two	  cell	  types	  form	  two	  segregated	  assemblies.	  
	  
The	   simplicity	   of	   DAH	   has	   provided	   a	   basis	   for	   bottom-­‐up	   tissue	   engineering	   (See	  
Section	   1.3).	   After	   Steinberg’s	   DAH,	   the	   Differential	   Interfacial	   Tension	   Hypothesis	  
(DITH)	  was	  proposed,	  which	  can	  be	  regarded	  as	  both	  antagonist	  and	  complementary	  
to	  DAH.9-­‐11	  The	  DITH	  states	   that	  a	  cell’s	  mechanical	  energy	  and	  the	  cortical	   tension	  
contribute	   to	   the	  cell	   sorting,	  cell	   shape	  and	  migration	  during	  development.9,12	  The	  
biophysics	  of	  cell	   sorting	  during	  development	   is	   still	  not	   fully	  understood	  and	  there	  
are	  several	  experimental	  studies	  in	  order	  to	  understand	  the	  cohesive	  and	  mechanical	  
forces	   driving	   this	   process.12-­‐14	   For	   instance,	   Moore	   et	   al.	   used	   N-­‐	   and	   E-­‐cadherin	  
knockout	  and	  wild	  type	  embryoid	  bodies	   from	  murine	  stem	  cells	   to	  understand	  the	  
mechanism	   of	   cell	   sorting.13	   They	   showed	   that	   in	   undifferentiated	   state,	   the	   cells	  
followed	   DAH	   when	   different	   cell	   types	   were	   mixed	   (for	   example,	   E-­‐cadherin	  
knockout	   and	   wild	   type	   cells).	   However,	   differentiated	   cells	   were	   sorted	   to	   the	  
surface	   forming	   an	   enveloping	   layer	   (endoderm)	   independent	   of	   their	   adhesive	  
strength;	   hence,	   they	   no	   longer	   followed	   DAH.13	   The	   reason	   for	   this	   is	   the	   apical	  
polarity	  of	  these	  cells	  after	  differentiation	  was	  the	  determining	  factor	  in	  sorting	  and	  
positioning.13	  
	  
Since	  cadherins	  are	  linked	  to	  the	  actomyosin	  network	  inside	  the	  cell,	  it	  contributes	  to	  
the	   formation	  and	  dissipation	  of	   the	   interfacial	  or	   cortical	   tension.14-­‐16	  Borghi	  et	  al.	  
has	   visualized	   the	   pulling	   forces	   of	   cells	   by	   using	   a	   cadherin-­‐FRET	   sensor.17	   A	   later	  
study	  from	  Ng	  et	  al.	  showed	  the	  measurement	  of	  cell-­‐cell	  forces	  at	  the	  individual	  cell-­‐
cell	   junctions	  at	  a	  multicellular	  scale.18	  Both	  studies	  suggest	  that	  cadherins	  function	  
as	  adhesion-­‐dependent	  mechanosensors	  to	  respond	  both	  to	  extracellular	  mechanical	  
stress	  and	  to	  the	  intracellular	  changes	  by	  corresponding	  signaling	  cascades,	  which	  are	  
mediated	  by	  p120	  catenin.17-­‐19	  
	  
p120	  catenin	  is	  also	  an	  important	  mediator	  of	  β-­‐catenin	  trafficking	  inside	  the	  cell.	  The	  
phosphorylation	   of	   p120	   catenin	   leads	   to	   dissociation	   of	   cadherin-­‐	   α-­‐,β-­‐	   and	   p120	  
catenin	  complex	  and	  loss	  of	  cell-­‐cell	  contacts.20	  As	  a	  result,	  β-­‐catenin	  is	  released	  and	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its	   cytosolic	   concentration	   increases.	   This	   cytosolic	  β-­‐catenin	  has	   than	   two	  possible	  
fates.	   It	   can	   be	   degraded	   by	   26S	   proteasome	   consisting	   of	   the	   serine/threonine	  
kinases	  casein	  kinase	  I	  (CKI),	  glycogen	  synthase	  3β	  (GSK-­‐3β),	  a	  scaffolding	  complex	  of	  
protein	  axin	  and	  adenomatous	  polyposis	  coli	  (APC)	  protein	  (Figure	  1.3A).20	  When	  it	  is	  
not	   degraded	   due	   to	   the	   presence	   of	   growth	   factors	   or	   the	   activation	   of	   the	  Wnt	  
pathway,	  which	  inhibits	  GSK-­‐3β	  activity,	  β-­‐catenin	  is	  translocated	  into	  the	  nucleus	  to	  
act	  as	  a	  transcription	  cofactor	  of	  T	  cell	  factor/lymphoid	  enhancer	  factor	  (TCF/LEF).20,21	  
This	  induces	  the	  expression	  of	  Wnt	  target	  genes,	  which	  in	  turn	  induce	  cell	  migration	  
(Figure	  1.3B).	  
	  
Figure	  1.3	  β-­‐catenin/Wnt	  signaling	  pathway.	  A)	  In	  the	  absence	  of	  the	  Wnt	  ligand,	  cytosolic	  β-­‐catenin	  
is	   degraded	   by	   the	   proteasome	   complex;	   hence,	   the	   Wnt	   target	   genes	   are	   repressed.	   B)	   In	   the	  
presence	   of	   the	   Wnt	   ligand,	   it	   binds	   to	   two	   receptors,	   frizzled	   proteins	   and	   lipoprotein	   receptor-­‐
related	  proteins	  5	  and	  6	  (LRP5/6).	  This	  activates	  another	  protein,	  disheveled	  (Dsh),	  which	  uncouples	  β-­‐
catenin	  from	  the	  proteasome	  complex.	  Then,	  β-­‐catenin	  is	  translocated	  into	  the	  nucleus	  to	  activate	  the	  
Wnt	  target	  genes.	  Adapted	  from	  Moon	  et.	  al.22	  
	  
β-­‐catenin/Wnt	  signaling	  is	  one	  of	  the	  pathways	  required	  for	  tissue	  segregation	  during	  
development	  since	  the	  final	  products	  of	  Wnt	  pathway	  induces	  cell	  migration.	  For	  this	  
to	   occur,	   cells	   disassemble	   adherens	   junctions	   and	   change	   their	   morphology	   in	   a	  
process	   called	   epithelial-­‐to-­‐mesenchymal	   transition	   (EMT).21	   During	   EMT,	   cells	   lose	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their	  epithelial	  phenotype,	  dissemble	  cell-­‐cell	  contacts,	  reorganize	  their	  cytoskeleton	  
and	  gain	  motility.19	  During	   the	  course	  of	  development,	  after	   the	  cells	  have	  reached	  
their	  final	  differentiated	  state,	  they	  switch	  back	  to	  their	  epithelial	  phenotype	  through	  
mesenchymal-­‐to-­‐epithelial	   transition	   (MET)	   in	   order	   to	   support	   the	   tissues	   (Figure	  
1.4).23	  Other	  triggers	  of	  EMT	  include	  hypoxia,	  growth	  factors	  (eg.	  TGF-­‐β,	  EGF,	  PDGF)	  
or	   other	   initiating	   signals	   (eg.	  Wnt,	   Notch).	   Several	   transcription	   factors	   (eg.	   Snail,	  
Zeb1/2,	   Twist),	   epigenetic	   regulators	   and	   non-­‐coding	   mRNAs	   (miR200,	   miR34)	  
mediate	   EMT-­‐MET	   by	   repressing	   or	   activating	   expression	   of	   epithelial	   or	  
mesenchymal	  markers.24	  
	  
Figure	  1.4	  Epithelial	  to	  mesenchymal	  and	  mesenchymal	  to	  epithelial	  transitions	  (EMT-­‐MET).	  EMT	  can	  
be	   triggered	   by	   multiple	   mechanisms	   such	   as	   hypoxia,	   growth	   factors	   or	   initiating	   signals.	   Several	  
intracellular	   signaling	   molecules	   that	   include	   transcription	   factors,	   epigenetic	   regulators	   and	   non-­‐
coding	   RNAs	   orchestrate	   the	   progress	   of	   EMT	   and	  MET.	   This	   progress	   involves	   many	   intermediary	  
steps	   and	   through	   this	   EMT-­‐MET	   spectrum	   where	   some	   cells	   may	   express	   both	   epithelial	   (E)	   and	  
mesenchymal	  (M)	  markers.	  	  Adapted	  from	  Li	  et.	  al.24	  
	  
EMT	   is	   not	   a	   binary	   process	   and	   includes	   several	   intermediary	   steps,	   where	   both	  
epithelial	   and	   mesenchymal	   markers	   can	   be	   expressed	   simultaneously.24	   This	  
plasticity	   in	   formation	  and	  dissociation	  of	   cell-­‐cell	   contacts	   shows	   the	  dynamic	   and	  
reversible	   nature	   of	   these	   contacts	   and	   involves	   complex	   signaling	   mechanisms,	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which	  have	  to	  be	  regulated	  in	  space	  and	  time.	  In	  cases	  of	  aberrant	  regulation	  cancer	  
develops	  and	  metastasis	  takes	  place.19	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1.2	  Cell-­‐Extracellular	  Matrix	  (ECM)	  interactions	  
	  
The	   interaction	   between	   cells	   and	   their	   extracellular	   matrix	   is	   also	   crucial	   for	   cell	  
survival	  and	  tissue	  integrity.	   	  Cells	  attach	  to	  the	  basement	  membranes,	  which	  cover	  
all	   epithelia,	   surfaces	  of	  muscle	   fibers	  and	  nerves.3	   There	  are	   two	  distinct	   layers	  of	  
basements:	   the	   reticular	   lamina	   and	   the	   basal	   lamina.	   The	   reticular	   lamina	   is	  
generated	   by	   fibroblasts	   that	   are	   present	   in	   the	   underlying	   connective	   tissue.	   The	  
basal	   lamina	   is	   adjacent	   to	   the	   cells	   and	   has	   different	   adhesive	   ECM	   glycoproteins	  
such	  as	  collagen	  IV,	  fibronectin,	  vitronectin,	  laminin.3	  	  
	  
A	   family	   of	   cell-­‐surface	   transmembrane	   glycoproteins,	   named	   integrins,	   mediates	  
cell-­‐ECM	   interactions.	   Integrins	   are	   heterodimers,	   which	   consist	   of	   an	   α	   and	   a	   β	  
subunit	   (Figure	   1.5).	   There	   are	   18	   α	   and	   8	   β	   subunits	   in	   vertebrates.25	   Different	  
combinations	  of	  the	  α	  and	  8	  β	  subunits	  can	  form	  24	  different	  integrins	  with	  different	  
binding	  specificity	  to	  ECM	  proteins,	  signaling	  properties	  and	  distributions	  in	  different	  
tissues.25,26	   Integrins	   can	   bind	   to	   large	   ECM	   proteins	   such	   collagen,	   laminin	   and	  
fibronectin	  and	  some	  can	  recognize	  short	  peptide	  sequences	  within	  the	  large	  protein,	  
such	  as	  RGD	  (Arg-­‐Gly-­‐Asp)	  that	  is	  found	  in	  fibronectin	  and	  vitronectin.4	  	  
	  
Both	   integrin	   subunits	   are	   similar	   in	   structure:	   a	   large	   globular	   N-­‐terminal	  
extracellular	   domain,	   a	   single-­‐pass	   transmembrane	   domain	   and	   a	   C-­‐terminal	  
cytoplasmic	   domain	   (Figure	   1.5).27	   The	   ectodomain	   of	   the	   α	   subunit	   consists	   of	   a	  
seven-­‐bladed	   β-­‐propeller,	   a	   thigh	   and	   two	   calf	   domains.	   The	   lower	   side	   of	   the	   β-­‐
propeller	   contains	   Ca2+	   binding	   pockets.	   The	   thigh	   and	   calf	   domains	   are	   similar	   in	  
structure	   and	   they	   contain	   linkers	   for	   flexibility	   of	   the	   α	   subunits,	   which	   are	   also	  
found	  in	  β	  subunits	  at	  similar	  position	  so	  that	  they	  can	  form	  a	  bent	  structure	  in	  the	  
inactive	  state	  (Figure	  1.5,	   left).25	  The	  ectodomain	  of	  β	  subunit	  has	  also	  a	  β-­‐I	  domain	  
that	   is	   located	   in	   the	   hybrid	   domain.	   The	   hybrid	   domain	   is	   inserted	   in	   the	   plexin-­‐
semaphorin-­‐integrin	   (PSI)	  domain.	  Four	  cysteine-­‐rich	  epidermal	  growth	   factor	   (EGF)	  
modules	  link	  to	  the	  PSI	  and	  the	  hybrid	  domains.	  	  EGF	  modules	  are	  followed	  by	  β-­‐tail	  
domain	   at	   the	   juxtamembrane.25	   The	   N-­‐terminal	   domains	   of	   α	   and	   β	   subunits	   (β-­‐
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propeller	   and	  β-­‐I,	   respectively)	   assemble	   non-­‐covalently	   to	   form	   the	   ligand-­‐binding	  
site	  of	  the	  integrins	  (Figure	  1.5,	  right).28,29	  
	  
Figure	   1.5	   Integrin	   structure.	   Integrins	   are	   heterodimers	   composed	   of	   an	   α	   and	   a	   β	   subunit.	   Each	  
subunit	  has	  an	  extracellular,	  a	   transmembrane	  and	  a	  cytosolic	  domain.	  β–propeller	  and	  β-­‐I	  domains	  
form	   the	   ligand-­‐binding	   site	   of	   the	   integrins	   (right).	   The	   transmembrane	   domains	   of	   the	   α	   and	   β	  
subunits	  are	   found	   to	  be	  associated	   in	   the	   resting	  or	   inactive	   state	   (left).	  Adapted	   from	  Campbell	  &	  
Humphries.25	   	  
	  
The	  cytosolic	  domain	  of	  integrins	  is	  associated	  with	  adaptor	  proteins,	  which	  connect	  
integrins	   to	   the	   actin	   cytoskeleton	   forming	   focal	   adhesions	   (Figure	   1.6).4	   The	  
activation	   of	   integrin	   takes	   place	   when	   talin,	   an	   adaptor	   protein,	   binds	   to	   the	  
cytosolic	  tail	  of	  the	  β	  subunit	  and	  induces	  the	  separation	  of	  the	  cytosolic	  domains	  of	  
both	  of	  the	  subunits.30	  Then,	  other	  integrin-­‐associated	  proteins	  (FAK,	  Src,	  paxillin,	  ILK-­‐
Parvin	  complex)	  are	  recruited	  to	  the	  integrin-­‐rich	  adhesion	  sites	  and	  this	  recruitment	  
initiates	   the	   downstream	   signal	   transduction.30	   Phosphorylation	   of	   focal	   adhesion	  
kinase	   (FAK)	  activates	  Src	   family	  kinases	  and	  activated	  FAK/Src	  complex	  can	   further	  
phosphorylate	   other	   proteins	   such	   as	   paxillin	   at	   the	   adhesion	   site,	  which	   results	   in	  
the	   activation	   of	   downstream	   signaling	   pathways	   (e.g	   mitogen	   activated	   protein	  
(MAP)	  kinase	  pathway).30	  Integrin-­‐linked	  kinase	  (ILK)	  and	  its	  binding	  partner,	  parvin,	  
also	   form	   a	   bridge	   between	   the	   integrins	   and	   actin	   cytoskeleton.	   This	   complex	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activates	  the	  downstream	  Akt/PKB	  (protein	  kinase	  B)	  pathway,	  which	  promotes	  cell	  
survival	  and	  growth.30	  
	  
Figure	   1.6	   Integrin	   signaling.	   The	   initial	   contact	   between	   integrins	   and	   the	   actin	   cytoskeleton	   is	  
formed	  by	  talin.	  Then	  other	  adaptor	  proteins	  are	  recruited	  to	  the	  integrin-­‐rich	  adhesion	  sites.	  Vinculin	  
crosslinks	   talin	  with	  actin	   to	  strengthen	   focal	  adhesions.	  This	  crosslinking	   is	   further	  stabilized	  by	  α	  –
actinin,	  which	  interacts	  with	  integrin	  β-­‐tails,	  vinculin,	  talin	  and	  actin.	  Phosphorylation	  of	  focal	  adhesion	  
kinase	  (FAK)	  is	  a	  key	  event	  initiating	  Src	  family	  tyrosine	  kinase	  dependent	  signaling	  cascade.	  Integrin-­‐
linked	  kinase	  (ILK)	  can	  link	  to	  actin	  through	  its	  binding	  partner,	  parvin.	  Adapted	  from	  Millard	  et.	  al.31	  
	  
Another	   important	   feature	   related	   to	   integrins	   is	   that	   they	   can	   change	   their	  
confirmation	  depending	  on	  the	  presence	  of	  extracellular	  or	  intracellular	  signals.	  This	  
implicates	   the	   bidirectional-­‐signaling	   feature	   of	   the	   integrins	   (Figure	   1.7);	   i.e.,	   the	  
ECM	   binding	   activity	   is	   regulated	   from	   the	   inside	   of	   the	   cell	   (inside-­‐out	   signaling)	  
while,	   receiving	   and	   transmitting	   the	   signals	   upon	   ECM	   binding	   occurs	   through	  
outside-­‐in	  signaling.26,28	  The	  bidirectional	  signaling	  of	  integrins	  is	  important	  to	  control	  
cell	  polarity,	  cytoskeletal	  structure,	  gene	  expression,	  cell	  survival	  and	  proliferation.29	  
The	  variety	  of	  integrin	  subtypes	  provides	  versatility	  in	  cell	  adhesion.	  Their	  specificity	  
for	  different	  kinds	  of	  ECM	  components	  and	  their	  dynamic	  nature	  is	  crucial	  for	  cells	  to	  
attach	   at	   the	   right	   time	   and	   place.28	   A	   complex	   intracellular	   signaling	   mechanism	  
underlies	  the	  specificity	  and	  dynamicity	  of	  integrin-­‐ECM	  interactions,	  which	  indicates	  




Figure	   1.7	   Bi-­‐directional	   integrin	   signaling.	   Two	   directions	   of	   integrin	   signaling:	   inside-­‐out	   and	  
outside-­‐in.	  	  During	  inside-­‐out	  signaling,	  talin	  activates	  the	  integrins	  and	  triggers	  their	  binding	  to	  ECM.	  
This	  allows	  cells	  to	  form	  strong	  cell-­‐ECM	  contacts	  that	  are	  needed	  for	  cell	  migration.	  During	  outside-­‐in	  
signaling,	   ligand	   binding	   to	   integrins	   triggers	   conformational	   change	   leading	   to	   activation	   of	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1.3	  Tissue	  engineering	  
	  
Tissue	   engineering	   is	   an	   interdisciplinary	   field	   that	   combines	   the	   principles	   of	  
molecular	  biology,	  material	  science,	  biomechanics	  and	  medicine	  in	  order	  to	  produce	  
functional	  tissues	  de	  novo	  so	  that	  the	  defective	  or	  diseased	  tissues	  can	  be	  repaired	  or	  
replaced.32,33	   There	   are	   two	  main	   approaches	   in	   tissue	   engineering:	   top-­‐down	   and	  
bottom-­‐up	  approaches	  (Figure	  1.8).	  
	  
1.3.1	  Top-­‐down	  tissue	  engineering	  
Traditional	  tissue	  engineering	  approach	  (also	  called	  as	  top-­‐down	  approach)	  relies	  on	  
biodegradable	  polymeric	  scaffold	  within	  which	  cells	  populate	  and	  produce	  their	  own	  
extracellular	   matrix	   (Figure	   1.8A).34	   These	   cells	   are	   then	   cultured	   in	   a	   bioreactor,	  
which	   provides	   microenvironmental	   control	   and	   required	   molecular	   and	   physical	  
regulatory	  signals,	  such	  as	  growth	  factors	  or	  mechanical	  stimulation.33,34	  
	  
Figure	  1.8	  Top-­‐down	  vs	  bottom-­‐up	   tissue	  engineering.	  A)	  Top-­‐down	  approach	   in	  tissue	  engineering	  
combines	  cells	  and	  biodegradable	  scaffolds.	  The	  cells	  are	  cultured	  in	  a	  bioreactor	  until	  the	  cells	  fill	  the	  
support	  structure	  and	  reach	  a	  desired	  developmental	  stage.	  B)	   In	  bottom-­‐up	  tissue	  engineering,	  cells	  
are	  used	  as	  building	  blocks	  to	  form	  individual	  subunits,	  which	  are	  then	  assembled	  into	  an	  engineered	  
tissue	  by	  several	  methods	  such	  as	  directed	  assembly,	  stacking,	  etc.	  Adapted	  from	  Lu	  et	  al.35	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Scaffold-­‐based	  tissue	  engineering	  is	  attractive	  since	  scaffolds	  provide	  a	  3-­‐dimensional	  
structure	  for	  the	  developing	  tissue	  and	  allow	  cells	  to	  adhere,	  proliferate,	  differentiate	  
and	  produce	  ECM.32,36	  In	  addition	  to	  mechanical	   integrity,	  which	  is	  especially	  crucial	  
for	  anchorage-­‐dependent	  cells,	  scaffolds	  also	  provide	  precise	  control	  of	  surrounding	  
microenvironment.32	  However,	  scaffold-­‐base	  tissue	  engineering	  has	  some	  drawbacks.	  
The	   scaffold	  material	   should	   be	   biodegradable	   after	   the	   production	  of	   ECM	  by	   the	  
cells,	  which	   in	   itself	  may	   lead	  to	  toxicity	  or	   immunogenic	  responses	   in	  the	  host.32,33	  
Furthermore,	   scaffolds	   may	   interfere	   with	   the	   normal	   organization	   of	   cells	   and	  
obstruct	   mechanotransduction	   by	   stress	   shielding.32,36	   Finally,	   it	   is	   difficult	   to	  
uniformly	  distribute	  high	  numbers	  of	  cells	  or	  introduce	  multiple	  cell	  types	  at	  specific	  
positions.33	  	  
	  
1.3.2	  Bottom-­‐up	  tissue	  engineering	  
Due	   to	   the	   above-­‐mentioned	   limitations	   of	   top-­‐down	   tissue	   engineering,	   many	  
researchers	   have	   taken	   a	   scaffoldless	   approach	   (also	   called	   bottom-­‐up	   tissue	  
engineering)	  in	  which	  there	  is	  no	  requirement	  of	  cell	  seeding	  or	  adherence	  of	  cells	  to	  
an	  exogenous	   scaffolds	   (Figure	   1.8B).32	   There	  are	   several	   advantages	  of	  bottom-­‐up	  
approach	  over	  the	  top-­‐down.	  First,	  in	  the	  scaffoldless	  approach,	  cells	  show	  increased	  
cell	   viability	   since	   they	   are	   not	   exposed	   to	   harsh	   processing	   conditions	   (spinning	  
shear,	   elevated	   temperatures,	   toxic	   polymerizing	   chemicals).32	   There	   is	   high	  
biocompatibility	   due	   to	   the	   absence	   of	   a	   scaffold:	   i.e.,	   there	   is	   not	   any	   toxic	   by-­‐
products	  of	  scaffold	  degradation	  or	  any	  scaffold-­‐dependent	  immunogenicity.	  Finally,	  
the	  scaffoldless	  approach	  allows	  having	  a	  biomimetic	  environment,	  where	  maximum	  
cell-­‐cell	   communication	   is	   achieved	   leading	   to	   an	   increase	   in	   ECM	   production.32	  
Hence,	   after	   implantation	   into	   the	   host,	   mechanotransduction	   and	   other	   signaling	  
event	  can	  directly	  occur	  in	  the	  tissue.32	  
	  
Scaffold-­‐free	  tissue	  engineering	  is	  based	  on	  the	  self-­‐assembly	  and	  self-­‐organization	  of	  
the	  cells	  into	  multicellular	  subunits	  such	  as	  spheroids,	  cell	  sheets	  or	  cylinders	  (Figure	  
1.8B).33	  Self-­‐organization	  in	  tissue	  engineering	  is	  a	  process	  where	  there	  is	  an	  external	  
energy	   or	   force	   put	   into	   the	   system	   in	   order	   to	   produce	   tissues	   having	   different	  
morphology	   and	   structure	   resembling	   the	   native	   tissues.32	   Self-­‐assembly	   process	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requires	  no	  external	  energy	  (Figure	  1.9).32	  The	  spontaneous	  organization	  in	  the	  self-­‐
assembling	  process	  occurs	  as	  a	   result	  of	  minimization	  of	   free	  energy	  by	  maximizing	  
cell-­‐cell	  contacts.32	  	  
Figure	  1.9	   Self-­‐organization	  and	   self-­‐assembling	  processes	   in	  bottom-­‐up	   tissue	  engineering.	  Tissue	  
fusion	   takes	   place	   in	   both	   self-­‐organizing	   and	   self-­‐assembling	   processes.	   Tissue	   fusion	   includes	   cell-­‐
cell,	  cell-­‐to-­‐matrix	  and	  matrix-­‐to-­‐matrix	  contacts.	  Adapted	  from	  Athanasiou	  et	  al.32	  
	  
Self-­‐organization	  can	  be	  achieved	  by	  several	  techniques	  such	  as	  cell-­‐encapsulating	  (or	  
cell-­‐laden)	   hydrogels	   (microgels),	   cell-­‐sheet	   generation	   and	   cell	   printing	   (Figure	  
1.8B).32,35	  Cell-­‐laden	  hydrogels	  are	  used	  to	  create	  robust	  microtissues	  from	  the	  cells,	  
which	   are	   not	   able	   to	   produce	   sufficient	   ECM.	   Commonly	   cells	   are	   embedded	   in	  
photopolymerizable	   polymers	   such	   as	   polyethyleneglycol	   (PEG),	   temperature	  
sensitive	  hydrogels	  or	   self-­‐assembling	  peptide	  gels.34	  Cell-­‐sheet	   technology	   involves	  
the	   generation	   of	   sheets	   of	   cells	   under	   conditions	   that	   stimulate	   ECM	   production.	  
Stacking	   these	   cell-­‐sheets	   layer-­‐by-­‐layer	   leads	   to	   the	   formation	   of	   mechanically	  
robust	   tissues.34	   In	   cell-­‐printing	   technique,	   cells	   are	   deposited	   in	   small	   groups	   to	  
engineer	  tissues	  with	  a	  variety	  of	  properties	  and	  geometries.34	  	  
	  
Generation	   of	   cell	   aggregates	   is	   a	   self-­‐assembly	   process.	   It	   involves	   use	   of	   a	   non-­‐
adherent	  substrate	  so	  that	  the	  cells	  will	  form	  aggregates	  or	  spheroids	  by	  minimizing	  
the	  tissue	  free	  energy	  (Figure	  1.9).32	  This	  is	  achieved	  by	  maximizing	  cell-­‐cell	  contacts,	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a	  phenomena	  which	   is	  explained	  by	  differential	  adhesion	  and	  differential	   interfacial	  
hypotheses.32	  The	  modular	  tissues	  generated	  by	  these	  self-­‐organization	  or	  assembly	  
processes	  can	  be	  further	  combined	  with	  random,	  directed	  and	  magnetic	  assembly	  or	  
by	  stacking	  the	  modular	  tissues	  in	  order	  to	  engineer	  a	  macrotissue.34,35	  
	  
Although	  bottom-­‐up	  approach	  provides	   flexibility	   in	   tissue	  engineering,	   it	   still	   faces	  
challenges	   in	   retaining	   the	   microarchitecture	   and	   cellular	   behavior	   while	   keeping	  
robust	  mechanical	  properties	  for	  clinical	  implantation.34	  Hence,	  studies	  now	  integrate	  
top-­‐down	   and	   bottom-­‐up	   approaches	   to	   create	   materials	   with	   biomimetic	  
mechanical	   properties	   and	   functional	   microvasculature	   for	   nutrient	   and	   oxygen	  
supply.34	   The	   examples	   include	   engineered	   hepatic	   microtissue,	   cardiac	   tissue,	  
capillary	   networks	   and	   blood	   vessels34.	  With	   all	   these	   developments	   in	   the	   field	   of	  
tissue	   engineering,	   it	   is	   now	   possible	   to	   create	   functional	   and	   suitable	   implants	   to	  
repair	   failing	   tissues	  and	  organs	  such	  as	   skin,	   cartilage	  and	  bladder.35	  However,	   the	  
major	  challenge	  in	  tissue	  engineering	  is	  precise	  control	  of	  spatial	  organization	  of	  cells	  
at	  a	  given	  time.34	  It	  is	  also	  significant	  to	  control	  cell-­‐cell	  and	  cell-­‐ECM	  or	  cell-­‐material	  
interactions	   in	   the	  presence	  of	  different	  cell	   types	   since	   the	   response	  of	   cells	  upon	  
these	   interactions	   affect	   their	   behavior	   and	   hence	   function	   within	   a	   tissue.37	   In	  
addition,	   techniques	   to	   engineer	   a	   tissue	   also	   allows	   to	   study	   both	   physiology	   and	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1.4	  Controlling	  cell	  interactions	  
	  
One	   of	   the	   fundamental	   questions	   in	   cell	   and	   developmental	   biology	   is	   how	   the	  
composition	  or	  the	  physical	  organization	  of	  cells	  as	  building	  blocks	  of	  the	  body	  affects	  
the	  function	  of	  tissues	  and	  organs.38	  Although	  controlling	  relative	  spatial	  positions	  of	  
cells	   is	   challenging,	   bottom-­‐up	   tissue	   engineering	   approaches	   provide	   additional	  
means	   of	   controlling	   spatial	   organization	   of	   cells	   starting	   from	   cells	   or	   cell	  
aggregates.38,39	   Engineering	   the	   surfaces	   of	   cells	   such	   that	   these	   cells	   can	   form	  
interactions	  with	  neighboring	   cells	   and	  matrix	   components	   to	  mimic	   cadherins	   and	  
integrins,	  respectively,	  are	  an	  attractive	  way	  to	  control	  cell	  adhesion.37	  
	  
1.4.1	  Controlling	  cell-­‐cell	  interactions	  
There	   are	   two	   approaches	   in	   order	   to	   control	   cell-­‐cell	   interactions:	   biological	   and	  
chemical	  approaches.	  In	  the	  biological	  approach,	  the	  expression	  level	  of	  cadherins	  is	  
manipulated	   by	   genetic	  methods	   such	   as	   knockdown,	   knockout,	   overexpression	   or	  
mutations,	  and	  cell	  behavior	  is	  studied,	  as	  previously	  described	  in	  Section	  1.1	  (Figure	  
1.2).6,40,41	  These	  interactions	  are	  genetically	  encoded,	  hence,	  sustained	  overtime	  and	  
are	  biocompatible;	  however,	   it	   is	  problematic	   to	  alter	   these	   interactions	   locally	  and	  
rapidly	  at	  a	  given	  time.	  
	  
In	  the	  chemical	  approach,	  bio-­‐orthogonal	  functional	  groups	  have	  been	  employed	  to	  
chemically	   modify	   the	   surfaces	   of	   the	   cells.	   One	   example	   is	   the	   introduction	   of	  
oxyamines	   or	   ketone	   groups	   to	   the	   cell	   surface	   by	   liposome	   fusion.42,43	   In	   this	  
approach,	  a	  covalent	  bond	  is	  formed	  when	  oxyamines	  and	  ketone	  groups	  of	  the	  cells	  
react	   resulting	   in	  a	  chemoselective	  and	  stable	   interaction	  between	  the	  cells	   (Figure	  
1.10A).	   In	  another	  study,	  azide	  groups	  are	  inserted	  on	  the	  cell	  surface	  by	  metabolic	  
glycoengineering,	  and	  tetrazine	  or	  trans-­‐cyclooctane	  molecules	  are	  then	  attached	  to	  
these	  azides	  on	  the	  cell	  surface.44	  When	  the	  cells	  are	  mixed	  together,	  they	  are	  glued	  
together	   due	   to	   the	   covalent	   bond	   formation	   between	   tetrazine	   and	   trans-­‐




Figure	  1.10	   Engineering	   cell	   surface	   to	   induce	   cell-­‐cell	   interactions.	  A)	  Cell-­‐cell	   interactions	  by	  click	  
chemistry.43	  B)	  Aggregation	  of	  biotinylated	  cells	   in	   the	  presence	  of	  avidin.	  Adapted	   from	  De	  Bank	  et	  
al.45	   C)	   Cell-­‐cell	   interactions	   by	   DNA	   hybridization.46	   D)	   Cell	   clustering	   induced	   electrostatically	   by	  
modification	   of	   the	   charge	   of	   the	   cell	   surface.47	  E)	   Induction	   of	   cell-­‐cell	   interaction	   by	   special	   lipids	  
combined	  by	  specific	  ligand	  to	  target	  a	  receptor.	  This	  interaction	  can	  be	  reversed	  by	  trimethoprim.48	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Cell	   surfaces	   have	   also	   been	  modified	  with	   non-­‐covalent	   interaction	  partners,	   such	  
biotin-­‐avidin	   or	   biotin-­‐streptavidin.	   De	   Bank	   et	   al.	   functionalized	   the	   cell	   surfaces	  
with	  biotin	  by	  generating	  aldehyde	  groups	  at	  the	  sialic	  acid	  residues	  and	  then	  ligating	  	  
biotin	  hydrazide	  by	   the	   formation	  of	  an	  hydrazone	  bond.45	  They	   showed	   the	  cross-­‐
linking	   of	   biotinylated	   cells	   in	   the	   presence	   of	   avidin	   into	   multicellular	   aggregates	  
(Figure	  1.10B).	  In	  a	  similar	  approach,	  Wang	  et	  al.	  controlled	  induction	  of	  apoptosis	  of	  
biotinylated	   Jurkat	   cells	   by	   inducing	   interactions	   with	   streptavidin-­‐functionalized	  
natural	  killer	  cells.49	  
	  
Another	   strategy	   to	   induce	   non-­‐covalent	   cell-­‐cell	   interactions	   is	   modifying	   the	  
surfaces	   of	   the	   cells	  with	   single	   stranded	  DNA	   (ssDNA)	  molecules	   so	   that	   the	   cells	  
interact	   through	   sequence	   specific	   DNA	   hybridization	   (Figure	   1.10C).46,50,51	   There	  
have	  been	  two	  strategies	  to	  modify	  the	  cell	  surface	  with	  ssDNA	  molecules.	  Teramura	  
et	  al.	  used	  a	  DNA-­‐polyethylene	  glycol	  conjugated	  with	  a	  lipid	  tail	  to	  insert	  the	  ssDNA	  
on	   the	   cell	   surface	   by	   hydrophobic	   interaction.50	   Gartner	   et	   al.	   labeled	   the	   cells	  
metabolically	   with	   N-­‐azidoacetylmannosamine	   and	   the	   resulting	   cell	   surface	   azido	  
sialic	   acid	   residues	  were	   ligated	  with	  phosphine	   conjugated	   ssDNA.46	  Gartner	  et	  al.	  
was	  also	  able	  to	  engineer	  tissues	  in	  3D	  through	  DNA	  hybridization	  and	  subsequently	  
embedded	   these	   tissues	   in	   matrigel	   matrix,	   which	   combines	   bottom-­‐up	   with	   top-­‐
down	  tissue	  engineering.51	  
	  
The	   cell	   surface	   sialic	   acids	  have	  a	   versatile	   chemistry	   and	  a	   caged	   version	  of	   sialic	  
acid	   has	   been	   used	   to	   control	   cell-­‐cell	   interactions	   by	   altering	   electrostatic	  
interactions.	  N-­‐(propargyloxycarbonyl)mannosamine	   is	   an	  analogue	  of	   the	  naturally	  
occurring	   sialic	  acids	  and	  can	  be	  metabolically	   inserted	  on	   the	  cell	   surface.47	   In	   the	  
presence	  of	  palladium,	  which	  is	  a	  catalyst	  for	  cleavage	  of	  propargyl	  groups,	  a	  positive	  
charge	  on	  the	  cell	  surface	  can	  be	  generated,	  which	  results	  in	  irreversible	  electrostatic	  
cell	  clustering	  (Figure	  1.10D).47	  	  
	  
Chemically	   self-­‐assembled	   nanorings	   (CSANs)	   have	   been	   developed	   to	   induce	   high	  
affinity	   dimerization	   to	   control	   cell-­‐cell	   interactions	   reversibly	   (Figure	   1.10E).48	  
Dihydrofolate	   reductase	   (DHFR)	   was	   recombinantly	   fused	   to	   another	   DHFR	   with	   a	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peptide	   linker	   to	   form	   CSANs.	   Then,	   these	   CSANs	   were	   recombinantly	   fused	   to	  
antibodies	  or	  other	  peptide	  to	  target	  cell	  surface	  receptors.	  It	  is	  known	  that	  DHFR	  can	  
dimerize	  robustly	  with	  its	  inhibitor	  methotrexate	  (MTX).	  	  By	  fusing	  MTX	  to	  a	  lipid	  for	  
insertion	  on	   the	  plasma	  membrane,	   these	   lipid-­‐MTX-­‐DHFR-­‐peptide	  CSANs	   could	   be	  
used	  for	  cell-­‐cell	  assembly.48	  It	  was	  also	  shown	  in	  this	  study	  that	  the	  disassembly	  of	  
the	  cells	  could	  be	  achieved	  in	  the	  presence	  of	  trimethoprim,	  which	   is	  an	  FDA	  (Food	  
and	  Drug	  Administration)	  approved	  bacterial	  DHFR	   inhibitior.48	  Although	   the	  CSANs	  
provide	  only	   reversible	   interaction	  of	   all	   above-­‐mentioned	  approaches,	   the	   cell-­‐cell	  
assembly	  cannot	  be	  re-­‐established	  due	  to	  the	  complete	  dissociation	  of	  DHFR-­‐peptide	  
molecules	  from	  the	  cell	  membrane	  in	  the	  presence	  of	  trimethoprim.	  
	  
All	  the	  above-­‐mentioned	  chemical	  modifications	  of	  the	  cell	  surface	  have	  limitations.	  
Firstly,	   they	   can	   interfere	   unpredictably	   with	   other	   biological	   processes.	   Secondly,	  
chemical	  modifications	  are	  difficult	  to	  sustain	  over	  longer	  periods	  since	  they	  are	  not	  
embedded	   in	   any	   cellular	  machinery,	   and	  will	   diminish	   as	   cells	   divide	   and	   degrade	  
them.	   In	   addition,	   apart	   from	   CSANs,	   none	   of	   the	   current	   platforms	   provide	  
reversible	   interactions	   and	   hence,	   do	   not	   reflect	   the	   dynamic	   nature	   of	   cell-­‐cell	  
interactions.	   Most	   importantly,	   these	   chemical	   modifications	   do	   not	   provide	  
spatiotemporal	  control	  over	  the	  cell-­‐cell	  interactions.	  
	  
1.4.1.1	  Light	  controlled	  cell-­‐cell	  interactions	  
Recently,	   light	  responsive	  chemical	  groups	  have	  been	   introduced	  to	  the	  cell	  surface	  
to	   gain	   better	   spatiotemporal	   control	   over	   cell-­‐cell	   interactions.52,53	   Luo	   et	   al.	   also	  
used	  the	  click	  chemistry	  between	  oxyamines	  and	  ketone	  groups,	  which	  were	  inserted	  
on	  the	  cell	  membrane	  by	  liposome	  fusion.	  In	  addition,	  a	  photocleavage	  site	  between	  
the	   oxyamines	   and	   the	   lipid	   was	   also	   inserted	   in	   order	   to	   irreversibly	   break	   the	  
covalent	   bond	   formed	   between	   the	   cells	   by	   UV	   light	   (Figure	   1.11A).54	   In	   another	  
study,	  cell	  surfaces	  were	  labeled	  with	  β-­‐cyclodextrin	  either	  through	  lipid	  insertion	  or	  
through	   the	   combination	   of	   metabolic	   glycan	   labeling	   and	   bio-­‐orthogonal	   click	  
reactions.	   Subsequently,	   the	   host-­‐guest	   interactions	   between	   azobenzenes	   and	   β-­‐
cyclodextrin	   were	   used	   to	   render	   the	   cell-­‐cell	   interactions	   light	   responsive.	  
Azobenzenes	   are	   photoswitchable	   molecules	   and	   have	   two	   confirmations:	   the	   cis-­‐	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confirmation	   under	   UV	   light	   illumination,	   which	   cannot	   bind	   to	   β-­‐cyclodextrin	   and	  
trans-­‐	  confirmation	  under	  visible	  light,	  which	  can	  bind	  to	  β-­‐cyclodextrin.	  An	  azo-­‐PEG-­‐
azobenzene	   linker	   served	   as	   homobifunctional	   guest	   molecule	   to	   induce	   cell-­‐cell	  
interactions	   under	   visible	   light	   and	   break	   them	   under	   UV	   light	   (Figure	   1.11B).52,53	  
Although	   this	   approach	   is	   the	   first	   to	   achieve	   high	   spatiotemporal	   and	   reversible	  
control	   over	   cell-­‐cell	   interactions,	   these	   interactions	   respond	   to	   UV	   light,	   which	   is	  
toxic	  for	  cells	  and	  the	  general	  problems	  associated	  with	  the	  chemical	  modification	  of	  
cell	  surfaces	  still	  hold	  true. 	  
	  
Figure	   1.11	   Light	   controlled	   cell-­‐cell	   interactions.	   A)	   Cell-­‐cell	   interaction	   is	   induced	   by	   clicking	  
oxyamines	  and	  ketone	  groups	  present	  on	  the	  cell	  surface.	  This	  interaction	  is	  irreversibly	  broken	  by	  UV	  
light	   illumination.54	   B)	   Light	   induced	   cell-­‐cell	   interactions	   based	   on	   host-­‐guest	   recognition	   of	  
azobenzene	  and	  β-­‐cyclodextrin.	  β-­‐cyclodextrin	   is	  presented	  on	   the	  cell	   surface	   (in	  blue)	  and	  cell-­‐cell	  
contacts	  can	  be	  switched	  on	  and	  off	  by	  UV/VIS	  illumination.53	  
	  
Overall,	  a	  platform	  is	  still	  missing	  in	  order	  to	  control	  cell-­‐cell	  interactions	  dynamically,	  
reversibly	  and	  with	  high	  spatial	  and	  temporal	  resolution	  in	  a	  noninvasive,	  sustainable	  
and	  bio-­‐orthogonal	  way.	   	   The	  design	   and	  development	   of	   photoswitchable	   cell-­‐cell	  
interactions	  that	  fulfill	  these	  requirements	  is	  the	  first	  aim	  of	  this	  PhD	  thesis	  and	  this	  
would	  enable	  us	  to	  study	  cell-­‐cell	   interactions	  and	  to	  build-­‐up	  complex	  multicellular	  
architectures.	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1.4.2	  Independently	  controlling	  multiple	  cell-­‐material	  interactions	  
Cells	   respond	   to	   their	   immediate	   environment	   by	   interacting	   with	   different	  
components	   of	   the	   ECM.	   Different	   ligands	   presented	   in	   the	   ECM,	   which	   are	  
recognized	   by	   integrins,	   regulate	   cellular	   processes	   such	   as	   adhesion,	   migration,	  
growth,	  secretion,	  gene	  expression	  and	  apoptosis.55	  Mimicking	  cell-­‐ECM	  interactions	  
and	   controlling	   them	   with	   molecular	   approaches	   are	   of	   central	   importance	   in	   the	  
fields	   of	   tissue	   engineering,	  medical	   implantation	   and	   immunology.55,56	   Hence,	   it	   is	  
crucial	   to	  achieve	  dynamic	  control	  over	   the	   interface	  between	  the	  cells	  of	  different	  
types	  and	  the	  artificial	  substrates.55	  
	  
One	   approach	   to	   selectively	   control	   cell-­‐material	   interactions	   of	   two	   different	   cell	  
types	   is	   to	   modify	   substrates	   (e.g.	   glass,	   gold	   or	   titanium	   dioxide	   surfaces)	   with	  
peptidomimetics,	  which	   are	   selective	   for	   either	   integrin	   αvβ3	   or	   α5β1.57,58	  With	   this	  
strategy	  it	  is	  possible	  to	  differentially	  adhere	  cell	  types	  expressing	  different	  integrins	  
and	  to	  study	  the	  role	  of	  specific	   integrins	   in	  biological	  events	  such	  as	  migration	  and	  
proliferation.57,58	   In	   a	   similar	   approach,	   antibody	   functionalized	   biomaterials	   have	  
been	  used	  to	  isolate	  and	  recruit	  specific	  cell	  types,	  namely	  human	  adipose	  stem	  cells	  
and	   osteoblast-­‐like	   cells.59	   In	   this	   study,	   chitosan,	   a	   linear	   polymer	   of	   glucosamine	  
and	  N-­‐acetyl	  glucosamine,	  was	  used	  to	  immobilize	  different	  antibodies	  since	  chitosan	  
is	   known	   to	   be	   biocompatible,	   biodegradable	   and	   nontoxic.59	   With	   this	   approach,	  
selective	   cell	   attachment	   from	   a	   co-­‐culture	   was	   achieved	   and	   it	   was	   spatially	  
controlled.	  	  
	  
Another	   strategy	   to	   control	   the	   adhesion	  of	  multiple	   cell	   types	   independently	   is	   to	  
modify	   the	   surfaces	   of	   cells	  with	   synthetic	   orthogonal	   interaction	   partners	   such	   as	  
ssDNAs	   to	   selectively	   bind	   these	   cells	   to	   substrates	   with	   complementary	   DNA	  
strands.60,61	  As	  described	  above,	  ssDNA	  molecules	  were	  conjugated	  to	  the	  cell	  surface	  
combining	  metabolic	   labeling	  with	   the	   click	   reaction	  between	   azide	   and	  phosphine	  
groups	  (Staudinger	  ligation).60	  The	  complementary	  DNA	  strand	  was	  immobilized	  on	  a	  
microfluidic	  channel	  of	  (poly)-­‐dimethylsiloxane	  (PDMS)	  such	  that	  cells	  can	  bind	  to	  the	  
surfaces	  of	  the	  microfluidic	  device	  (Figure	  1.12A).60,61	  This	  strategy	  allowed	  different	  
cells	  to	  be	  immobilized	  in	  a	  DNA	  sequence	  specific	  manner	  and	  has	  been	  used	  to	  co-­‐
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pattern	  multiple	   cell	   types61	   as	   well	   as	   to	   construct	   3D-­‐tissues.51	   Leroy	   et	   al.	   have	  
combined	   DNA	   hybridization	   and	   antibody-­‐specific	   cell	   adhesion	   approaches	   to	  
design	   a	   biochip	   where	   cells	   can	   be	   removed	   from	   their	   substrate	   with	   a	  
photothermal	   effect	   (Figure	   1.12B).62	   Immunoglobulins	   (Ig)	   specific	   for	   B	   and	   T	  
lymphocytes	  were	  covalently	  conjugated	  with	  ssDNA	  molecules	  and	  immobilized	  on	  
ssDNA	   based	   biochip.	   The	   primary	   lymphocytes	   could	   then	   be	   captured	   by	  
recognition	  of	  these	  Ig	  molecules	  with	  specific	  receptors.	  These	  lymphocytes	  could	  be	  
released	  by	  laser	   induced	  local	  heating.62	  Although	  this	  approach	  is	  gentle	  and	  non-­‐
invasive,	  it	  does	  not	  reflect	  the	  reversible	  nature	  of	  cell-­‐material	  interactions.	  
	  
Figure	  1.12	  Cell-­‐capture	   strategies	   from	  co-­‐culture	  of	   cells.	  A)	  Sequence	  specific	  cell	  attachment	  by	  
DNA	  hybridization.60	  B)	  Immobilization	  of	  immunoglobulins	  by	  DNA	  hybridization	  for	  antibody	  specific	  
cell	  adhesion	  and	  detachment	  of	  cells	  by	  laser	  induced	  local	  heating.62	  
	  
For	   improved	   spatial	   control	   of	   cell	   adhesion	   of	   multiple	   cell	   types	   and	   prompt	  
different	  cells	  to	  adhere	  to	  specific	  positions	  on	  substrates,	  adhesion	  molecules	  have	  
been	  immobilized	  to	  preformed	  micro-­‐	  and	  nano-­‐	  patterns.63,64	  For	  example,	  chitosan	  
membranes	  have	  been	  functionalized	  with	  o-­‐nitrobenzyl	  caged	  biotin.	  Light-­‐triggered	  
binding	  of	   streptavidin	  coupled	  antibodies	   led	   to	  specific	  cell	  adhesion	  of	  cells	  with	  
different	   cell	   surface	   receptors.63	   Another	   strategy	   is	   orthogonal	   immobilization	   of	  
different	   combinations	   of	   peptidomimetics,	   which	   are	   selective	   for	   either	   integrin	  
αvβ3	  or	  α5β1,	  onto	  a	  micropatterned	  gold-­‐metal	  oxide	  substrates.64	  This	  orthogonally	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functionalized	  and	  micropatterned	   substrates	  provide	  an	   insight	   to	   localize	   integrin	  
specific	  focal	  adhesions	  and	  quantification	  of	  spatial	  organization	  of	  integrins,	  which	  
affects	  cell	  adhesion	  and	  migration.64	  
	  
Although	   these	   above-­‐mentioned	   strategies	   provide	   selective	   adhesion	   of	  multiple	  
cell	  types	  to	  functionalized	  materials,	  they	  do	  not	  capture	  the	  reversibility	  of	  native	  
cell	   adhesions	   and	   only	   provide	   limited	   spatiotemporal	   control.	   To	   mimic	   this	  
dynamic	   nature	   of	   cell-­‐matrix	   adhesion	  with	   synthetic	  materials,	   stimuli-­‐responsive	  
surfaces	   can	   be	   used	   to	   alter	   cell	   adhesion	   with	   light,	   temperature,	   pH	   and	  
biochemical	   signals.55	   Of	   all,	   light	   responsive	   cell-­‐material	   interactions	   provide	   the	  
highest	  spatiotemporal	  control.	  	  
	  
1.4.2.1	  Light	  controlled	  cell-­‐material	  interactions	  
A	   general	   strategy	   for	   light	   controlled	   cell	   adhesion	   is	   caging	   RGD	   peptides	   with	  
photolabile	   caging	   groups	   like	   nitrobenzyl.65,66	   The	   caging	   group	   leads	   to	   steric	  
hindrance,	   conformational	   constrain	  or	   alterations	   in	   the	   charge	  distribution	  of	   the	  
RGD	  peptide;	  hence,	  prevent	  recognition	  by	  the	  integrins.67	  The	  caging	  group	  can	  be	  
removed	  with	   UV	   light	   (350	   nm)	   to	   render	   the	   RGD	   peptide	   active	   resulting	   in	   an	  
adhesive	   substrate	   (Figure	   1.13A).	   The	   disadvantages	   of	   this	   approach	   are	   that	  
photodecaging	   is	   achieved	   by	   UV	   light,	   which	   is	   damaging	   for	   the	   cells	   and	   it	   is	  
irreversible;	  thus,	  the	  cell	  adhesion	  can	  only	  be	  altered	  once.	  
	  
Another	   strategy	   is	   to	   fuse	   RGD	   to	   reversible	   photoisomerization	   units	   such	   as	  
azobenzenes	   to	   make	   the	   cell	   attachment	   and	   detachment	   reversible.68-­‐70	  
Azobenzenes	  undergo	  trans	   to	  cis	   isomerization	  upon	  UV	  light	   irradiation	  and	  cis	  to	  
trans	   isomerization	  under	  visible	   light	   illumination.68	  Hence,	  when	  immobilized	  on	  a	  
non-­‐adhesive	   substrate,	   the	   RGD	   peptide	   is	   only	   presented	   to	   the	   cells	   in	   when	  
azobenzenes	   are	   in	   trans	   configuration	   whereas	   under	   UV	   light	   in	   the	   cis	  
configuration	   the	   azobenzenes	   orients	   the	   RGD	  peptide	   towards	   the	   substrate	   and	  
prevent	  the	  cell	  adhesion	   (Figure	  1.13B).70	  Although	  azobenzenes	  provides	   fast	  and	  
reversible	  switching,	   the	  drawback	  of	  these	  approaches	   is	   the	  constant	  exposure	  of	  
cells	  to	  UV	  light,	  which	  is	  damaging	  to	  cells.	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Figure	   1.13	   Light	   controlled	   cell-­‐material	   interactions.	   A)	  RGD	  peptides	   are	   caged	  with	  photolabile	  
nitrobenzyl	   groups,	   which	   can	   be	   cleaved	   by	   UV	   light	   illumination.65	   B)	   RGD	   peptide	   is	   fused	   to	  
azobenzene	  molecules,	  which	  undergo	  trans	   to	  cis	   isomerization	  upon	  UV	   light	   irradiation	  and	  cis	  to	  
trans	   isomerization	  under	  visible	  light	  illumination.70	  C)	  Modification	  of	  UCNPs	  with	  a	  photocleavable	  
linker	   and	   an	   RGD	   peptide.71	   D)	   Combination	   of	   UCNPs	   with	   fibronectin	   coated	   photochromic	  
spiropyran	  molecules,	  which	  also	  has	  two	  confirmations	  under	  UV	  and	  visible	  light.72	  
	  
One	  of	  the	  most	  promising	  approaches	  is	  to	  combine	  the	  above-­‐mentioned	  systems	  
with	   lanthanide-­‐doped	  upconversion	  nanoparticles	   (UCNPs),	  which	  can	  absorb	  near	  
infrared	  (NIR)	  light	  (980	  nm)	  and	  emit	  UV	  or	  visible	  light	  depending	  on	  the	  power	  of	  
the	  NIR	   light.71,72	  One	  strategy	   is	  to	  modify	  UCNPs	  with	  a	  photocleavable	   linker	  and	  
an	  RGD	  peptide.71	  Upon	  illumination	  with	  NIR	  light,	  the	  UV	  light	  emission	  from	  UCNPs	  
resulted	   in	   cleavage	   of	   the	   photolytic	   group	   and	   the	   RGD	   peptide,	   which	   led	   to	  
irreversible	  cell-­‐detachment	  from	  the	  substrate	  (Figure	  1.13C).71	  The	  other	  strategy	  is	  
combining	   UCNPs	   with	   fibronectin	   coated	   photochromic	   spiropyran	   molecules.72	  
Spiropyrans	   have	   two	   conformations:	   the	   spiro	   form	   (under	   visible	   light)	   and	   the	  
merocyanine	   form	   (under	  UV	   light).	   This	   isomerization	  of	   spiropyrans	  was	  used	   for	  
reversible	   control	   of	   cell	   attachment	   and	   detachment	   (Figure	   1.13D).72	   Although	  
promising,	   there	   is	  no	  system	  that	  allows	   to	   independently	  control	   the	  adhesion	  of	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multiple	   cell	   types	   with	   light	   as	   none	   of	   these	   present	   orthogonal	   cell	   adhesion	  
ligands	  to	  the	  cells.	  In	  addition	  exposing	  the	  cells	  to	  UV	  light	  remains	  a	  problem.	  	  
	  
Overall,	   none	   of	   these	   light	   responsive	   strategies	   provides	   bio-­‐orthogonal,	  
noninvasive	   and	   independent	   control	   over	   multiple	   cell-­‐material	   interactions	   in	  
multicellular	  mixtures.	  This	  is	  due	  to	  the	  lack	  of	  photoswitchable	  cell	  adhesion	  ligands	  
that	   specifically	   interact	   with	   different	   cell	   types	   and	   that	   can	   be	   addressed	  
orthogonally	  with	  different	  wavelengths	  of	  light.	  This	  summarizes	  the	  second	  aim	  of	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1.5	  Non-­‐neuronal	  optogenetics	  
	  
Light	  is	  fundamental	  to	  life	  on	  earth	  and	  crucial	  for	  organisms	  of	  all	  kingdoms.	  Thus,	  
there	   are	   a	   number	   of	   light-­‐responsive	   proteins	   evolved	   over	   time,	   which	   have	  
different	  biochemical	  and	  biophysical	  properties.73,74	  These	  photoreceptors	  respond	  
to	  a	  specific	  wavelength	  and	  they	  undergo	  a	  reversible	  conformational	  change	  upon	  
photon	   absorption,	   which	   affects	   their	   binding	   affinities	   for	   interacting	   proteins.73	  
These	  natural	  resources	  have	  been	  used	  in	  the	  emerging	  field	  of	  optogenetics,	  which	  
provides	  genetically	  encodable	  light	  responsive	  proteins	  as	  synthetic	  biology	  tools.74	  
The	  major	   advantage	   of	   the	   optogenetic	   tools	   is	   that	   addition	   of	   photo-­‐responsive	  
chemical	  inducers	  or	  introduction	  of	  caged	  aminoacids,	  which	  can	  interfere	  with	  and	  
perturb	  the	  mammalian	  systems,	  is	  not	  needed.74	  
	  
The	   use	   of	   Channelrhodopsin-­‐2,	   an	   algal	   blue	   light	   sensitive	   cation	   channel	   from	  
Chlamydomonas	   reinhardtii,	   in	   mammalian	   neurons	   marked	   the	   beginning	   of	   the	  
neuronal	   optogenetics	   era.73,75	   This	   development	  was	   followed	  by	  employing	  other	  
microbial	  and	  animal	  opsins	  to	  control	  neural	  and	  muscle	  activity	  by	  activating	  these	  
channels	   for	  specific	   ions.76-­‐78	  These	  opsins	  utilize	  retinal	  as	   their	  chromophore	  and	  
induce	  ion	  flux	  upon	  blue	  or	  orange	  light	  illumination.74	  Hence,	  they	  act	  as	  potential	  
channels	  and	  their	  activity	  can	  be	  blocked	  in	  the	  dark.74	  
	  
The	   other	   light	   sensitive	   proteins	   found	   in	   plants,	   fungi	   and	   microbes	   change	  
conformation	   in	   response	   to	   light	  or	   interact	  with	  other	  proteins	   forming	  homo-­‐	  or	  
heterodimers	   (Figure	   1.14).79,80	   The	   prime	   example	   of	   an	   ultraviolet	   sensing	  
photoreceptor	   is	  UVR8	   from	  Arabidopsis	   thaliana.	   Its	   light	  perception	   is	  dependent	  
on	  intrinsic	  tryptophan	  residues;	  hence,	  this	  protein	  does	  not	  need	  a	  cofactor.	  In	  dark	  
UVR8	   is	   a	   homodimer	   and	   upon	   illumination	   with	   UV-­‐B	   light	   (280-­‐315	   nm),	   it	  
interacts	   with	   constitutive	   photomorphogenesis	   protein	   1	   (COP1).73	   This	   tool	   has	  




A	  class	  of	  optogenetic	  building	  blocks	  are	  light-­‐oxygen-­‐voltage	  (LOV)	  domains,	  which	  
are	   blue	   light	   sensing	   proteins	   conserved	   in	   prokaryotes,	   fungi	   and	   plants.74	   LOV	  
domains	   have	   a	   conserved	   Per-­‐ARNT-­‐Sim	   	   (PAS)-­‐	   core	   flanked	   by	   α-­‐helices.	   The	   C-­‐
terminal	   α-­‐helix	   is	   unwinded	   upon	   blue	   light	   illumination	   due	   to	   a	   covalent	   bond	  
formation	   between	   a	   cysteine	   residue	   and	   its	   chromophore	   flavin	  mononucleotide	  
(FMN).74	  The	  hydrolysis	  of	  the	  cysteinyl-­‐flavin	  bond	  occurs	  in	  dark	  so	  that	  the	  α-­‐helix	  
turns	   back	   to	   the	   LOV	   core	   in	   its	   resting	   state.73,74	   Three	   versions	   of	   LOV	   domains	  
were	   developed	   as	   optogenetic	   tools:	   FKF1-­‐GI	   heterodimers	   from	   Arabidopsis	  
thaliana,	  AsLOV2	  which	  is	  based	  on	  unwinding	  of	  the	  Jα-­‐helix	  from	  Avena	  sativa	  and	  
VVD	  which	  homodimerizes	  under	  blue	  light	  from	  Neurospora	  crassa.73	  These	  domains	  
have	  been	  used	  to	  control	  important	  processes	  including	  gene	  transcription82,83,	  cell	  
signaling84	  and	  protein-­‐protein	  interactions.85	  
	  
A	   couple	   of	   fluorescent	   proteins	   such	   as	  DRONPA	   from	   the	   stone	   coral	  Pectiniidae	  
have	   also	   been	   used	   as	   optogenetic	   tools.	   This	   green	   photoswitchable	   fluorescent	  
protein	   is	   found	   as	   a	   fluorescent	   tetramer	   or	   dimer	   in	   dark	   and	   upon	   cyan	   light	  
illumination	   (500	  nm)	   it	   forms	  monomers.86,87	  This	   system	  has	  been	  used	   for	   super	  
resolution	  imaging86	  and	  control	  of	  enzyme	  activities.88,89	  	  
	  
Blue	  and	  red	   light	  dependent	  CRY2/CIBN	  and	  PhyB/PIF6	  heterodimers	  were	  used	   in	  
















Figure	  1.14	  Chimeric	  photoreceptors	  as	  optogenetic	  tools.	  The	  photoswitchable	  proteins	  are	  groups	  
based	   on	   their	   absorption	   peaks.	   AsLOV2:	   Avena	   sativa	   light-­‐oxygen-­‐voltage	   domain	   2,	   CRY2:	  
cryptochrome	   2,	   CIB1:	   cryptochrome	   interacting	   basic	   helix-­‐loop-­‐helix	   1,	   COP1:	   constitutive	  
photomorphogenesis	   protein	   1,	   Cph1:	   cyanobacterial	   phytochrome	   1,	   FKF1:	   Kelch	   repeat	   F-­‐box	  
protein,	   GI:	   GIGANTEA,	   PhyB:	   phytochromes	   B,	   PIF6:	   phytochromes	   interacting	   factor	   6,	   UVR8,	  




1.5.1	  Cryptochromes	  (CRY)	  
Cryptochromes	   are	   blue	   light	   sensing	   photoreceptors	   that	   regulate	   growth	   and	  
development	   in	   plants	   and	   the	   circadian	   clock	   in	   both	   plants	   and	   animals.90	  
Cryptochromes	   were	   first	   identified	   and	   best	   studied	   in	   Arabidopsis	   thaliana	   and	  
there	  are	  three	  members	  of	  cryptochromes	  in	  Arabidopsis,	  CRY1-­‐3.73,90	  There	  are	  two	  
domains	  in	  CRY	  apoprotein:	  and	  N-­‐terminal	  photolyase	  homology	  region	  (PHR)	  and	  a	  
cryptochrome	   C-­‐terminal	   extension	   (CCE)	   domain.90	   The	   PHR	   domain	   is	   the	  
chromophore	   binding	   domain	   of	   cryptochromes	   and	   they	   non-­‐covalently	   interact	  
with	  flavin	  adenine	  dinucleotide	  (FAD).90	  In	  the	  dark,	  FAD	  is	  in	  its	  oxidized	  state	  and	  
upon	   absorption	   of	   blue	   light,	   the	   flavin	   chromophore	   is	   reduced	   leading	   to	   a	  
conformational	  change	  in	  the	  cryptochromes.73,90	  This	   is	  the	  biologically	  active	  form	  
of	   the	  cryptochromes	  and	  they	  can	  either	   form	  homooligomers	  or	  heterodimers	  by	  
interacting	   with	   cryptochrome-­‐interacting	   basic	   helix-­‐loop-­‐helix	   1	   (CIB1)	  
proteins.73,74,80	  CIB1	  is	  a	  transcription	  factor	  and	  has	  a	  nuclear	  localization	  sequence,	  
which	  is	  deleted	  for	  optogenetic	  studies	  in	  mammalian	  cells.73,91	  
	  
Cryptochrome	  2	  (CRY2)	  was	  first	  used	  as	  an	  optogenetic	  building	  block	  in	  mammalian	  
cells	   in	   2010	   by	   Kennedy	   et	   al.	   In	   this	   study,	   the	   activity	   of	   CRY2-­‐CIB1	  
heterodimerization	  was	  investigated	  for	  full	  length	  CRY2	  and	  only	  the	  PHR	  domain	  of	  
CRY2	  (CRY2PHR)	  together	  with	  full	   length	  CIB1	  and	  an	  N-­‐terminal	  truncated	  version	  
of	  CIB1	  (CIBN),	  which	  lacks	  DNA	  binding	  domain.91	  It	  was	  shown	  that	  CRY2-­‐CIB1	  and	  
CRY2-­‐CIBN	  were	  equally	  active	  under	  blue	   light.	  CRY2PHR	  expression	  was	  shown	  to	  
be	  higher	  due	  to	  its	  smaller	  size,	  hence	  showed	  higher	  activity	  than	  full	  length	  CRY2	  
but	  with	   a	   higher	   dark	  background.91	   In	   the	   same	   study,	   CIBN	  was	   localized	   to	   the	  
plasma	   membrane	   of	   the	   human	   embryonic	   kidney	   (HEK)	   cells	   and	   the	   blue	   light	  
dependent	   reversible	   membrane	   recruitment	   of	   CRY2	   from	   the	   cytosol	   was	  
demonstrated.	  The	  authors	  further	  showed	  that	  CRY2-­‐CIBN	  heterodimerization	  takes	  
place	  within	   seconds	  and	   the	   complex	  dissociates	  within	  12	  min.	   The	  advantage	  of	  
this	  blue	   light	  dependent	  system	  is	  that	  CRY2	  does	  not	  need	  an	  exogenously	  added	  
chromophore	   since	   FAD	   is	   found	   in	   mammalian	   cells.92	   Taslimi	   et	   al.	   improved	  
versatility	  and	  tenability	  of	  the	  CRY2-­‐CIB	  heterodimerization	  for	  specific	  applications	  
by	   single	   mutations	   within	   the	   proteins	   or	   truncations.93	   For	   instance	   CRY2-­‐CIBN	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heterodimerization	   was	   used	   to	   control	   DNA	   recombination	   by	   induction	   of	  
dimerization	  splitted	  Cre	  recombinase	  under	  blue	  light.91,93	  	  
	  
Che	   et	   al.	   systematically	   characterized	   the	   two	   blue	   light	   dependent	   responses	   of	  
CRY2	   under	   different	   conditions.94	   They	   proposed	   that	   there	   are	   two	   independent	  
binding	   sites	   of	   CRY2	   for	   CRY2-­‐CRY2	   and	   CRY2-­‐CIBN	   interactions,	   and	   CRY2-­‐CIBN	  
interaction	   sterically	   hinders	   the	   CRY2	   oligomerization.	   The	   blue	   light	   dependent	  
homooligomerization	  of	  CRY2	  has	  been	  used	  for	  optogenetic	  control	  of	   intracellular	  
signaling	   events.	   For	   instance,	   Bugaj	   et	   al.	   used	   the	   blue	   light	   dependent	  
homooligomerization	  of	  CRY2	  to	  control	  Wnt/β-­‐catenin	  pathway	  and	  Rho	  GTPases	  in	  
mammalian	   cells.95	   In	   this	   study	   CRY2	   was	   fused	   to	   lipoprotein	   receptor-­‐related	  
protein	  6	  (LRP6),	  which	  oligomerizes	   in	  the	  presence	  of	  Wnt	   ligand	  and	  activates	  β-­‐
catenin	  signaling.	  In	  the	  absence	  of	  the	  Wnt	  ligand,	  β-­‐catenin	  expression	  was	  turned	  
on	   and	   off	   depending	   on	   the	   blue	   light	   illumination	   and	   a	   higher	   transcriptional	  
response	  was	   achieved	   compared	  with	   that	   of	   induced	   by	   the	   natural	  Wnt	   ligand.	  
Further,	   CRY2	   was	   fused	   to	   Rho	   GTPase	   Rac1,	   which	   is	   involved	   in	   cytoskeletal	  
reorganization.	  By	  activating	  Rac1	  with	  blue	  light,	  its	  direct	  effect	  on	  actin	  dynamics	  
was	   studied.95	   CRY2	   homooligomerization	   was	   also	   used	   by	   Kim	   et	   al.	   to	   control	  
fibroblast	   growth	   factor	   receptors	   (FGFRs)	   to	   control	   actin	   dynamics	   and	   cell	  
polarization,	   and	   to	   induce	   directed	   cell	   migration.96	   Later	   an	   improved	   variant	   of	  
CRY2,	  CRY2olig,	  which	  homooligomerizes	  more	  robustly,	  was	  developed	  by	  Taslimi	  et	  
al.	  and	  used	  to	  control	  clathrin	  mediated	  endocytosis.97	  	  
	  
CRY2-­‐CIBN	  heterodimerization	  has	  also	  been	  used	  to	  control	  a	  variety	  of	  intracellular	  
signaling	   events.	   Idevall-­‐Hagren	   et	   al.	   used	   the	   blue	   light	   dependent	   CRY2-­‐CIBN	  
heterodimerization	   to	   control	   the	   phosphoinositide	   metabolism	   in	   mammalian	  
cells.98	  In	  this	  study,	  CIBN	  was	  localized	  to	  the	  plasma	  membrane	  and	  CRY2	  was	  fused	  
to	   5-­‐phosphatases.	   The	   cellular	   mechanisms	   dependent	   on	   dephosphorylation	  
phosphoinositides	  at	  the	  plasma	  membrane	  were	  tested	  by	  CRY2	  recruitment	  to	  the	  
plasma	   membrane	   upon	   blue	   light	   illumination.	   In	   a	   later	   study,	   the	   same	   group	  
provided	  a	  more	  detailed	  insight	  on	  the	  regulation	  of	  membrane	  lipid	  metabolism	  by	  
blue	  light	  illumination.99	  Xu	  et	  al.	  used	  CRY2-­‐CIBN	  heterodimerization	  to	  unravel	  the	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contributions	   of	   the	   phosphoinositide-­‐3-­‐kinase	   and	   Akt	   in	   the	   translocation	   of	   the	  
glucose	  transporter	  4	  in	  response	  the	  insulin	  in	  adipocytes.100	  CRY2-­‐CIBN	  system	  was	  
also	  used	  to	  study	  the	  roles	  of	  proteins	  and	  transcription	  factors	  in	  the	  cellular	  forces	  
with	  high	  spatiotemporal	  resolution.101	  Hence,	   it	   is	  now	  possible	  to	  study	  the	  direct	  
effects	  of	  the	  players	  of	  different	  signaling	  cascades	  in	  cellular	  response	  and	  function.	  
	  
A	   variety	   of	   different	   cellular	   events	   were	   also	   controlled	   by	   CRY2-­‐CIBN	  
heterodimerization.	   For	   instance,	  Duan	  et	  al.	   used	  blue	   light	  dependent	  CRY2-­‐CIBN	  
heterodimerization	  to	  reversibly	  control	  organelle	  distribution,	  which	  is	  important	  in	  
a	  variety	  of	  cellular	  functions	  including	  cell	  survival	  and	  apoptosis.102	  By	  fusing	  CRY2	  
to	   an	   organelle	   (mitochondria,	   peroxisomes	   and	   lysosomes)	   and	   CIBN	   to	   motor	  
proteins	  (dynein	  or	  kinesin),	  light	  controlled	  organelle	  distribution	  was	  achieved	  and	  
can	   be	   used	   to	   study	   the	   effect	   of	   organelle	   distribution	   on	   cellular	   functions.102	  
Sinnen	  et	  al.	  used	  CRY2-­‐CIB1	  heterodimerization	   in	  neurons	   in	  order	   to	  control	   the	  
composition	  of	  the	  postsynaptic	  densities,	  which	  are	  protein	  dense	  regions	  bringing	  
receptors	   and	   other	   proteins	   for	   neurotransmitter	   release	   in	   neuronal	  
communication.103	  Deb	  Roy	  et	  al.	  employed	  CRY2-­‐CIB1	  heterodimerization	  in	  order	  to	  
study	   the	   repulsion	   between	   osteoblasts	   and	   osteoclasts	   upon	   contact	   formation	  
with	  high	  spatiotemporal	  resolution.104	  Polstein	  and	  Gersbach	  have	  developed	  a	  light	  
activated	   CRISPR-­‐Cas9	   (clustered	   regularly	   interspaced	   short	   palindromic	   repeats-­‐	  
CRISPR	   associated	   protein	   9)	   effector	   (LACE)	   system	   to	   control	   transcription	   of	  
endogenous	  genes.105	  They	   fused	  CRY2	  and	  CIB1	  to	   the	   transactivation	  domain	  and	  
catalytically	   inactive	   Cas9,	   respectively,	   and	   induced	   endogenous	   gene	   expression	  
under	  blue	  light	  illumination.	  	  
	  
The	  CRY2-­‐CIBN	  optogenetic	  system	  has	  been	  used	  to	  gain	  insight	  into	  developmental	  
and	   aging	   processes.	   Choudhury	   et	   al.	   investigated	   the	   epigenetic	   regulatory	  
mechanisms	   of	   telomere	   length	  maintenance	   by	   using	   blue	   light	   dependent	   CRY2-­‐
CIB1	   heterodimerization.106	   CRY2	   and	   CIB1	   were	   fused	   to	   human	   DNA	  
methyltransferase	   3A	   and	   telomere-­‐associated	   protein	   telomere	   repeat	   binding	  
factor-­‐1,	  respectively,	  and	  methylation	  at	  the	  subtelomeric	  sites	  was	  increased	  under	  
blue	  light	  illumination,	  resulting	  in	  the	  increase	  in	  the	  telomere	  length.106	  In	  another	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study	  from	  Krishnamurthy	  et	  al.,	  blue	  light	  dependent	  CRY2-­‐CIBN	  pair	  was	  employed	  
to	   control	   cell	   differentiation	   in	   mammalian	   cells	   and	   in	   developmental	   stages	   of	  
Xenopus	  embryos	  by	  targeting	  Raf/MEK/Erk	  signaling	  cascades	  to	  study	  the	  effect	  of	  
these	  signaling	  events	  in	  development.107	  
	  
Recently	   more	   mechanistic	   insight	   for	   CRY2	   homooligomerization	   and	  
heterodimerization	   has	   emerged.108	   Duan	   et	   al.	   showed	   the	   effect	   of	   the	   charged	  
residues	   at	   the	   N-­‐	   and	   C-­‐	   terminal	   of	   CRY2	   on	   heterodimerization	   with	   CIBN	  
homooligomerization	   of	   CRY2,	   respectively.	   General	   protocols	   based	   on	   blue	   light	  
dependent	   CRY2-­‐CIB1	   heterodimerization	   for	   studying	   and	   analyzing	   the	   protein	  
kinases92,	   	   membrane	   lipid	   metabolism99	   and	   embryonic	   development109	   are	   also	  
available.	  	  
	  
In	   summary,	   all	   these	   studies	   show	   that	   CRY2-­‐CIBN	   heterodimerization	   and	   CRY2	  
homooligomerization	  are	  powerful	  optogenetic	  tools	  to	  control	  and	  study	  a	  variety	  of	  
cellular	   functions	   from	   gene	   transcription	   to	   neuronal	   communication	   with	   high	  
spatiotemporal	  resolution.	  
	  
1.5.2	  Phytochromes	  (Phy)	  
The	  phytochromes	  are	  red	  and	  far-­‐red	  light	  absorbing	  photoreceptors	  in	  plants,	  fungi	  
and	   bacteria.74	   There	   are	   five	   members	   of	   phytochromes	   (PhyA-­‐E)	   in	   Arabidopsis	  
thaliana	   and	   they	   regulate	   seed	   germination,	   seedling	   de-­‐etiolation	   and	   shade	  
avoidance	   response.110	   They	   are	   covalently	   linked	   to	   an	   open	   chain	   tetrapyrrole	  
chromophore,	  phytochromobilin	  (PφB)	  and	  they	  exist	  in	  two	  reversible	  confirmations	  
with	   different	   spectroscopic	   and	   functional	   properties.111	   The	   red	   light	   absorbing	  
form	   (Pr	   form)	   is	   biologically	   inactive	   and	   red	   light	   absorption	   switches	   Pr	   to	  
biologically	  active	  far-­‐red	  light	  absorbing	  form	  (Pfr	  form).	  The	  Pfr	  form	  can	  interact	  to	  
form	   heterodimers	   with	   the	   basic	   helix-­‐loop-­‐helix	   transcription	   factor	   superfamily,	  
phytochrome	  interacting	  factors	  (PIFs).111	  Upon	  far-­‐red	  light	  illumination	  the	  Phy-­‐	  PIF	  
heterodimer	  dissociates	  back	  to	  the	  ground	  state.73	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The	  phytochromobilin	  chromophore	  is	  synthesized	  in	  chloroplasts	  of	  plants	  and	  then	  
exported	   to	   the	   cytosol,	   where	   it	   is	   bound	   to	   phytochromes	   through	   a	   thioether	  
linkage.110	  Since	  biosynthesis	  of	  phytochromobilin	  does	  not	  take	  place	  in	  mammalian	  
systems,	   phycocyanobilin	   (PCB),	   a	   derivative	   of	   phytochromobilin,	   which	   can	   be	  
extracted	  from	  cyanobacterium	  Spirulina	  and	  must	  be	  added	  exogenously	  to	  the	  cell	  
culture	  medium	  for	  optogenetic	  control.73,74,112	  The	  biosynthesis	  pathway	  of	  PCB	  can	  
also	   be	   genetically	   implemented	   in	   mammalian	   cells	   by	   encoding	   the	   necessary	  
enzymes.113,114	  	  
	  
The	   PhyB-­‐PIF6	   and	   PhyB-­‐PIF3	   heterodimerization	   have	   been	   engineered	   as	   an	  
optogenetic	   tool	   in	   mammalian	   systems.	   The	   first	   study	   with	   red	   light	   dependent	  
PhyB-­‐PIF3/6	   heterodimers	   in	   mammalian	   systems	   was	   done	   by	   Levskaya	   et	   al.	   in	  
2009.115	   In	   this	   study,	   different	   truncated	   versions	   of	   PhyB	   were	   anchored	   to	   the	  
plasma	  membrane	  and	  a	  YFP-­‐fused	  PIF3	  and	  PIF6	  protein	  was	   tested	   for	   reversible	  
membrane	  recruitment	  under	  red	  and	  far-­‐red	  light.	  It	  was	  shown	  that	  only	  PIF6	  was	  
recruited	  to	  the	  plasma	  membrane	  under	  red	  light	  and	  this	  interaction	  was	  reversible	  
under	   far-­‐red	   light	   provided	   that	   C-­‐terminal	   PAS	   domain	   of	   the	   phytochrome	   is	  
intact.115	   After	   showing	   precise	   and	   reversible	   recruitment	   of	   PIF6	   to	   the	   plasma	  
membrane	   under	   red	   light	   illumination,	   this	   PhyB/PIF6	   interaction	   was	   used	   to	  
modulate	   the	   upstream	   activators	   of	   Rho	   family	   GTPases	   under	   red	   light,	   which	  
control	  actin	  cytoskeleton,	  thereby	  cell	  morphology.	  For	  this,	  PhyB	  was	   localized	  on	  
the	  plasma	  membrane	  and	  PIF6	  was	  fused	  to	  the	  Dbl	  homology-­‐pleckstrin	  homology	  
(DH-­‐PH)	   domains	   of	   either	   Tiam	   or	   intersectin,	   which	   are	   Rho	   guanine	   nucleotide	  
exchange	  factors	  (GEFs)	  and	  are	  responsible	  for	  activation	  of	  Rho	  family	  GTPases.115	  
Depending	  on	  which	  PIF6-­‐RhoGEF	  was	  recruited	  to	  the	  plasma	  membrane	  upon	  red	  
light	  illumination,	  filopodia	  or	  lamellipodia	  protrusions	  were	  observed	  indicating	  the	  
activation	  of	  the	  downstream	  GTPase	  signaling.115	  	  
	  
Although	   PhyB/PIF3	   heterodimerization	   has	   been	   used	   for	   controlling	   gene	  
expression116-­‐118	   and	   intein	   splicing119	   in	   yeast,	   this	   system	   was	   not	   successful	   to	  
control	   interactions	   in	  mammalian	  systems.120	  Pathak	  et	  al.	   compared	   the	  activities	  
of	  PhyB/PIF3	  and	  PhyB/PIF6	  systems	  using	  a	  yeast	  transcriptional	  assay.120	  This	  study	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revealed	   that	   to	   control	   transcription	   in	   yeast,	   compared	   to	   PhyB/PIF6	   system,	  
PhyB/PIF3	  system	  was	  activated	  more	  robustly	  with	  a	  low	  background	  and	  reversible	  
under	  far-­‐red	  light;	  however,	  extra	  light	  care	  had	  to	  be	  taken	  as	  it	  was	  quite	  sensitive	  
to	   the	   ambient	   light.120	   Hence,	   PhyB/PIF6	   heterodimers	   has	   been	   mainly	   used	   to	  
control	  protein	  interactions	  and	  other	  intracellular	  signaling	  events	  in	  the	  mammalian	  
cells.	  
	  
The	   red	   light	   dependent	   PhyB-­‐PIF6	   interaction	   has	   been	   used	   to	   control	   signaling	  
inside	  the	  cell.	  Toettcher	  et	  al.	  used	  red	  light	  dependent	  PhyB-­‐PIF6	  heterodimers	  to	  
follow	   the	   flow	   of	   information	   in	   signaling	   cascade	   from	   Ras	   to	   Erk.121	   PhyB-­‐PIF6	  
system	   was	   also	   used	   in	   a	   study	   by	   Yu	   et	   al.	   to	   regulate	   the	   second	   messenger	  
molecules,	  Ca2+	  and	  cAMP,	  by	  fusing	  PhyB	  and	  PIF6	  to	  the	  subunits	  of	  heterotrimeric	  
G	   proteins.122	   Juillot	  et	   al.	   designed	   a	   synthetic	   signaling	   cascade	   starting	   from	   the	  
plasma	  membrane	  to	  the	  nucleus	  and	  combined	  PhyB-­‐PIF3	  heterodimerization	  with	  
small	  molecules	  to	  sequentially	  control	  the	  protein	  localization.123	  These	  approaches	  
in	   controlling	   intracellular	   signaling	   based	   on	   red/far-­‐red	   light	   dependent	  
photoswitch	  provide	   insights	  about	  the	  role	  of	  each	  step	   in	  the	  signaling	  cascade	   in	  
the	  cellular	  response	  and	  function.	  	  
	  
The	  PhyB-­‐PIF6	  interaction	  has	  also	  been	  used	  in	  the	  context	  of	  gene	  expression	  and	  
gene	   delivery.	   Müller	   et	   al.	   used	   PhyB-­‐PIF6	   heterodimerizers	   to	   control	   gene	  
transcription	   in	   mammalian	   cells	   by	   fusing	   PhyB	   and	   PIF6	   to	   splitted	   transcription	  
factors.124	   Gomez	   et	   al.	   used	   PhyB-­‐PIF6	   heterodimerization	   to	   improve	   viral	   gene	  
delivery	   to	   the	   mammalian	   cells.125	   In	   this	   study,	   adeno-­‐associated	   viruses	   were	  
engineered	   to	  display	  PIF6	  on	   their	   capsids.	  A	  nuclear	   localization	   sequence,	  which	  
was	   linked	   to	  PhyB,	  allowed	  modulating	   the	  efficiency	  of	   the	  viral	   gene	  delivery	  by	  
changing	   the	   red/far-­‐red	   light	   ratio.	  This	  approach	  provided	  enhanced,	   tunable	  and	  
spatiotemporally	  regulated	  viral	  gene	  delivery	  into	  the	  cells.125	  
	  
Finally,	   red	   light	  dependent	   interaction	  between	  PhyB	  and	  PIF6	  was	  used	   in	  vivo	   to	  
study	   the	   roles	  of	   the	  key	   signaling	  events	   in	   the	  embryonic	  development	  by	  using	  
model	  organisms.	  Müller	  et	  al.	  also	  applied	  this	  red/far-­‐red	  light	  switch	  to	  control	  and	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modulate	   angiogenesis	   in	   chicken	   embryos.124	   This	   PhyB-­‐PIF6	   mediated	   Ras/Erk	  
signaling	  pathway	  was	  further	  developed	  and	  characterized126	  and	  also	  implemented	  
in	   Drosophila	   embryos	   to	   follow	   the	   effects	   of	   Erk	   signaling	   in	   morphogenesis.127	  
Further,	   Buckley	   et	   al.	   used	   the	   light	   induced	   heterodimerization	   of	   PhyB-­‐PIF6	   to	  
rapidly	   and	   reversibly	   recruit	   proteins	   to	   specific	   regions	   within	   specific	   cells	   in	  
zebrafish	  embryo.128	  In	  this	  study,	  they	  optimized	  the	  expression	  of	  PhyB	  and	  PIF6	  in	  
zebrafish	  embryo	  and	  also	  delivered	  PCB	  deep	   in	   the	  embryo	  without	   toxic	  effects.	  
Hence,	  PhyB-­‐PIF6	  system	  was	  suitable	   to	  study	  developmental	   stages	  noninvasively	  
and	  with	  high	  spatiotemporal	  resolution.	  	  
	  
Not	  only	  plant	  PhyB	  but	  also	  cyanobacterial	  phytochrome	  1	  (CPH1)	  has	  recently	  taken	  
its	   place	   in	   the	   optogenetic	   tool	   kit.	   Like	   PhyB,	   CPH1	   also	   utilizes	   PCB	   as	   its	  
chromophore;	   however,	   in	   contrast	   to	   PhyB,	   CPH1	   homodimerizes	   under	   red	   light	  
and	   dissociates	   under	   far-­‐red	   light	   irradiation.73	   Reichhart	   et	   al.	   used	   red	   light	  
dependent	   CPH1	   homodimerization	   to	   trigger	   mitogen	   activated	   protein	  
kinase/extracellular	   signal	   regulated	  kinase	   (MAPK/ERK)	  pathways	   through	   receptor	  
tyrosine	  kinase	  (RTK)	  activation.129	  
	  
All	   these	  studies	  show	  that	  PhyB-­‐PIF3	  and	  PhyB-­‐PIF6	  heterodimerization	  have	  been	  
powerful	  optogenetic	  tools	  to	  control	  a	  variety	  of	  cellular	  functions	  raging	  from	  cell	  
signaling	  to	  gene	  delivery	  and	  development	  with	  high	  spatiotemporal	  resolution.	  The	  
advantage	  of	  this	  red/far-­‐red	  light	  responsive	  system	  is	  that	  it	  provides	  an	  orthogonal	  
fast	  switching	  within	  seconds.	  PCB	  chromophore	  has	  to	  be	  added	  exogenously,	  which	  
was	   considered	   as	   a	   disadvantage;	   however,	   it	   brings	   an	   advantage	   of	   handling	  
without	   extra	   light	   safety	   in	   the	   absence	   of	   PCB.	   Furthermore,	   the	   genetic	  

















2.	  	  Results	  and	  Discussion	  
2.1	  Part	  1:	  Blue	  light	  induced	  reversible	  cell-­‐cell	  interactions	  
The	   interactions	   between	   cells	   is	   crucial	   for	   formation	   and	   function	   of	   tissues	   and	  
organs;	   hence,	   controlling	   the	   arrangement	   of	   cells	   with	   respect	   to	   each	   other	  
provides	  an	   insight	   into	  underlying	  cellular	  processes	   in	  development	  and	  allow	  the	  
generation	  of	   functional	   tissues	  de	  novo.4,38	  The	  current	  genetic	  approaches6,40,41	  or	  
covalent42-­‐44	   and	   non-­‐covalent45-­‐51	  modifications	   of	   cell	   surfaces	   to	   control	   cell-­‐cell	  
interactions	  are	  neither	  sustainable	  nor	  reversible	  and	  do	  not	  provide	  spatiotemporal	  
resolution.	   Although	   recently	   developed	   light	   controlled	   methods52-­‐54	   provide	  
reversible	  control	   in	  space	  and	  time,	  the	  sustainability	  of	  the	  cell	  surface	  properties	  
still	  remains	  challenging.	  Furthermore,	  use	  of	  UV	  light	  in	  these	  systems	  is	  phototoxic	  
for	  cells.	  	  Therefore,	  a	  platform	  to	  control	  cell-­‐cell	  interactions	  dynamically,	  reversibly	  
and	  with	  high	  spatial	  and	  temporal	  resolution	  in	  a	  noninvasive,	  sustainable	  and	  bio-­‐
orthogonal	  way	   is	   needed.	   	   	   The	   aim	   of	   the	   first	   part	   of	   this	   thesis	   deals	  with	   the	  
reversible	   control	   of	   cell-­‐cell	   interactions	   in	   space	   and	   time	   by	   using	   CRY2/CIBN	  
heterodimerization	   as	   an	   optogenetic	   tool.	   Towards	   this	   aim,	   the	   photoswitchable	  
proteins	  CRY2	  or	  CIBN	  were	  stably	  expressed	  on	  the	  surfaces	  of	  MDA-­‐MB-­‐231	  cells	  to	  
switch	  on	  cell-­‐cell	  interactions	  under	  blue	  light.	  The	  hypothesis	  is	  that	  when	  CRY2	  and	  
CIBN	   expressing	   cells	   are	   mixed	   in	   equal	   proportions,	   they	   would	   form	   cell-­‐cell	  
contacts	  under	  blue	   light	   illumination	  and	  these	  contacts	  would	  reverse	   in	  the	  dark	  
(Figure	  2.1).	  
	  
Figure	  2.1	  Schematic	   representation	  of	  blue	   light	   induced	  cell-­‐cell	  contacts.	  Cells	  that	  express	  CRY2	  
(green)	  and	  CIBN	  (yellow)	  form	  cell-­‐cell	  interactions	  under	  blue	  light	  and	  dissociate	  from	  each	  other	  in	  
the	  dark.	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2.1.1	  Generation	  and	  characterization	  of	  stable	  cell	  lines	  
In	  order	  to	  control	  cell-­‐cell	  interactions	  with	  blue	  light,	  the	  first	  step	  is	  to	  display	  the	  
blue	   light	  dependent	  heterodimers,	  CRY2	  and	  CIBN,	  on	  the	  surfaces	  of	   the	  cells.	  To	  
maintain	  the	  expression	  of	  these	  proteins	  over	  longer	  periods,	  stable	  cell	  lines	  were	  
generated.	  The	  human	  breast	  cancer	  line,	  MDA-­‐MB-­‐231,	  was	  chosen	  as	  host	  cell	  line	  
since	  MDA-­‐MB-­‐231	  cells	  lack	  E-­‐cadherin	  expression	  and	  do	  not	  form	  any	  native	  cell-­‐
cell	   contacts.41	   To	   express	   these	   proteins	   on	   the	   cell	   surface,	   CRY2-­‐mCherry	   and	  
CIBN-­‐GFP	   were	   inserted	   into	   a	   plasmid	   (pDisplay)	   having	   an	   N-­‐terminal	   Igκ	   leader	  
sequence	   to	   lead	   the	   proteins	   into	   the	   secretory	   pathway	   and	   a	   C-­‐terminal	  
transmembrane	   domain	   of	   the	   platelet	   derived	   growth	   factor	   receptor	   (PDGFR)	  
(Figure	   2.2A).	   Subsequently,	   MDA-­‐MB-­‐231	   cells	   were	   transfected	   with	   either	  
pDisplay-­‐CRY2-­‐mCherry	  or	  pDisplay-­‐CIBN-­‐GFP	  plasmids	   to	   yield	  MDA-­‐CRY2-­‐mCherry	  
and	  MDA-­‐CIBN-­‐GFP	   stable	   cell	   lines	   that	   constantly	   express	   these	   proteins	   on	   the	  
their	  surfaces.	  For	  detection	  of	  mCherry	  and	  GFP	  signals	  from	  the	  transfected	  stable	  
cell	  lines,	  confocal	  imaging	  was	  done,	  which	  showed	  the	  expression	  of	  the	  CRY2	  and	  
CIBN	  fused	  to	  fluorescent	  proteins	  in	  the	  cells	  (Figure	  2.2B).	  
	  
Figure	   2.2	   Generation	   of	   MDA-­‐CRY2-­‐mCherry	   and	   MDA-­‐CIBN-­‐GFP	   stable	   cell	   lines.	   A)	   Protein	  
domains	  of	  pDisplay.	  B)	  Confocal	  images	  of	  MDA-­‐CRY2-­‐mCherry	  (left)	  and	  MDA-­‐CIBN-­‐GFP	  (right).	  Red:	  
mCherry,	  Green:	  GFP,	  Blue:	  DAPI.	  The	  discontinuous	  signal	  of	  mCherry	  and	  GFP	  observed	  from	  xz-­‐view	  
indicates	  the	  presence	  of	  the	  proteins	  on	  the	  plasma	  membrane.	  Scale	  bar:	  5	  μm.	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To	  further	  confirm	  that	  the	  CRY2	  and	  CIBN	  proteins	  were	  expressed	  in	  the	  stable	  cell	  
lines,	  the	  cells	  were	  immunostained	  for	  the	  c-­‐myc	  epitope,	  which	  is	  located	  between	  
the	  transmembrane	  domain	  of	  PDGFR	  and	  the	  protein	  of	  interest	  (CRY2-­‐mCherry	  and	  
CIBN-­‐GFP)	  in	  pDisplay	  plasmids	  (Figure	  2.3).	  To	  detect	  the	  protein	  in	  the	  whole	  cell,	  
cells	   were	   first	   permeabilized	   with	   Triton-­‐X-­‐100	   before	   the	   addition	   of	   anti-­‐c-­‐myc	  
antibody	   (Figure	  2.3A).	  To	  detect	   the	  protein	  expression	  only	   from	  the	  cell	  surface,	  
cells	  were	   incubated	  with	  anti-­‐c-­‐myc	  antibody	  without	  permeabilization	  so	   that	   the	  
antibody	  could	  only	  bind	  to	  the	  proteins	  on	  the	  plasma	  membrane	  (Figure	  2.3B).	  An	  
Alexa	  488	  conjugated	  secondary	  antibody	  was	  used	   to	  visualize	   the	  proteins	  and	  z-­‐
stack	   images	   were	   acquired	   from	   both	   permeable	   and	   impermeable	   cells.	   In	   the	  
permeabilized	  cells,	  where	  the	  whole	  cell	  proteins	  were	  detected,	   the	  side	  view	  (yz	  
axes)	  showed	  a	  continuous	  green	  signal,	  which	  indicates	  the	  proteins	  were	  expressed	  
in	   the	   cells	   and	   could	   be	   found	   both	   in	   the	   cytosol	   and	   on	   the	   plasma	  membrane	  
(Figure	   2.3A).	   This	  was	   expected	   since	   the	   transmembrane	   domain	   fused	   to	   these	  
proteins	  can	  localize	  the	  protein	  to	  all	  membranes	  in	  the	  cells	  via	  vesicular	  trafficking.	  
The	   side	   view	   (yz	   axes)	   of	   impermeable	   cells	   showed	  a	   discontinuous	   green	   signal,	  
which	   indicates	   that	   the	   proteins	   were	   on	   the	   plasma	   membrane	   (Figure	   2.3B).	  
Hence,	  immunostainings	  confirmed	  that	  CRY2	  and	  CIBN	  proteins	  were	  expressed	  and	  
localized	  on	  the	  cell	  membrane.	  	  
	  
The	  constant	  expression	  of	  CRY2	  and	  CIBN	  on	  the	  cell	  surface	  provides	  maintenance	  
for	   longer	   periods.	   Compared	   to	   other	   approaches	   in	   which	   cell	   surfaces	   are	  
chemically	  modified,	  the	  use	  of	  genetically	  encodable	  proteins	   is	  an	  advantage.	  The	  
chemical	   modifications	   of	   cell	   surfaces	   may	   lead	   to	   decrease	   in	   cell	   viability	   and	  






Figure	  2.3	  Immunostaining	  for	  c-­‐myc	  epitope	  showing	  the	  expression	  of	  CRY2	  and	  CIBN	  on	  the	  cell	  
surface.	  The	  c-­‐myc	  epitope	  was	  used	  to	  detect	  protein	  expression	  A)	  in	  the	  whole	  cell	  (permeable)	  and	  
B)	  on	  the	  cell	  surface	  (impermeable).	  MDA-­‐MB-­‐231	  cells	  were	  used	  as	  negative	  control.	  Blue:	  Nuclear	  
stain	   (DAPI),	   Red:	   F-­‐Actin	   stain	   (phalloidin-­‐TRITC)+mCherry,	   Green:	   c-­‐myc	   epitope	   (goat	   anti-­‐Mouse	  
Alexa	   Fluor	   488)+GFP.	   The	   discontinuous	   green	   signal	   in	   the	   yz-­‐axis	   is	   due	   to	   the	   proteins	   on	   the	  
plasma	  membrane.	  Scale	  bar:	  5	  μm.	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2.1.2	  Blue	  light	  induced	  heterophilic	  cell-­‐cell	  interactions	  
It	  was	  hypothesized	   that	  upon	  blue-­‐light	   illumination	  cells	  expressing	   the	  blue	   light	  
sensitive	  complementary	  interaction	  partners,	  CRY2	  and	  CIBN,	  will	  interact	  and	  form	  
cell	   clusters	   (Figure	   2.1).	   In	   order	   to	   test	   this	   hypothesis,	  MDA-­‐CRY2-­‐mCherry	   and	  
MDA-­‐CIBN-­‐GFP	   cells	   were	   mixed	   in	   equal	   proportions	   and	   incubated	   in	   dark	   and	  
under	  blue	   light	   (480	  nm,	  80	  μW/cm2)	   for	  4	  hours.	  After	   incubation,	   the	  cells	  were	  
fixed	  and	  bright	  field	  microscopy	  images	  were	  obtained	  (Figure	  2.4A).	  The	  bright	  field	  
images	  showed	  clusters	  of	  cells	  in	  the	  cultures	  that	  were	  incubated	  under	  blue	  light	  
illumination	   and	  mostly	   single	   cells	   in	   cultures	   kept	   in	   the	   dark.	   This	   demonstrates	  
that	   the	  blue	   light	  dependent	   interactions	  between	  cells	  expressing	  CRY2	  and	  CIBN	  
on	  the	  cell	  surface	  is	  suitable	  to	  induce	  cell-­‐cell	  interactions.	  
	  
In	   order	   to	   quantify	   these	   interactions,	   the	   actin	   cytoskeleton	   was	   stained	   with	  
phalloidin-­‐TRITC	  and	  the	  nucleus	  with	  DAPI.	  Fluorescence	  images	  of	  a	  total	  area	  of	  1	  
cm2	  were	  obtained	  in	  the	  TRITC	  and	  DAPI	  channels	  	  (Figure	  2.4B).	  The	  actin	  staining	  
was	   used	   to	   visualize	   the	   cell	   boundaries	   and	  measure	   the	   spreading	   area	   of	   cells,	  
which	  allowed	  to	  separate	  single	  cells	  from	  cells	  in	  clusters.	  Based	  on	  that,	  the	  area	  
occupied	  by	  clusters	  having	  more	  than	  3	  cells	  (objects	  with	  an	  area	  >	  10000	  µm2)	  and	  
by	   single	   cells	   (objects	  with	   an	   area	   of	   300-­‐3000	  µm2)	  were	   calculated	   in	   dark	   and	  
under	   blue	   light	   from	   the	   TRITC	   channel.	   The	   %	   area	   was	   then	   calculated	   by	  
normalizing	  the	  total	  area	  of	  clusters	  to	  that	  of	  all	  cells	  as	  follows:	  
	   %  𝑎𝑟𝑒𝑎 =   Σ  𝑎𝑟𝑒𝑎  𝑜𝑐𝑐𝑢𝑝𝑖𝑒𝑑  𝑏𝑦  𝑐𝑙𝑢𝑠𝑡𝑒𝑟𝑠   ≥   3  𝑐𝑒𝑙𝑙𝑠Σ  𝑎𝑟𝑒𝑎  𝑜𝑐𝑐𝑢𝑝𝑖𝑒𝑑  𝑏𝑦  𝑎𝑙𝑙  𝑐𝑒𝑙𝑙𝑠   𝑥  100	  
	  
DAPI	  staining	  was	  used	  to	  determine	  the	  total	  number	  of	  cells	  in	  the	  cultures	  in	  order	  
to	   confirm	   that	   the	   increase	   in	   cell	   clustering	   under	   blue	   light	   was	   not	   due	   to	  
differences	   in	  cell	   seeding.	  The	   total	  number	  of	  cells	  was	  calculated	   for	   the	  objects	  




Figure	  2.4	  Blue	  light	  induced	  cell-­‐cell	  interactions.	  A)	  Bright	  field	  images	  of	  MDA-­‐CRY2	  and	  MDA-­‐CIBN	  
co-­‐culture	  in	  dark	  and	  under	  blue	  light	  illumination.	  Scale	  bar:	  80	  μm	  B)	  Fluorescence	  images	  of	  MDA-­‐
CRY2	   and	  MDA-­‐CIBN	   co-­‐culture	   in	   dark	   and	   under	   blue	   light	   illumination.	   Cells	   cultured	   in	   the	   dark	  
remained	   as	   single	   cells	   but	   cells	   cultured	   under	   blue	   light	   formed	   cell	   clusters	   due	   to	   CRY2-­‐CIBN	  
heterodimerization.	  Red:	  actin	  stain,	  Blue:	  nuclear	  stain.	  Scale	  bar:	  50	  μm.	  
	  
To	  quantify	  the	  light	  dependent	  clustering,	  cell	  density	  in	  the	  co-­‐cultures	  of	  CRY2	  and	  
CIBN	  expressing	  cells	  was	  adjusted	  depending	  on	  their	  clustering	  behavior	  under	  blue	  
light	  illumination	  and	  in	  the	  dark	  (Figure	  2.5).	  The	  two	  cell	  types	  were	  mixed	  in	  a	  1:1	  
ratio,	   seeded	   at	   densities	   of	   2000,	   5000,	   10	   000,	   20	   000	   and	   50	   000	   cells/cm2	  and	  
were	  cultured	  under	  blue	  light	  illumination	  or	  in	  the	  dark	  for	  4	  hours.	  Quantification	  
of	   the	   cluster	   formation	   in	   terms	   of	   %	   area	   and	   the	   total	   number	   of	   cells	   was	  
performed	   as	   described	   above.	   The	   DAPI	   count	   showed	   that	   there	   was	   not	   any	  
significant	  difference	  in	  the	  total	  number	  of	  cells	  between	  the	  cultures	  incubated	  in	  




Figure	  2.5	  Cell	  number	  optimization	  for	  blue	  light	  induced	  cell-­‐cell	  interactions. MDA-­‐CRY2-­‐mCherry	  
and	  MDA-­‐CIBN-­‐GFP	   cells	  were	   seeded	   in	   equal	   proportions	   at	   different	   cell	   densities.	   	  A)	   Total	   cell	  
number	  after	  4	  hours	  incubation,	  which	  was	  calculated	  from	  the	  DAPI	  staining.	  B)	  %	  area	  occupied	  by	  
cell	  clusters	  and	  single	  cells	  at	  the	  different	  cell	  densities.	  The	  error	  bars	  are	  the	  standard	  error	  of	  the	  
mean	  of	  two	  technical	  replicates.	  
	  
The	  occupied	  %	  area	  analysis	  showed	  that	  at	  higher	  cell	  densities	  (>10	  000	  cells/cm2),	  
the	   light	   dependent	   cell-­‐cell	   interactions	   were	   not	   distinguishable	   from	   general	  
crowding	   in	   the	  cell	   culture	  and	  at	  very	   low	  cell	  densities	   (2000	  cells/cm2)	   the	  cells	  
were	   too	   sparse	   to	   efficiently	   interact	   with	   each	   other	   (Figure	   2.5B).	   Hence,	   the	  
optimal	  cell	  density	  was	  determined	  as	  5000	  cells/cm2.	  	  
	  
A	  potential	   error	   source	   is	   the	  phototoxicity	   caused	  by	  blue	   light	   illumination	   since	  
some	   cell	   lines	   are	   known	   to	   be	   sensitive	   to	   photostress.130	   In	   order	   to	   detect	  
whether	   the	  blue	   light	   illumination	  used	   in	   these	  experiments	  caused	  phototoxicity	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and	   to	   determine	   the	   range	   of	   non-­‐toxic	   blue	   light	   intensity,	   the	   cell	   viability	   was	  
checked	  for	  the	  parent	  cell	  line	  MDA-­‐MB-­‐231	  using	  the	  MTT	  assay	  at	  three	  different	  
light	  intensities	  (Figure	  2.6).	   In	  the	  host	  cell	   line	  (MDA-­‐MB-­‐231),	  no	  phototoxicity	  at	  
80	  μW/cm2	  after	  4	  hours	  incubation	  was	  observed,	  which	  were	  the	  parameters	  used	  
in	  all	  experiments.	  It	  was	  also	  observed	  that	  cell	  viability	  was	  not	  lowered	  even	  at	  a	  
100-­‐fold	   higher	   light	   intensity	   in	   the	   given	   incubation	   period	   (8000	   μW/cm2,	   4	   h	  
illumination).	   This	   also	   demonstrates	   that	   the	   here	   used	   light	   intensities	   were	   not	  
harmful	   and	   that	   this	   approach	   is	   non-­‐hazardous	   for	   cells.	   Therefore,	   blue-­‐light	  
dependent	   CRY2/CIBN	   heterodimerization	   provides	   a	   platform	   to	   control	   cell-­‐cell	  
interactions	  non-­‐invasively,	  as	  opposed	  to	  for	  the	  UV	  light	  controlled	  systems.52-­‐54	  
	  
	  
Figure	  2.6	  Cell	  viability	  under	  blue	  light	  illumination.	  MDA-­‐MB-­‐231	  cells	  were	  incubated	  under	  three	  
different	  intensities	  of	  blue	  light	  and	  in	  dark	  for	  4	  hours.	  Subsequently,	  cell	  viability	  was	  measured	  by	  
MTT	  assay.	  The	  absorbance	  values	  were	  normalized	  to	  the	  dark	  value	  to	  determine	  %	  cell	  viability.	  80	  
µW/cm2	  blue	  light	  illumination	  was	  used	  in	  all	  other	  cell	  experiments.	  The	  measurements	  were	  done	  in	  
duplicates	  and	  the	  error	  bars	  are	  standard	  error	  of	  the	  mean.	  
	  
After	   confirming	   that	   the	   blue	   light	   intensity	   (80	   μW/cm2)	  was	   non-­‐hazardous	   and	  
obtaining	  the	  optimal	  cell	  density	  (5000	  cells/cm2),	  the	  co-­‐cultures	  of	  CRY2	  and	  CIBN	  
expressing	   cells	  were	   incubated	  under	  blue	   light	   and	   in	  dark	   and	   cluster	   formation	  
was	  quantified	  as	  described	  above.	   	  The	  area	  occupied	  by	  cell	   clusters	   increased	  6-­‐
fold	  under	  blue	  light	  illumination	  compared	  to	  dark	  (Figure	  2.7A).	  Similarly,	  the	  area	  
occupied	   by	   single	   cells	   was	   higher	   in	   the	   dark	   in	   the	   co-­‐culture.	   In	   the	   same	   co-­‐
cultures,	   number	   of	   clusters	   with	   ≥3	   cells	   was	   also	   calculated.	   There	   were	   180	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clusters/cm2	   in	   the	  co-­‐culture	   incubated	  under	  blue	   light	   illumination	  whereas	  only	  
20	   clusters/cm2	   could	   be	   detected	   in	   the	   co-­‐culture	   that	   was	   kept	   in	   dark	   (Figure	  
2.7B)	  
	  
CRY2	  has	  been	  shown	  to	  homodimerize	  to	  some	  extent	  under	  blue	  light.94	  In	  order	  to	  
exclude	   the	   effect	   of	   homodimerization	   of	   CRY2	   on	   cell	   clustering,	   the	   same	  
experimental	   conditions	   were	   used	   for	   the	   monocultures	   of	   CRY2	   and	   CIBN	  
expressing	   cells.	   It	   was	   observed	   that	   CRY2	   and	   CIBN	   expressing	   cells	   were	   found	  
mainly	  as	  single	  cells	  both	  in	  dark	  and	  under	  blue	  light	  (Figure	  2.7A)	  with	  low	  number	  
of	   clusters	   (Figure	   2.7B),	   resembling	   the	   co-­‐cultures	   kept	   in	   the	   dark.	   Again,	   there	  
was	  no	  significant	  difference	  in	  the	  total	  number	  of	  cells	  in	  all	  cultures	  (Figure	  2.7C).	  
Hence,	   these	  data	  demonstrates	   that	   the	  blue	   light	  dependent	  cell-­‐cell	   interactions	  
are	  heterophilic	  and	  mediated	  by	  specific	  CRY2-­‐CIBN	  heterodimerization.	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Figure	  2.7	  Quantification	  of	  cell-­‐cell	  interactions	  between	  CRY2	  and	  CIBN	  expressing	  cells	  in	  dark	  and	  
under	  blue	  light.	  A)	  %	  Area	  of	  cells	  that	  grow	  in	  cell	  clusters	  and	  as	  single	  cells.	  The	  cells	  kept	  in	  dark	  
primarily	   stayed	   isolated,	   whereas	   cells	   grown	   under	   blue	   light	   showed	   a	   higher	   number	   of	   cell	  
clusters.	   MDA-­‐CRY2-­‐mCherry	   and	   MDA-­‐CIBN-­‐GFP	   cells	   formed	   heterophilic	   and	   not	   homophilic	  
interactions	  since	  in	  monocultures	  cells	  grew	  as	  single	  cells.	  B)	  The	  number	  of	  cell	  clusters	  having	  ≥3	  
cells	   and	   single	   cells	   in	   the	   dark	   and	   under	   blue	   light.	   C)	   The	   number	   of	   cells	   in	   the	   co-­‐	   and	  
monocultures	  of	  MDA-­‐CRY2-­‐mCherry	  and	  MDA-­‐CIBN-­‐GFP	  cells	  were	  measured	  to	  prevent	  any	  errors	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due	  to	  cell	  number.	  There	  was	  not	  any	  significant	  difference	  between	  the	  number	  of	  cells,	  which	  may	  
affect	   the	   size	   or	   amount	   of	   the	   clusters.	   The	   error	   bars	   are	   the	   standard	   error	   of	   the	  mean	   from	  
technical	   duplicates	   with	   2	   replicates	   each.	   Unpaired	   parametric	   t-­‐test	   was	   used	   for	   statistical	  
significance	  (p	  value	  <0.0001	  (****),	  p	  value	  <	  0.001	  (***),	  p	  value<0.01	  (**)).	  
	  
2.1.3	  Reversible	  control	  of	  blue	  light	  dependent	  cell-­‐cell	  interactions	  
A	  critical	  merit	  of	  the	  CRY2-­‐CIBN	  based	  cell-­‐cell	  interactions	  is	  that	  these	  interactions	  
are	  reversed	  in	  the	  dark,	  which	  reflects	  the	  dynamic	  and	  reversible	  nature	  of	  cell-­‐cell	  
interactions.	  The	  interaction	  between	  CRY2	  and	  CIBN	  has	  been	  reported	  to	  turn	  on	  in	  
a	  few	  seconds	  with	  blue	  light	  when	  the	  protein	  is	  located	  directly	  towards	  each	  other	  
and	  to	  turn	  off	  in	  a	  couple	  of	  minutes	  in	  the	  dark.91	  To	  show	  the	  reversibility	  of	  blue	  
light	   dependent	   cell-­‐cell	   interactions,	   MDA-­‐CRY2-­‐mCherry	   cells	   were	   seeded	   on	  
adhesive	   circular	   patterns	   with	   20	   µm	   in	   diameter,	   such	   that	   isolated	  MDA-­‐CRY2-­‐
mCherry	  cells	  grew	  on	  an	  otherwise	  non-­‐adhesive	  background.	  Subsequently,	  MDA-­‐
CIBN-­‐GFP	  cells	  were	  added	  and	  their	   interactions	  with	  the	  MDA-­‐CRY2-­‐mCherry	  cells	  
were	   monitored	   under	   blue	   light	   and	   in	   the	   dark	   and	   a	   time-­‐lapse	   movie	   was	  
recorded	  in	  light/dark	  cycles	  (Figure	  2.8A).	  CIBN	  cells	  were	  seeded	  on	  top	  of	  the	  CRY2	  
expressing	  cells	  under	  blue	  light	  illumination	  and	  the	  first	  time	  interval	  was	  set	  as	  30	  
min	  to	  allow	  CIBN	  cells	  to	  settle	  and	  interact	  with	  the	  CRY2	  cells.	  Then	  the	  blue	  light	  
was	  switched	  off	  and	  imaging	  time	  intervals	  were	  shortened	  to	  20	  min	  which	  allowed	  
to	  monitor	  many	  cells	  at	  one	  time	  point	  and	  also	  to	   follow	  the	   fast	   interaction	  and	  
dissociation	   of	   the	   proteins	   that	   were	   reported	   to	   take	   place	   within	   several	  
minutes.91	   It	   was	   observed	   that	   under	   blue	   light	   illumination	   MDA-­‐CIBN-­‐GFP	   cells	  
stayed	   close	   to	   MDA-­‐CRY2-­‐mCherry	   cells	   showing	   a	   reduced	   mobility	   upon	  
interacting	  with	  MDA-­‐CRY2-­‐mCherry	  cells.	  When	  the	  blue	  light	  was	  switched	  off,	  the	  
MDA-­‐CIBN-­‐GFP	  cells	  gained	  mobility	   in	  dark	  due	  to	   the	  dissociation	   from	  the	  MDA-­‐
CRY2-­‐mCherry	  cells.	  This	  cycle	  was	  performed	  twice	  and	  each	  time	  under	  blue	   light	  
the	  two	  cells	  interacted	  with	  each	  other	  and	  dissociated	  from	  each	  other	  in	  the	  dark.	  
Hence,	   these	   blue	   light	   dependent	   cell-­‐cell	   interactions	   are	   reversible	   and	   can	   be	  
switched	  on	  and	  off	  repeatedly.	  	  
Based	  on	  this	  time-­‐lapse	  movie,	  the	  distance	  between	  CIBN	  and	  CRY2	  expressing	  cells	  
was	  calculated	  at	  each	  minute	   for	   the	   repeated	   light/dark	  cycles	   (Figure	   2.8B).	  The	  
boundaries	  of	   the	  CRY2	  and	  CIBN	  expressing	  cells	  were	  marked	  with	  red	  and	  green	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circles,	   respectively.	   It	  was	  observed	   that	   the	  distance	  between	   the	  CRY2	  and	  CIBN	  
expressing	   cells	   increased	   to	   a	  maximum	   of	   15	   μm	   in	   the	   dark	   within	   1	  min.	   This	  
distance	  completely	  disappeared	  also	  within	  1	  min	  when	  the	  blue	  light	  was	  switched	  
on.	   This	   is	   a	   similar	   time	   range	   to	   what	   was	   observed	   with	   the	   photoswitchable	  
protein	  interactions	  based	  on	  this	  pair.91	  	  
	  
Figure	  2.8	  Reversible	   control	  of	   cell-­‐cell	   interactions.	  A)	  Phase	  contrast	   images	  from	  the	  time-­‐lapse	  
movie	  showing	  the	  binding	  of	  a	  MDA-­‐CIBN-­‐GFP	  cell	   (green	  circle)	  to	  an	  MDA-­‐CRY2-­‐mCherry	  cell	   (red	  
circle)	   under	   blue	   light	   and	   its	   dissociation	   in	   the	   dark.	   Scale	   bar:	   25	   μm.	  B)	   Distance	   between	   the	  
MDA-­‐CRY2-­‐mCherry	   and	   MDA-­‐CIBN-­‐GFP	   cells	   over	   time.	   The	   distance	   between	   the	   two	   cells	  
decreased	  under	  blue	   light	  due	   to	   the	  CRY2/CIBN	  heterodimerization	  and	   increased	   in	  dark	  due	   the	  
CRY2/CIBN	  dissociation.	  
	  
Up-­‐to-­‐date	  there	  are	  few	  studies	  showing	  reversible	  control	  of	  cell-­‐cell	   interactions.	  
The	   first	   one	   was	   based	   on	   modifications	   of	   the	   plasma	   membranes	   with	   the	  
chemically	   self-­‐assembled	   nanorings	   (CSANs)	   targeting	   specific	   receptors	   on	  
neighboring	   cells	   (Figure	   1.10E).48	   Cell-­‐cell	   assembly	   triggered	   by	   CSANs	   could	   be	  
reversed	   by	   a	   competitor	   molecule	   for	   DHFRs,	   trimethoprim.	   However,	   in	   the	  
presence	   of	   trimethoprim,	   CSANs	   dissociated	   completely	   from	   the	   plasma	  
membrane;	   hence,	   cell-­‐cell	   assembly	   could	   not	   be	   re-­‐established.	   Additionally,	   this	  
approach	  does	  not	  provide	  spatial	  control	  over	  cell-­‐cell	  interactions.	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Light	   is	   a	   powerful	   tool	   to	   achieve	   spatiotemporal	   control	   over	   these	   interactions	  
since	   the	  stimulus	  can	  be	  delivered	  at	   the	  speed	  of	   light.	  Recently,	   light	   responsive	  
small	  molecules	  were	  also	   introduced	  on	   the	  plasma	  membrane	   to	   control	   cell-­‐cell	  
interactions.52-­‐54	  One	  approach	  was	  to	  introduce	  either	  oxyamines	  or	  ketone	  groups	  
on	  the	  plasma	  membrane	  by	  liposome	  fusion	  and	  a	  photocleavage	  site	  between	  the	  
oxyamines	   and	   the	   lipid	   bilayer	   (Figure	   1.11A).54	   When	   oxyamines	   and	   ketone	  
bearing	  cells	  were	  mixed,	  a	  covalent	  bond	  was	  formed	  between	  the	  cells	  and	  due	  to	  
the	  presence	  of	  the	  photocleavable	  linker,	  this	  bond	  would	  be	  irreversibly	  broken	  by	  
UV	   light.	   Again,	   the	   cell-­‐cell	   contacts	   could	   not	   be	   re-­‐established	   due	   to	   the	  
irreversibility	  of	   loss	  of	  covalent	  bonds	  between	  the	  chemical	  groups.	  Furthermore,	  
UV	  light	  is	  invasive	  and	  can	  damage	  the	  cells.	  	  
	  
Shi	  et	   al.	   controlled	   cell-­‐cell	   interactions	   reversibly	   and	  dynamically	   by	   labeling	   the	  
plasma	  membranes	  with	  β-­‐cyclodextrin	  and	  used	  host-­‐guest	  interactions	  between	  β-­‐
cyclodextrin	  and	  azobenzenes	  (Figure	  1.11B).52,53	   In	  this	  study,	  formation	  of	  cell-­‐cell	  
interactions	  was	   triggered	  by	   visible	   light	   and	   cell	   disassembly	  was	  achieved	  by	  UV	  
light	  illumination,	  and	  assembly-­‐disassembly	  cycle	  could	  be	  repeated.	  Apart	  from	  the	  
continuous	   UV	   exposure	   of	   cells,	   β-­‐cyclodextrin/azobenzene	   association	   and	  
dissociation	  have	   slower	   kinetics	   compared	   to	   the	  blue	   light	  dependent	  CRY2/CIBN	  
heterodimerization.	  	  
While	   cell	   assembly	   and	   disassembly	   mediated	   by	   azobenzenes	   took	   place	   in	   10	  
minutes,53	  this	  was	  achieved	  within	  2	  minutes	  with	  CRY2/CIBN	  system	  (Figure	  2.8B).	  
Thus,	   blue	   light	   dependent	   CRY2/CIBN	   heterodimerization	   provides	   a	   sustainable,	  









2.1.4	  Layer-­‐by-­‐layer	  tissue	  formation	  by	  blue	  light	  illumination	  
For	   tissue	   engineering	   and	   artificial	   organ	   research,	   a	   big	   challenge	   is	   to	   construct	  
three-­‐dimensional	   tissues	   consisting	   of	  multiple	   cell	   types.131	   Recently,	   two	   studies	  
showed	  3D	  tissue	  formation	  with	  the	  bottom-­‐up	  approach	  by	  ssDNA	  hybridization51,	  
which	  was	  then	  combined	  with	  a	  matrigel,	  and	  oxime	  ligation,42,43	  in	  which	  the	  ECM	  
secreted	  by	  the	  cells	  was	  used	  as	  mechanical	  support.	   In	  this	  thesis,	  CRY2	  and	  CIBN	  
expressing	  cells	  were	  used	  to	  constitute	  a	  defined	  microtissue	  from	  the	  bottom-­‐up	  by	  
seeding	   the	   cells	   layer-­‐by-­‐layer.	  Pre-­‐stained	  CIBN	  cells	   (in	  green)	  were	   seeded	  on	  a	  
glass	   bottom	   dish	   and	   grown	   to	   confluency	   overnight.	   Then,	   pre-­‐stained	   CRY2	  
expressing	   cells	   (in	   red)	   were	   seeded	   on	   top	   of	   CIBN	   cells.	   This	   co-­‐culture	   was	  
incubated	  under	  blue	  light	  and	  in	  the	  dark	  for	  8	  hours.	  Then,	  the	  cells	  were	  fixed	  and	  
stained	   for	   nuclei.	   In	   order	   to	   obtain	   z-­‐stack	   images	   of	   the	   micro-­‐tissue,	   confocal	  
microscopy	  was	  used	   (Figure	  2.9).	   In	   the	  dark,	   there	  was	  only	  a	  monolayer	  of	  CIBN	  
expressing	  cells	  and	  no	  CRY2	  cells	  were	  found	  to	  form	  a	  second	  layer	  on	  top	  of	  CIBN	  
cells	  	  (Figure	  2.9A).	  For	  the	  cells	  cultured	  under	  blue	  light	  illumination,	  formation	  of	  
two	  layers	  was	  observed	  at	  many	  different	  positions	  (Figure	  2.9B).	  	  
	  
Two	  complete	  monolayers	  on	  top	  of	  each	  other	  throughout	  the	  surface	  could	  not	  be	  
observed.	   This	   could	   be	   because	   CIBN	   expressing	   cells	   could	   not	   form	   a	   firm	  
monolayer	   due	   to	   lack	   of	   native	   cell-­‐cell	   contacts	   and	   lack	   of	   homodimerization	   of	  
CIBN.	   This	   led	   CRY2	   expressing	   cells	   also	   adhere	   to	   glass	   surface,	   in	   between	   CIBN	  
expressing	   cells.	   However,	   absence	   of	   any	   layer	   formation	   in	   the	   co-­‐culture	   in	   the	  
dark	  but	  only	  under	  blue	  light	  shows	  that	  the	  layers	  were	  formed	  through	  CRY2-­‐CIBN	  
heterodimerization.	   This	   system	   can	   be	   further	   optimized	   and	   utilized	   to	   obtain	  
scaffold-­‐free	  multicellular	  in	  vitro	  tissue	  formation	  defined	  by	  blue	  light	  illumination.	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Figure	  2.9	  Layer-­‐by-­‐layer	  tissue	  formation	  under	  blue	  light	  illumination.	  A)	  in	  the	  dark.	  Stack	  number	  
is	  8	  of	  44	  slices	  for	  the	  xy	  view.	  	  B)	  under	  blue	  light	  illumination.	  Stack	  number	  is	  23	  of	  54	  slices	  for	  the	  
xy	  view.	  Side	  views	  (yz	  and	  xz)	  shows	  that	  A)	  there	  is	  only	  a	  monolayer	  of	  CIBN	  expressing	  cells	  in	  the	  
dark	  whereas	  B)	  under	  blue	   light,	  CRY2	  expressing	  cells	   interacted	  with	  CIBN	  cells	   to	   form	  a	   second	  
layer.	  Blue:	  nuclear	  stain,	  green:	  MDA-­‐CIBN-­‐GFP	  cells,	  red:	  MDA-­‐CRY2-­‐mCherry	  cells.	  Scale	  bar:	  30	  μm.	  
	   	  
	  50	  
2.2	  Part	  2:	  Blue	  and	  red	  light	  controlled	  cell-­‐substrate	  interactions	  
Cells	   respond	   to	   their	   immediate	   environment	   by	   interacting	   with	   different	  
components	   of	   ECM	   and	   this	   interaction	   regulates	   cellular	   processes	   such	   as	  
adhesion,	  migration	   and	   apoptosis.55,56	   Different	   ligands	   presented	   in	   the	   ECM	   are	  
recognized	  by	  different	  cells	  and	  independent	  control	  of	  the	  interactions	  of	  different	  
cell	  types	  with	  different	  matrices	  is	  of	  central	  importance	  for	  tissue	  engineering	  and	  
medical	   implantation.55,56	   Current	   approaches	   to	   control	   cell-­‐material	   interactions	  
with	  multiple	   cell	   types	   involve	  modification	  of	   substrates	  with	  peptidomimetics	   as	  
ligands	   for	   different	   integrins,57,58	   antibodies	   for	   specific	   cell	   surface	   markers,59,62	  
ssDNA	  molecules,60,61	  and	  preformed	  micro-­‐	  and	  nano-­‐patterns.63,64	  These	  strategies	  
provide	   selective	   adhesion	   of	   multiple	   cell	   types	   to	   functionalized	   materials;	  
however,	   they	   do	   not	   capture	   the	   reversibility	   of	   native	   cell	   adhesions	   and	   only	  
provide	  spatiotemporal	  control.	  Light	  responsive	  functional	  molecules	  such	  as	  caging	  
groups,65-­‐67	   azobenzenes68-­‐70	   and	   UCNPs71,72	   have	   been	   employed	   to	   achieve	   the	  
spatiotemporal	   control	   over	   cell-­‐material	   interactions.	   Although	   azobenzenes	   and	  
UCNPs	  provide	  reversible	  control,	  they	  are	  invasive	  due	  to	  the	  exposure	  of	  cells	  to	  UV	  
light.	   The	   major	   drawback	   of	   these	   platforms	   is	   that	   none	   of	   them	   provides	  
independent	   and	   spatiotemporal	   control	   over	   cell-­‐material	   interactions	   in	   a	  
multicellular	   environment.	   Hence,	   a	   platform	   that	   provides	   reversible	   and	  
spatiotemporal	   control	  over	   cell-­‐material	   interactions	  and	   that	  allows	   cell	   adhesion	  
ligands	   to	   specifically	   interact	  with	  different	  cells	   is	  needed.	  The	  aim	  of	   the	  second	  
part	   of	   this	   thesis	   is	   to	   reversibly	   control	   cell-­‐material	   interactions	   of	  multiple	   cell	  
types	   in	   space	   and	   time	   by	   using	   CRY2/CIBN	   and	   PhyB/PIF6	   heterodimers	   as	  
optogenetic	   tools.	   Towards	   this	   aim,	   the	   photoswitchable	   proteins	   CRY2	   or	   PhyB	  
were	  expressed	  on	  the	  surfaces	  of	  MDA-­‐MB-­‐231	  cells	  to	  turn	  on	  the	  cell	  binding	  on	  
the	   substrates	   with	   the	   complementary	   interaction	   partners	   -­‐CIBN	   or	   PIF6-­‐	   under	  
blue	  or	  red	   light,	   respectively.	   It	  was	  hypothesized	  that	  by	   incubating	  the	  CRY2	  and	  
PhyB	   expressing	   cells	   on	   CIBN	   and	   PIF6	   functionalized	   substrates	   in	   the	   dark	   and	  
under	  blue	  and/or	  red	  light,	  different	  cell-­‐material	  interactions	  can	  be	  turned	  on	  and	  
off	  orthogonally	  in	  a	  wavelength-­‐dependent	  manner	  (Figure	  2.10).	  	  
	  51	  
	  
Figure	   2.10 Schematic	   representation	   of	   orthogonal	   and	   reversible	   control	   of	   cell-­‐material	  
interactions.	  Cells	  that	  express	  CRY2	  (green	  cell)	  or	  PhyB	  (orange	  cell)	  on	  their	  surfaces	  orthogonally	  
bind	  to	  substrates	  presenting	  CIBN	  and	  PIF6	  under	  blue	  or	  red	  light,	  respectively.	  In	  the	  dark	  neither	  of	  
the	  cells	  binds	   to	   the	  substrate.	  Under	  blue	   light	  only	  CRY2	  cells	  and	  under	   red	   light	  only	  PhyB	  cells	  
bind	  to	  the	  substrate.	  Both	  CRY2	  and	  PhyB	  cells	  bind	  to	  the	  substrate	  under	  co-­‐illumination	  with	  blue	  
and	  red	  light.	  All	  binding	  events	  are	  reversible	  in	  the	  dark.	  
	  
2.2.1	  Cell	  lines,	  protein	  purification	  and	  characterization	  
To	   achieve	   blue	   and	   red	   light	   controlled-­‐cell	   material	   interactions,	   one	   of	   the	  
complementary	  heterodimers	   is	   displayed	  on	   the	   cell	   surface	   (CRY2	  or	   PhyB)	  while	  
the	   other	   partner	   (CIBN	   or	   PIF6)	   is	   presented	   on	   a	   functionalized	   non-­‐adhesive	  
substrate	  (Figure	  2.10).	  In	  order	  to	  display	  CRY2	  and	  PhyB	  on	  the	  surfaces	  of	  the	  cells,	  
the	  genes	  encoding	  these	  proteins	  were	  inserted	  into	  a	  plasmid	  (pDisplay)	  having	  an	  
N-­‐terminal	  Igκ	  leader	  sequence	  to	  lead	  the	  proteins	  into	  the	  secretory	  pathway	  and	  a	  
C-­‐terminal	   transmembrane	   domain	   of	   the	   platelet	   derived	   growth	   factor	   receptor	  
(PDGFR).	   Subsequently,	   MDA-­‐MB-­‐231	   cells	   were	   transfected	   with	   pDisplay-­‐CRY2-­‐
mCherry	  and	  pDisplay-­‐PhyB-­‐YFP	  plasmids	   to	  yield	  MDA-­‐CRY2	  and	  MDA-­‐PhyB	   stable	  
cell	   lines	   that	  constantly	  express	   these	  proteins	  on	   their	   surfaces.	  The	   fluorescence	  
from	   the	   fused	  mCherry	   and	   YFP	   proteins	   in	   the	   stable	   cell	   lines	   was	   detected	   in	  
confocal	   imaging.	   This	   showed	   the	   expression	   of	   the	   CRY2	   and	   PhyB	   fused	   to	  
fluorescent	   proteins	   inside	   and	   on	   the	   surfaces	   of	   the	   cells	   (Figure	   2.11A).	  
Meanwhile,	  PIF6	  and	  CIBN	  were	  cloned	   into	  a	  pET21b	  vector,	  which	   includes	  an	  N-­‐
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terminal	  His6	  sequence.	  After	  bacterial	  expression	  of	  CIBN	  and	  PIF6	   in	  E.	  coli,	   these	  
proteins	   were	   purified	   by	   affinity	   and	   size	   exclusion	   chromatography.	   The	   purified	  
proteins	  were	   characterized	  with	   SDS-­‐PAGE	   (Figure	   2.11B),	  which	   showed	   that	   the	  
bands	   for	   CIBN-­‐GFP-­‐His6	   and	   PIF6-­‐CFP-­‐His6	   were	   at	   50	   and	   40	   kDa,	   respectively,	  
corresponding	  to	  their	  molecular	  weight	  and	  that	  both	  proteins	  were	  pure	  after	  two-­‐
step	   purification	   indicated	   by	   the	   presence	   of	   single	   bands	   for	   each.	   For	  
immobilization	   of	   CIBN	   and	   PIF6,	   a	   glass	   surface	   was	   functionalized	   with	   azide	  
terminated	   poly(ethylene	   glycol)	   (PEG-­‐N3)	   through	   silanization	   reaction	   to	   obtain	   a	  
non-­‐adhesive	  area.	  Subsequently,	  an	  alkyne	  with	  an	  NTA	  group	  was	  clicked	  through	  
copper	  catalyzed	  azide	  alkyne	  cycloaddition	  (CuAAC)	  reaction	  (Section	  6.2).132	  Then,	  
these	  surfaces	  were	  incubated	  first	  with	  100	  mM	  NiCl2,	  then	  with	  10	  μM	  CIBN	  and/or	  
PIF6	  to	  achieve	  His6-­‐Ni2+-­‐NTA	  coordination	  for	  immobilization.	  	  
	  
Figure	   2.11	  Characterization	  of	   stable	   cell	   lines	   and	  purified	  proteins.	  A)	  Confocal	   images	  of	  MDA-­‐
CRY2	  and	  MDA-­‐PhyB	  stable	  cell	  lines.	  Red:	  mCherry,	  Yellow:	  YFP,	  Blue:	  nuclear	  stain.	  Scale	  bar:	  5	  μm.	  
B)	  SDS-­‐PAGE	  of	  the	  purified	  CIBN-­‐GFP-­‐His6	  (50	  kDa)	  and	  PIF6-­‐CFP-­‐His6	  (40	  kDa)	  shows	  that	  both	  of	  the	  
proteins	  were	  obtained	  purely	  after	  two-­‐step	  purification.	  
	  
In	   order	   to	   show	   these	   proteins	   are	   immobilized	   specifically	   through	   this	  
coordination,	  their	  binding	  was	  measured	  with	  QCM-­‐D	  as	  a	  change	  in	  the	  frequency	  
(Figure	  2.12).	  SiO2	  QCM-­‐D	  sensors	  were	  functionalized	  in	  the	  same	  way	  as	  described	  
before	  for	  the	  glass	  surfaces.	  The	  sensors	  were	  washed	  with	  a	  buffer	  containing	  300	  
mM	  NaCl,	  50	  mM	  TRIS	  at	  pH	  7.4	  (Buffer	  A)	  until	  the	  baseline	  was	  reached.	  Then,	  the	  
proteins	  were	  flushed	  on	  the	  sensors	  and	  incubated	  approximately	  for	  15	  min	  until	  a	  
plateau	  was	  reached.	  The	  sensors	  were	  washed	  once	  again	  with	  Buffer	  A	  to	  remove	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unspecifically	  bound	  proteins.	  The	  net	  frequency	  change	  was	  13	  Hz	  for	  CIBN	  and	  15	  
Hz	  for	  PIF6.	  His6-­‐Ni2+-­‐NTA	  coordination	  can	  be	  broken	  in	  the	  presence	  of	  competitive	  
ligands	  as	   imidazole.	  Hence,	  the	  sensors	  were	  washed	  with	  Buffer	  A	  containing	  250	  
mM	   imidazole	   (Buffer	   B)	   and	   the	   frequency	   increased	   since	   all	   the	   protein	   was	  
washed	  off	  from	  the	  surfaces	  of	  the	  sensors.	  The	  sensors	  were	  washed	  further	  with	  
Buffer	  A	   until	   the	   frequency	  was	   back	   to	   its	   baseline.	   The	   big	   change	   in	   frequency	  
during	  this	  last	  washing	  step	  was	  due	  to	  the	  removal	  of	  imidazole.	  
	  
Figure	   2.12	   Frequency	   vs	   Time	   plots	   from	  QCM-­‐D	  measurements	   to	   show	   protein	   immobilization	  
through	   His6-­‐Ni
2+-­‐NTA	   coordination.	   A)	   CIBN-­‐GFP-­‐His6	   showed	   a	   net	   frequency	   change	   of	   13	   Hz	   B)	  
PIF6-­‐CFP-­‐His6	   showed	   a	   net	   frequency	   change	   of	   15	   Hz.	   Both	   of	   the	   proteins	   could	   be	   immobilized	  
through	  His6-­‐Ni
2+-­‐NTA	  coordination	  and	  this	  coordination	  was	  broken	  in	  the	  presence	  of	  imidazole.	  1:	  




2.2.2	  Blue	  and	  red	  light	  induced	  cell	  adhesion	  
After	   it	   was	   confirmed	   that	   the	   proteins	   could	   be	   immobilized	   to	   the	   NTA-­‐
functionalized	   glass	   surfaces	   specifically	   through	   His6-­‐Ni2+-­‐NTA	   coordination,	   CIBN	  
and	   PIF6	   were	   immobilized	   first	   separately	   on	   the	   Ni2+-­‐NTA	   functionalized	   glass	  
surfaces.	   The	   cells	   expressing	   CRY2	   and	   PhyB	   were	   seeded	   on	   CIBN	   and	   PIF6	  
functionalized	   substrates,	   respectively,	   and	   incubated	   in	   dark	   and	   under	   blue	   (480	  
nm)	  or	  red	  light	  (673	  nm)	  illumination	  for	  2	  hours.	  Then,	  the	  cells	  were	  fixed	  and	  the	  
nuclei	   were	   stained	   with	   DAPI.	   Then,	   the	   fluorescence	   images	   from	   DAPI	   channel	  
were	  obtained	  from	  a	  total	  area	  of	  1	  cm2.	  The	  number	  of	  cells	   (object	  with	  an	  area	  
between	   50-­‐5000	   μm2)	   was	   calculated	   in	   dark	   and	   under	   light	   illumination	   by	   the	  
analyze	   particles	   tool	   in	   ImageJ	   (Figure	   2.13).	   A	   PEGylated	   surface	   without	   any	  
protein	   immobilization	   was	   used	   as	   a	   negative	   control.	   The	   number	   of	   CRY2	   cells	  
adhered	  to	  the	  CIBN	  functionalized	  substrates	  was	  calculated	  as	  250	  cells/cm2	  under	  
blue	   light	   illumination,	  which	   is	  5-­‐fold	  more	  compared	  to	  the	  dark.	   It	  was	  observed	  
that	  there	  was	  no	  significant	  difference	  in	  the	  number	  of	  cells	  cultured	  in	  dark	  and	  on	  
the	   negative	   control	   (PEG).	   Similarly,	   the	   number	   of	   PhyB	   expressing	   cells	   was	  
calculated	  as	  300	  cells/cm2,	  also	  5-­‐fold	  higher	  compared	  to	  the	  dark.	  	  
	  
In	  order	  to	  test	  whether	  these	  two	  systems	  are	  orthogonal	  to	  each	  other,	  CRY2	  cells	  
were	   illuminated	  with	  red	   light	  and	  PhyB	  cells	  with	  blue	   light	   (Figure	  2.13).	   In	  both	  
cases,	  the	  number	  of	  cells	  that	  attached	  to	  the	  surfaces	  was	  similar	  to	  the	  dark	  and	  
the	   negative	   control.	   That	   is,	   MDA-­‐CRY2-­‐mCherry	   cells	   did	   not	   interact	   with	   CIBN	  
functionalized	  substrates	  under	  red	  light	  and	  MDA-­‐PhyB-­‐YFP	  cells	  were	  not	  found	  to	  
interact	  with	  PIF6	  functionalized	  substrates	  under	  blue	  light.	  This	  demonstrates	  that	  
these	  systems	  are	  exclusively	  responsive	  to	  their	  corresponding	  wavelengths,	  which	  
provides	  an	  orthogonal	  and	  selective	  system	  to	  control	  cell-­‐material	  interactions	  with	  




Figure	   2.13	   Quantification	   of	   light	   controlled	   cell-­‐material	   interactions.	  MDA-­‐CRY2	   cells	   bound	   to	  
CIBN	  functionalized	  substrates	  only	  under	  blue	   light	  but	  not	   in	  the	  dark	  or	  under	  red	   light.	  Likewise,	  
MDA-­‐PhyB	   cells	   attached	   to	   PIF6	   functionalized	   substrates	   only	   under	   red	   light	   but	   not	   in	   dark	   or	  
under	   blue	   light.	   The	   error	   bars	   are	   the	   standard	   error	   of	   three	   technical	   replicates	   with	   three	  
biological	  replicates	  in	  each	  (n	  =	  9),	  unpaired	  t-­‐test	  is	  used	  as	  statistical	  test	  (p	  value	  <0,0001	  (****)).	  
	  
2.2.3	  Cell	  spreading	  by	  photoswitchable	  interactions	  
In	   order	   to	   see	   whether	   the	   synthetic	   photoswitchable	   interactions	   are	   strong	  
enough	  to	  induce	  cell	  spreading	  like	  in	  the	  integrin	  mediated	  adhesions,	  the	  adhesion	  
area	  of	  cells	  on	  their	  complementary	  partners	  was	  compared	  to	  that	  of	  on	  the	  bare	  
glass.	   For	   this,	   MDA-­‐CRY2-­‐mCherry	   cells	   were	   seeded	   on	   CIBN	   functionalized	  
substrates	   and	  MDA-­‐PhyB-­‐YFP	   cells	  were	   seeded	  on	  PIF6	   functionalized	   substrates.	  
At	  the	  same	  time,	  these	  cells	  were	  cultured	  on	  bare	  glass	  substrates.	  Phalloidin-­‐TRITC	  
was	   used	   to	   stain	   actin	   cytoskeleton	   and	   Cell	   Outliner	   in	   ImageJ	   was	   used	   to	  
determine	  the	  spreading	  area	  of	  randomly	  selected	  cells	  (n=30)	  (Figure	  2.14A).	  It	  was	  
observed	   that	   there	  was	   no	   significant	   difference	   in	   spreading	   area	   of	   the	   cells	   on	  




Figure	  2.14	  Spreading	  area	  of	  CRY2	  and	  PhyB	  expressing	  cells.	  A)	  Fluorescence	  images	  of	  MDA-­‐CRY2	  
and	  MDA-­‐PhyB	   cells	   on	   their	   complementary	   substrates	   under	   light	   illumination	   and	   on	   glass.	   Red:	  
actin,	   Blue:	   nuclear	   stain.	   Scale	   bar:	   40	   μm.	  B)	  Quantification	   of	   spreading	   area	   of	   PhyB	   and	   CRY2	  
expressing	  cells	  on	  their	  complementary	  proteins	  and	  on	  bare	  glass.	  For	  both	  cell	  types,	  there	  was	  no	  
significant	   difference	   between	   their	   spreading	   area	   when	   they	   adhered	   to	   protein	   functionalized	  
substrates	   or	   to	   the	   glass.	   The	   error	   bars	   are	   the	   standard	   error	   of	   the	   mean	   of	   the	   area	  
measurements	  from	  30	  cells.	  
	  
Then,	  confocal	  imaging	  was	  done	  to	  monitor	  the	  morphology	  of	  the	  cells	  adhered	  on	  
the	  protein	  functionalized	  substrates	  and	  on	  the	  glass.	  The	  main	  difference	  between	  
the	   light	  dependent	  cell	  adhesion	  and	  the	   integrin-­‐mediated	  adhesions	  on	  the	  glass	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substrates	   is	   the	   structure	   of	   the	   actin	   network	   (Figure	   2.15).	   While	   the	   native	  
integrin	  mediated	  adhesions	   link	   to	   the	  actin	  network	  and	   lead	  to	   the	   formation	  of	  
actin	   fibres,	   the	   artificial	   photoswitchable	   cell	   adhesions	   are	   not	   connected	   to	   the	  
actin	  network	  and	  actin	  remains	  homogenously	  distributed	  in	  the	  cell.	  	  
	  
	  
Figure	   2.15	   Confocal	   images	   for	   comparison	   of	  morphology	   of	   CRY2	   and	   PhyB	   expressing	   cells	   on	  
protein	   and	   glass	   substrates.	   A)	  MDA-­‐CRY2-­‐mCherry	   cells	   on	   CIBN	   functionalized	   substrates	   under	  
blue	  light	  and	  on	  glass.	  Red:	  mCheery,	  green:	  actin	  (phalloidin-­‐FITC),	  blue:	  nuclear	  stain.	  B)	  MDA-­‐PhyB	  
cells	   on	   PIF6	   functionalized	   substrates	   under	   red	   light	   and	   on	   glass.	   Red:	   actin	   (phalloidin-­‐TRTIC),	  
yellow:	  YFP,	  blue:	  nuclear	   stain.	   The	   cells	  were	   stained	   for	   their	  nucleus	  and	  actin	   cytoskeleton	  and	  






2.2.4	  Adhesion	  and	  reversion	  kinetics	  
For	   further	   characterization	   of	   light-­‐dependent	   cell	   adhesion,	   a	   kinetic	   study	   was	  
done	  to	  determine	  the	  time	  needed	  for	  cell	  adhesion	  to	  the	  surface	  and	  for	  reversion	  
(Figure	   2.16).	   For	   adhesion	   kinetics,	   the	   CRY2	   and	   PhyB	   cells	   were	   seeded	   on	   the	  
CIBN	  and	  PIF6	  functionalized	  surfaces	  (t=0),	  respectively,	  and	  incubated	  for	  30,	  60,	  90	  
and	   120	   min	   under	   blue	   or	   red	   light	   and	   in	   the	   dark.	   At	   each	   time	   point,	   three	  
samples	   were	   fixed,	   stained	   with	   DAPI	   and	   the	   total	   cell	   number/cm2	   was	  
determined.	  It	  was	  observed	  that	  MDA-­‐CRY2-­‐mCherry	  cells	  reached	  saturation	  after	  
30	  min	   incubation,	  while	  PhyB	  expressing	  cells	  showed	  slower	  kinetics	  and	  reached	  
saturation	  after	  60	  min	  (Figure	  2.16A).	  It	  was	  observed	  that	  the	  number	  of	  CRY2	  and	  
PhyB	  expressing	  cells	  that	  adhere	  under	  blue	  and	  red	  light	  are	  about	  the	  same.	  	  
	  
For	  reversion	  kinetics,	  the	  CRY2	  and	  PhyB	  expressing	  cells	  were	  first	  incubated	  under	  
blue	   and	   red	   light,	   respectively,	   for	   1	  hour	  on	   their	   complementary	   substrates	   and	  
then	  they	  were	  taken	  in	  the	  reversion	  conditions.	  CRY2-­‐CIBN	  interaction	  can	  only	  be	  
reversed	  in	  the	  dark	  and	  PhyB-­‐PIF6	  heterodimerization	  can	  reverse	  both	  in	  dark	  and	  
under	  far-­‐red	  light	  (750	  nm)	  illumination.	  After	  1	  h	  blue	  or	  red	  light	  illumination,	  both	  
of	   the	   cell	   types	   were	   incubated	   in	   dark	   for	   30,	   60,	   90	   and	   120	   min.	   In	   addition,	  
substrates	   with	   PhyB	   expressing	   cells	   were	   also	   incubated	   under	   far-­‐red	   light	  
illumination	   for	   5,	   15	   and	   30	   min	   (Figure	   2.16B).	   CRY2	   and	   PhyB	   cells	   were	   also	  
incubated	  only	  in	  the	  dark	  and	  on	  PEG	  (negative	  control)	  in	  order	  to	  see	  whether	  the	  
reversions	   would	   be	   complete.	   For	   both	   CRY2-­‐CIBN	   and	   PhyB-­‐PIF6	   interactions,	   a	  
complete	  reversion	  could	  be	  achieved	  after	  2	  hours	  incubation	  in	  the	  dark.	  With	  far-­‐
red	  illumination	  PhyB-­‐PIF6	  interaction	  could	  be	  reversed	  completely	  in	  30	  min	  (Figure	  
2.16B).	  These	  findings	  confirm	  that	  these	  cell-­‐material	  interactions	  based	  on	  the	  blue	  
and	   red	   light	   switchable	   proteins	   are	   reversible	   and	   that	   the	   PhyB/PIF6	   mediated	  








Figure	  2.16	  A)	  Adhesion	  kinetics	  B)	  Reversion	  kinetics	  of	  light	  controlled	  cell-­‐material	  interactions.	  The	  
error	  bars	  are	  the	  standard	  error	  of	  three	  technical	  replicates	  with	  three	  biological	  replicates	  in	  each	  (n	  
=	  9),	  unpaired	  t-­‐test	  is	  used	  as	  statistical	  test.	  
	  
3.2.5	  Orthogonal	  switching	  of	  cell	  adhesion	  
The	  main	  goal	  of	  this	  study	  is	  to	  control	  the	  adhesion	  of	  two	  cell	  types	  to	  a	  substrate	  
orthogonally	   in	  space	  and	  time.	  Hence,	  the	  orthogonal	   interaction	  pairs,	  CRY2/CIBN	  
and	  PhyB/PIF6,	  were	  used	  for	  orthogonal	  switching.	  For	  this,	  the	  glass	  surfaces	  were	  
functionalized	  with	  Ni2+-­‐NTA	  groups	  as	  described	  above.	  Then,	  10	  μM	  CIBN	  and	  PIF6	  
proteins	   were	   premixed	   and	   incubated	   with	   the	   Ni2+-­‐NTA	   functionalized	   glass	  
surfaces	   for	   co-­‐immobilization.	   In	   order	   to	   distinguish	   the	   cell	   types	   on	   the	  
substrates,	  CRY2	  and	  PhyB	  expressing	  cells	  were	  pre-­‐stained	  with	  red	  (DiI)	  and	  green	  
(DiO)	   membrane	   intercalating	   fluorescent	   dyes,	   respectively.	   Again,	   a	   PEGylated	  
nonadhesive	  glass	  substrate	  without	  protein	   immobilization	  was	  used	  as	  a	  negative	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control.	   The	   cells	  were	   co-­‐cultured	  under	  only	  blue,	   blue	  and	   red	   (co-­‐illumination),	  
only	   red	   light	   illumination	   and	   in	   dark	   for	   2	   hours.	   In	   the	   co-­‐illuminated	   samples,	  
PhyB	  and	  CRY2	  cells	  were	  homogeneously	  distributed	  on	  the	  substrate	  (Figure	  2.17A)	  
and	  equally	  attached	  to	  it	  (Figure	  2.17B).	  On	  the	  other	  hand,	  none	  of	  the	  cell	  types	  
adhered	  to	  the	  substrates	  in	  the	  dark	  and	  the	  number	  of	  cells	  in	  dark	  was	  comparable	  
to	   that	  of	  on	  negative	  control.	   It	  was	  observed	   that	  when	  there	  was	  only	   red	   light,	  
only	   PhyB	   cells	   bound	   to	   the	   substrate.	   Similarly,	   when	   there	   was	   only	   blue	   light	  
illumination,	  only	  CRY2	  cells	   attached.	  This	  demonstrates	   that	   this	  dual	   visible	   light	  
responsive	   photoswitch	   provides	   an	   orthogonal	   control	   over	   cell-­‐material	  
interactions	  of	  multiple	  cell	  types	  and	  can	  be	  used	  to	  mimic	  real	  tissues,	  where	  cells	  
can	  secrete	  and	  interact	  with	  different	  ECM	  components.	  
	  
Although	   selective	  adhesion	  of	  multiple	   cell	   types	   to	   functionalized	  materials	   could	  
be	   achieved	   with	   the	   current	   strategies	   such	   as	   modification	   of	   substrates	   with	  
peptidomimetics	   as	   ligands	   for	   different	   integrins,57,58	   antibodies	   for	   specific	   cell	  
surface	  markers,59,62	  ssDNA	  molecules,60,61	  and	  preformed	  micro-­‐	  and	  nano-­‐patterns,	  
63,64	   these	   approaches	   do	   not	   provide	   spatiotemporal	   and	   reversible	   control.	   To	  
achieve	   the	   spatiotemporal	   control	   over	   these	   interactions,	   light	   responsive	  
functional	  molecules	  such	  as	  caging	  groups,65-­‐67	  azobenzenes68-­‐70	  and	  UCNPs71,72	  have	  
been	   employed.	   Although	   azobenzenes	   and	   UCNPs	   provide	   reversible	   control	   with	  
high	   spatiotemporal	   control,	   these	   platforms	   do	   not	   provide	   independent	   control	  
over	   cell-­‐material	   interactions	   in	   a	   multicellular	   environment.	   Additionally,	   these	  
systems	  are	  responsive	  to	  UV	  light,	  which	  is	  invasive	  for	  the	  cells.	  Hence,	  CRY2/CIBN	  
and	   PhyB/PIF6	   mediated	   photoswitchable	   cell-­‐material	   interactions	   provide	   a	  
platform	   where	   cell-­‐material	   interactions	   of	   multiple	   cell	   types	   can	   be	   controlled	  
noninvasively,	   reversibly,	   independently	  and	   in	  a	  wavelength	  selective	  manner	  with	  








Figure	  2.17 Orthogonal	  blue	  and	  red	  light	  switchable	  cell	  adhesions.	  A)	  Fluorescence	  image	  of	  MDA-­‐
CRY2-­‐mCherry	  (in	  red)	  and	  MDA-­‐PhyB-­‐YFP	  (in	  green)	  cells	  on	  CIBN	  and	  PIF6	  co-­‐immobilized	  substrates	  
under	  co-­‐illumination	  with	  blue	  and	  red	  light.	  Both	  cell	  types	  equally	  adhered	  to	  the	  substrate.	  Scale	  
bar:	  75	  μm.	  B)	  Quantification	  of	  the	  number	  of	  MDA-­‐CRY2-­‐mCherry	  and	  MDA-­‐PhyB-­‐YFP	  cells	  in	  dark,	  
under	   red	   and	   blue	   co-­‐illumination,	   only	   red	   or	   only	   blue	   light	   illumination.	   Number	   of	   cells	   were	  
calculated	   from	   red	   (MDA-­‐CRY2-­‐mCherry)	   and	   green	   (MDA-­‐PhyB-­‐YFP)	   fluorescence	   channels.	   The	  
error	  bars	  are	  the	  standard	  error	  of	  three	  technical	  replicates	  with	  three	  biological	  replicates	  in	  each	  


























3.	  Summary	  and	  Outlook	  
Cells	  interact	  with	  the	  extracellular	  matrix	  and	  neighboring	  cells	  forming	  cell-­‐cell	  and	  
cell-­‐matrix	   contacts,	   which	   are	   mainly	   mediated	   by	   cadherins	   and	   integrins,	  
respectively.	   These	   processes	   are	   dynamic	   and	   are	   both	   spatially	   and	   temporally	  
tightly	   regulated	   during	   many	   biological	   events	   including	   embryogenesis,	   wound	  
healing	   and	   cancer	   development.	   Controlling	   these	   interactions	   is	   crucial	   for	   both	  
understanding	  the	  biochemical	  machinery	  and	  for	  several	  applications	  in	  biomedicine	  
such	   as	   bottom-­‐up	   tissue	   engineering,	   medical	   implantation	   and	   developing	   cell-­‐
based	   screening	   devices.	   Current	   approaches	   for	   controlling	   cell-­‐cell	   or	   cell-­‐matrix	  
contacts	   are	   limited	   in	   terms	   of	   dynamicity,	   reversibility,	   sustainability,	   bio-­‐
orthogonality,	   high	   spatiotemporal	   resolution	   and	   noninvasiveness.	   In	   this	   thesis,	  
genetically	  encodable	  blue	  and	  red	  light	  switchable	  cell	  contacts	  were	  developed	  to	  
overcome	  all	  the	  above-­‐mentioned	  limitations.	  
	  
In	  the	  first	  part	  of	  this	  project,	  blue	  light	  switchable	  cell-­‐cell	  interactions	  by	  using	  the	  
blue	   light-­‐dependent	  heterodimerization	  of	  CRY2	  and	  CIBN	  was	  developed.	  Cell-­‐cell	  
contact	   formation	   was	   induced	   between	   MDA-­‐CRY2-­‐mCherry	   and	   MDA-­‐CIBN-­‐GFP	  
cells	  under	  blue	  light.	  This	  interaction	  was	  reversed	  by	  simply	  switching	  the	  blue	  light	  
off.	   It	   was	   also	   shown	   in	   this	   study	   that	   blue	   light	   dependent	   CRY2-­‐CIBN	  
heterodimerization	  could	  be	  further	  developed	  to	  form	  microtissues	  layer-­‐by-­‐layer	  in	  
the	  direction	  of	  bottom-­‐up	  tissue	  engineering.	  	  
	  
The	  CRY2-­‐CIBN	  mediated	  photoswitchable	  cell-­‐cell	   interactions	  have	  key	  features	  of	  
native	  cell-­‐cell	   interactions;	  hence,	  provide	  unmatched	  advantages	  over	  the	  current	  
platforms. First	   of	   all,	   the	   control	   with	   light	   makes	   it	   possible	   to	   induce	   these	  
interactions	  with	  unmatched	  precision	  in	  space	  and	  time.	  The	  low	  intensity	  blue	  light	  
that	  triggers	  these	  cell-­‐cell	  interactions	  is	  noninvasive	  for	  the	  cells.	  These	  interactions	  
are	  dynamic	  and	  reversible,	  which	  enables	  manipulation	  of	  cell-­‐cell	  interactions	  over	  
time.	  Additionally,	  these	  protein-­‐based	  photoswitches	  are	  well-­‐suited	  to	  sustainably	  
control	   the	   cell-­‐cell	   interactions	   over	   a	   long	   period	   of	   time	   because	   they	   are	  
genetically	   encodable	   and	  new	  proteins	   are	   expressed	   in	   the	   cells	   as	   they	  degrade	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and	  the	  cell	  divides. Finally,	  the	  high	  specificity	  of	  the	  CRY2-­‐CIBN	  heterodimerization	  
provides	  specific	  induction	  of	  heterophilic	  interactions	  but	  not	  homophilic	  ones.	  	  
	  
In	  this	  study	  only	  the	  extracellular	  domains	  of	  E-­‐cadherins	  was	  mimicked	  by	  CRY2	  and	  
CIBN	  to	  induce	  cell-­‐cell	  contacts;	  hence,	  there	  is	  no	  link	  to	  the	  actin	  cytoskeleton	  or	  
any	   scaffold	   proteins	   that	   transmit	   signals	   inside	   the	   cells	   as	   happens	   upon	   native	  
cell-­‐cell	  contact	  formation.	  However,	  by	  addition	  of	  the	  cytosolic	  tail	  of	  cadherins	  to	  
the	   blue	   light-­‐induced	   heterodimerization	   system,	   this	   bridge	   to	   the	   actin	  
cytoskeleton	   could	   be	   achieved	   and	   used	   for	   studying	   signaling	   mechanisms,	   cell	  
migration	  and	  mechanotransduction	  upon	   cell-­‐cell	   contact	   formation.	   Furthermore,	  
the	   current	   2D	   system	   can	   be	   transferred	   into	   3D	   spheroid	   cultures	   to	   study	   cell-­‐
sorting	  behavior	  with	  and	  without	  link	  to	  the	  actin	  cytoskeleton	  in	  order	  to	  observe	  
the	  impact	  of	  interfacial	  tension.	  	  
	  
In	   the	   second	   part	   of	   the	   project,	   orthogonal	   blue	   and	   red	   light	   switchable	   cell-­‐
material	   interactions	   of	   multiple	   cell	   types	   were	   developed.	   The	   adhesion	   of	   cells	  
expressing	  CRY2	  or	  PhyB	  to	  the	  CIBN	  and	  PIF6-­‐functionalized	  substrates	  was	  achieved	  
depending	  on	  blue	  or	  red	  light	  illumination,	  respectively.	  This	  adhesion	  was	  reversed	  
in	  the	  dark	  or	  under	   far-­‐red	   light	   illumination.	  The	  time	  needed	  for	  cell	  attachment	  
and	  detachment	  was	  also	  determined	  from	  the	  kinetic	  studies.	  It	  was	  also	  shown	  in	  
this	  study	  that	  cell	  spreading	  area	  due	  to	  photoswitchable	  interactions	  was	  similar	  to	  
the	   integrin	   mediated	   spreading	   area.	   The	   cells	   were	   only	   differing	   in	   their	  
morphology;	  while	  the	  integrin	  mediated	  adhesions	  led	  to	  the	  rearrangements	  of	  the	  
actin	  cytoskeleton,	  actin	  was	  homogeneously	  distributed	  in	  the	  cells	  that	  are	  adhered	  
through	  photoswitchable	   interactions.	   Finally,	   depending	  on	   the	  wavelength	  of	   the	  
light,	  adhesion	  of	  either	  CRY2	  or	  PhyB,	  or	  both	  cell	  types	  to	  their	  substrate	  was	  also	  
shown.	  
	  
The	   CRY2/CIBN	   and	   PhyB/PIF6	  mediated	   photoswitchable	   cell-­‐material	   interactions	  
have	   key	   features	   of	   native	   ones;	   hence,	   they	   are	   advantageous	   compared	   to	   the	  
current	  platforms. First	  of	  all,	  the	  control	  with	  light	  makes	  provides	  high	  spatial	  and	  
temporal	  resolution.	  The	  low	  intensities	  of	  blue	  and	  red	  light	  that	  triggers	  these	  cell-­‐
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material	   interactions	   are	   noninvasive	   for	   the	   cells.	   Additionally,	   these	  
photoswitchable	   cell-­‐material	   interactions	   are	   reversible;	   hence,	   it	   is	   possible	   to	  
dynamically	   attach	   and	   detach	   a	   specific	   cell	   type.	   Finally,	   it	   was	   shown	   that	   this	  
system	   is	   suitable	   for	   independent	   and	   wavelength	   selective	   cell	   adhesion	   of	  
different	   cell	   types	   due	   to	   the	   orthogonality	   of	   the	   blue	   and	   red	   light	   responsive	  
systems.	  
	  
Here,	  both	  the	  ECM	  components	  and	  integrins	  were	  mimicked	  but	  once	  again	  there	  is	  
not	  any	   link	   to	   the	  actin	   cytoskeleton.	  This	   study	   showed	   that	  PhyB	  and	  CRY2	  cells	  
could	  spread	  on	  their	  complementary	  protein	  functionalized	  substrates	  only	  without	  
forming	  actin	  fibers.	  An	  actin	  link	  can	  be	  added	  by	  fusing	  cytosolic	  tail	  of	  the	  integrin	  
β-­‐subunit,	  which	  interacts	  with	  actin	  cytoskeleton	  through	  adaptor	  proteins,	  to	  CRY2	  
and	   PhyB	   and	   focal	   adhesions	   can	   be	   studied	  with	   high	   spatiotemporal	   resolution.	  
This	  orthogonal	  blue	  and	  red	  light	  dependent	  heterodimerization	  system	  can	  also	  be	  
integrated	  into	  hydrogel	  systems,	  where	  3D	  ECM	  can	  be	  achieved,	  depending	  on	  the	  
protein	  stability	  under	  the	  hydrogel	  preparation	  conditions.	  	  
	  
Last	   but	   not	   least,	   there	   are	   more	   visible	   light	   responsive	   proteins	   engineered	   as	  
optogenetic	   tools,	   which	   are	   used	   to	   control	   intracellular	   and	   receptor	   signaling	  
pathways.82,84,85,129,133	  These	  tools	  can	  also	  be	  introduced	  to	  control	  cell-­‐cell	  and	  cell-­‐
material	   contacts	   by	   visible	   light	   to	   open	   a	   new	   door	   for	   developments	   in	   tissue	  
engineering	  and	  biomedicine,	  where	  dynamic	  and	  high	  spatiotemporal	  control	  over	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4.	  Materials	  and	  Methods	  	  
	  
	   4.1	  Equipment	  list	  
	  
General	  laboratory	  equipment	  
Amersham	  Imager	  600	   GE	   Healthcare	   Europe	   GmbH,	   Freiburg,	  
Germany	  
Cell	  culture	  hood	  (Herasafe™)	   Thermo	   Fisher	   Scientific	   Germany	   BV	   &	  
Co	  	  	  	  	  KG,	  Braunschweig,Germany	  
Centrifuges	  
	  	  	  	  5417R	  centrifuge	   	   	   	   Eppendorf	  AG,	  Hamburg,	  Germany	  
	  	  	  	  5702R	  centrifuge	   	   	   	   Eppendorf	  AG,	  Hamburg,	  Germany	  
	  	  	  	  Avanti	  J-­‐26XP	  centrifuge	  	   	   	   Beckman	  Coulter	  Inc.,	  Brea,	  USA	  
	   (JA-­‐10,	  JA-­‐25.50	  rotors)	  	  	  	  	  
Rotina	  R380	  centrifuge	  	   Andreas	  Hettich	  GmbH	  &	  Co.	  KG,	  
Tuttlingen,	  Germany	  
Electroporator	  	  (GenePulser	  Xcell™)	   	   Bio-­‐Rad	  Laborotories,	  Inc.	  Munich,	  	  
	   	   	   	   	   	   Germany	  
Gel	  electrophoresis	   	   	   	   Bio-­‐Rad	  Laborotories,	  Inc.	  Munich,	  	  
	  	  	  	  Agarose	  gel	   	   	   	   	   Germany	  
	  	  	  	  SDS	  gel	  
	  
GFL	  Water	  bath	   	   	   	   ProfiLab24	  GmbH,	  Berlin,	  Germany	  
Hemacytometer	   	   	   	   Laboroptik	  Ltd.,	  Lancing,	  United	  Kingdom	  
HiLoadTM	  16/600	  SuperdexTM	  200	  pg	   GE	   Healthcare	   Europe	   GmbH,	   Freiburg,	  
Germany	  
HisTrapTM	  HP	   GE	   Healthcare	   Europe	   GmbH,	   Freiburg,	  
Germany	  	  
HPLC-­‐	  ÄKTA	  Pure	   GE	   Healthcare	   Europe	   GmbH,	   Freiburg,	  
Germany	  
Incubators	  
	  Cell	  culture	  incubator	  (culturing)	   Thermo	  Fisher	  Scientific	  Germany	  BV	  &	  
Co	  	  	  KG,	  Braunschweig,Germany	  
	  	  	  Cell	  culture	  incubator	  (experimental)	   Thermo	   Fisher	   Scientific	   Germany	   BV	   &	  
Co	  	  	  KG,	  Braunschweig,Germany	  
Excella	  E24R	  incubator	  shaker	   New	   Brunswick	   Scientific	   Co.,	   Inc.,	  
Enfield,	  USA	  
	  	  	  	  Minitron	  shaker	   	   	   	   Infors	  AG,	  Bottmingen/Basel,	  Switzerland	  
	  	  	  	  Plate	  incubator	  	   	   	   	   VWR	  International	  LLC.,	  Radnor,	  PA,	  USA	  
	  
Lamps	  
	  	  	  	  Bulbs	  (red,	  blue	  and	  far-­‐red),	  15	  Watts	  	  	  	  	  	  	  Osram	  GmbH,	  Munich,	  Germany	  
	  	  	  	  FloraLED	  230V/50Hz	  2A	   CLF	  PlantClimatics	  GmbH,	  Wertingen,	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  Modell	  V10	  with	  TS110-­‐Controller	  	  	  	  	  	  Germany	  
	  
ND	  1000	  Spectrophotometer	   PEQLAB	  Biotechnologie	  GmbH,	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Omni	  Sonic	  Ruptor	  400	  	   Omni	  International	  Inc.,	  Tulsa,	  USA	  
	  	  	  Ultrasonic	  homogenizer	  
Pipette	  boy	  and	  micro	  pipettes	   	   Eppendorf	  AG,	  Hamburg,	  Germany	  
Plasma	  system	  (100-­‐E)	   	   	   TePla,	  Kirchheim,	  Germany	  
Plate	  reader	  (Infinite	  M200)	   Tecan	  Group	  Ltd.,	  Männedorf,	  
Switzerland	  
QCM-­‐D	   Q-­‐Sense,	  Västra	  Frölunda,	  Sweden	  
	  	  	  Q-­‐sense	  E4	  	  
	  	  	  SiO2	  QCM-­‐D	  sensors	  (QSX	  303)	  
Rotary	  evaporator	  (Laborota	  4000)	   Heidolph	   Instruments	   GmbH	   &	   Co.	   KG,	  
Schwabach,	  Germany	  
Sonication	  bath	   BANDELIN	   electronic	   GmbH	   &	   Co.	   KG,	  
Berlin,	  Germany	  
Thermocycler	  (T100TM)	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  Bio-­‐Rad	   Laboratories,	   Inc.	   Munich,	  
Germany	  
UV-­‐VIS	  spectrophotometer	   Lambda25,	  Perkin	  Elmer,	  Germany	  
Vortex	  (Reax	  Top)	   Heidolph	   Instruments	   GmbH	   &	   Co.	   KG,	  




Bright	  field	  microscope	  	   Carl	   Zeiss	   Microscopy	   GmbH,	   Jena,	  
Germany	  
	  	  	  	  Zeiss	  Axiovert	  40C	  
	  	  	  	  10x	  air	  lens	  objective	  (A-­‐Plan	  10X/0,25	  Phase	  contrast)	  
	  	  	  	  Digital	  Sight	  DS-­‐2Mv	  Camera	   	   Nikon	  GmbH,	  Düsseldorf,	  Germany	  
	  
Confocal	  microscope	   	   	   	   Carl	  Zeiss	  Microscopy	  GmbH,	  Jena,	  	  
	  	  	  Zeiss	  LSM	  880	  inverted	  microscope	  	   Germany	  
	  	  	  UV	  diode	  (405	  nm),	  Ar	  laser	  (488	  nm),	  HeNe	  laser	  (633	  nm)	  
	  	  	  ZEN	  black2.0	  software	  
	  	  	  63x/1.4	  oil-­‐immersion	  objective	  
	  
Delta	  Vision	  
Olympus	  IX	  inverted	  microscope	   Olympus	   Deutschland	   GmbH,	   Hamburg,	  
Germany	  
	  	  	  Delta	  Vision	  RT	  system	   	   	   Applied	  Precision	  Inc.,	  Issaquah,	  USA	  
	  	  	  Cooled	  CCD	  camera	   	   	   	   Photometrics,	  Tucson,	  USA	  
	  	  	  Resolve	  3D	  software	   	   	   Applied	  Precision	  Inc.,	  Issaquah,	  USA	  
	  	  	  20x	  air	  lens	  objective	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Carl	  Zeiss	  AG,	  Jena,	  Germany	  
	  	  	  	  	  	  	  	  	  	  	  	  	  UPlanFI	  20x/0.50	  phase	  contrast	  
	  
Fluorescence	  microscope	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  Leica	  Microsystems	  GmbH,	  Wetzlar,	  	  
	   Leica	  DM6000B	  upright	  microscope	   Germany	  
	   EL6000	  external	  light	  source	  with	  aliquid	  optical	  fiber	  
	   DFC	  365	  FX	  camera	  
	   LAS	  AF	  3.1.0	  software	  
	   10x	  air	  lens	  (HCX	  PL	  APO	  10X/0.40)	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   20x	  air	  lens	  (HCX	  PL	  APO	  20X/7)	  
	   40x	  air	  lens	  (HCX	  PL	  APO	  40X/0.85)	  
	  
Chemicals	  
Acetic	  acid	   	   	   	   	   J.T>	  Baker,	  Deventer,	  Netherlands	  
Agarose	   Carl	   Roth	   GmbH	   &Co.	   KG,	   Karlsruhe,	  
Germany	  
Antibiotics	  
Ampicillin	   	  Carl	   Roth	   GmbH	   &Co.	   KG,	   Karlsruhe,	  
Germany	  
Geneticin	  (G418)	   Gibco	  by	  Life	  Technologies,	  distributed	  by	  
Thermo	   Fisher	   Scientific	   BV	   &	   Co	   KG,	  
Braunschweig,	  Germany	  
Kanamycin	   	  Carl	   Roth	   GmbH	   &Co.	   KG,	   Karlsruhe,	  
Germany	  
Penicillin/Streptomycin	   Gibco	   by	   Life	   Technologies,	   distributed	  
by	  Thermo	  Fisher	  Scientific	  BV	  &	  Co	  KG,	  
Braunschweig,	  Germany	  
Brilliant	  blue	   	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
Citric	  acid	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Sigma	  Aldrich,	  Munich,	  Germany	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Chloroform	   	   	   	   	   Merck	  KGaA,	  Darmstadt,	  Germany	  
CuSO4.5H2O	   Grüssing	   GmbH	   Analytika,	   Filsum,	  
Germany	  
Diethylether	   	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
DMSO	   	   	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
DTT	   	   	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
EDTA	   	   	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
Ethanol	   Carl	   Roth	   GmbH	   &Co.	   KG,	   Karlsruhe,	  
Germany	  
Ethyl	  acetate	   	   	   	   	   Merck	  KGaA,	  Darmstadt,	  Germany	  
Glycerol	   	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
Glycine	   	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
H2O2	  	  (33	  %)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  AppliChem,	  GmbH,	  Darmstadt,	  Germany	  
H2SO4	   (96%)	   	   	   	   	   Merck	  KGaA,	  Darmstadt,	  Germany	  
Imidazole	   	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
L-­‐Ascorbic	  acid	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
Methanol	   Carl	   Roth	   GmbH	   &Co.	   KG,	   Karlsruhe,	  
Germany	  
MTT	   	   	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
NaCl	   	   	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
NaHCO3	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Sigma	  Aldrich,	  Munich,	  Germany	  
NiCl2.6H2O	   	  Sigma	  Aldrich,	  Munich,	  Germany	  
NTA	  alkyne	   	   	   	   	  	  	  	  	   Synthesized	  by	  Julia	  Ricken134,135	  
Paraformaldehyde	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Sigma	  Aldrich,	  Munich,	  Germany	  
PEG-­‐N3	   Rapp	   Polymer	   GmbH,	   Tübingen,	  
Germany	  
PMSF	   	   	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	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Ponceau	   	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
SDS	   Carl	   Roth	   GmbH	   &Co.	   KG,	   Karlsruhe,	  
Germany	  
Toluene	   	   	   	   	   Merck	  KGaA,	  Darmstadt,	  Germany	  
Triethyl	  amine	  	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
TRIS-­‐base	   Carl	   Roth	   GmbH	   &Co.	   KG,	   Karlsruhe,	  
Germany	  
Triton	  X-­‐100	   	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  





Anti-­‐mouse	  AlexaFluor	  488	   Thermo	  Fisher	  Scientific	  Germany	  BV	  &	  
	  	  	  	  	  	  catalogue	  #:	  A-­‐11029	   	  Co	  KG,	  Braunschweig,Germany	  
	  
	  	  	  anti-­‐c-­‐myc	  (catalogue	  #:	  DLN-­‐07720)	   Dianova	  GmbH,Hamburg,	  Germany	  
	  
Bacterial	  medium	   Carl	  Roth	  GmbH	  &Co.	  KG,	  Karlsruhe,	  	  
	  	  	  Agar	   	   	   	   	   	   Germany	  
	  	  	  LB	  
	  
Cell	  culture	  medium	   Gibco	  by	  Life	  Technologies,	  distributed	  	  
DMEM:	  F12	   by	  Thermo	  Fisher	  Scientific	  BV	  &	  Co	  KG,	  	  	  
	  	  	  DMEM:F12	  without	  phenol	  red	   	   Braunschweig,	  Germany	   	   	  
OPTI-­‐MEM	  	  
DAPI	   	   	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
DiI	   	   	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
DiO	   	   	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
DNA	  gel	  loading	  dye	   Thermo	   Fisher	   Scientific	   BV	   &	   Co	   KG,	  
Braunschweig,	  Germany	  
DNA	  ladder	  (0.1-­‐10	  kb)	   NEB	  GmbH,	  Frankfurt	  am	  Main,	  Germany	  
DNA	  stain	  G	   SERVA	   Electrophoresis	   GmbH,	  
Heidelberg,	  Germany	  
Enzymes	  
Accutase	   Gibco	   by	   Life	   Technologies,	   distributed	  
by	  Thermo	  Fisher	  Scientific	  BV	  &	  Co	  KG,	  
Braunschweig,	  Germany	  
	  	  	  HF	  Phusion	  DNA	  polymerase	   	   NEB	  GmbH,	  Frankfurt	  am	  Main,	  Germany	  
	  	  	  Restriction	  enzymes	  	   	   	   NEB	  GmbH,	  Frankfurt	  am	  Main,	  Germany	  
	  	  	  	  	  	  	  	  AscI,	  BglII,	  DpnI,	  NdeI,	  PstI-­‐HF	  
	  	  	  	  	  	  	  	  SacII,	  SalI,	  XhoI,	  XmaI	   	  
	  	  	  T4	  DNA	  ligase	   	   	   	   NEB	  GmbH,	  Frankfurt	  am	  Main,	  Germany	  
	  	  	  Trypsin-­‐EDTA	  (0.05%)	   Thermo	   Fisher	   Scientific	   BV	   &	   Co	   KG,	  
Braunschweig,	  Germany	  
FAD	   	   	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
Kits	   	   	   	   	   	   	   	  
	  	  	  Gel	  extraction	   	   	   	   QIAGEN	  Inc.,	  Hilden,	  Germany	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  Lipofectamine®	  2000	  Transfection	  Reagent	  Thermo	   Fisher	   Scientific	   BV	   &	   Co	   KG,	  	  
Braunschweig,	  Germany	  
	  	  	  MiniPrep	   	   	   	   	   QIAGEN	  Inc.,	  Hilden,	  Germany	  
	  	  	  PCR	  purification	   	   	   	   QIAGEN	  Inc.,	  Hilden,	  Germany	  
	  	  	  Site-­‐directed	  mutagenesis	  	   Agilent	   Technologies,	   Santa	   Clara,	   CA,	  
USA	  
L-­‐Glutamine	  (200	  mM)	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Gibco	  by	  Life	  Technologies,	  distributed	  by	  	  
Thermo	   Fisher	   Scientific	   BV	   &	   Co	   KG,	  
Braunschweig,	  Germany	  
MDA-­‐MB-­‐231	  cell	  line	  	   	   	   ATCC®,	  Wesel,	  Germany	  
Milk	  powder	  (low	  fat)	   Carl	   Roth	   GmbH	   &Co.	   KG,	   Karlsruhe,	  
Germany	  
Mowiol	  488	   	   	   	   	   Carl	   Roth	   GmbH	   &Co.	   KG,	   Karlsruhe,	  
Germany	  
Novex™	  Prestained	  Protein	  Standard	   Thermo	   Fisher	   Scientific	   BV	   &	   Co	   KG,	  
Braunschweig,	  Germany	  
NuPAGE®	  Antioxidants	   Thermo	   Fisher	   Scientific	   BV	   &	   Co	   KG,	  
Braunschweig,	  Germany	  
NuPAGE®	  LDS	  Sample	  buffer	   Thermo	   Fisher	   Scientific	   BV	   &	   Co	   KG,	  
Braunschweig,	  Germany	  
NuPAGE®	  MOPS	  SDS	  running	  buffer	   Thermo	   Fisher	   Scientific	   BV	   &	   Co	   KG,	  
Braunschweig,	  Germany	  
PBS	  tablets	   Gibco	   by	   Life	   Technologies,	   distributed	  	  
by	  Thermo	  Fisher	  Scientific	  BV	  &	  Co	  KG,	  
Braunschweig,	  Germany	  
Plasmids	   	  
	  	  	  	  pAL149	  (22275)115	   	   	   	   Addgene,	  Teddington,	  United	  Kingdom	  
	  	  	  	  pAL175	  (22276)115	   	   	   	   Addgene,	  Teddington,	  United	  Kingdom	  
	  	  	  	  pCIBN(deltaNLS)-­‐pmGFP	  (26867)91	  	   Addgene,	  Teddington,	  United	  Kingdom	  
	  	  	  	  pCRY2FL(deltaNLS)-­‐mCherryN1	  (26871)91	   Addgene,	  Teddington,	  United	  Kingdom	  
	  pDisplay	  (V660-­‐20)	   Invitrogen	   by	   Life	   Technologies,	  
distributed	   by	   Thermo	   Fisher	   Scientific	  
BV	  &	  Co	  KG,	  Braunschweig,	  Germany	  
	  pDisplay-­‐AP-­‐CFP-­‐TM	  (20861)136	   Addgene,	  Teddington,	  United	  Kingdom	  
	  pDisplay-­‐FLIPE-­‐600n	  (13545)137	   Addgene,	  Teddington,	  United	  Kingdom	  
	  	  	  	  pET21b	  (69741-­‐3)	   	   	   	   Novagen,	  EMD	  Chemical	  Inc.,	  San	  Diego	  
	   	   	   	   	   	   CA,	  USA	  
Phalloidin-­‐TRITC	   	   	   	   Sigma	  Aldrich,	  Munich,	  Germany	  
Primers	   Integrated	   DNA	   Technologies	   Inc.,	  
Leuven,	  Belgium	  
Spirulina	  (for	  PCB	  isolation)	   	   	   Rainforest	  Foods,	  Sheffield,	  UK	   	  
	  
Disposables	  
Amicon	  Ultra-­‐15	  centrifugal	  filter	  units	  	  	   Merck	  KGaA,	  Darmstadt,	  Germany	  
	  	  	  100K,	  50	  mL	  
Cell	  culture	  flasks	  (25	  and	  75	  cm2)	   Greiner	   CELLSTAR®,	   Sigma	   Aldrich,	  
Munich,	  Germany	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Cell	  scraper	   Greiner	   CELLSTAR®,	   Sigma	   Aldrich,	  
Munich,	  Germany	  
Cellulose	  filters	  (0.2	  and	  0.45	  μm)	   Carl	   Roth	   GmbH	   &Co.	   KG,	   Karlsruhe,	  
Germany	  
Cover	  slips	  (20	  x	  20,	  24	  x	  24	  mm)	   Carl	   Roth	   GmbH	   &Co.	   KG,	   Karlsruhe,	  
Germany	  
Cryovials	  (2	  mL)	   Greiner	   CELLSTAR®,	   Sigma	   Aldrich,	  
Munich,	  Germany	  
Electroporation	  cuvettes	  (1	  mm)	   	   Sigma	  Aldrich,	  Munich,	  Germany	   	  
Eppendorf	  tubes	  (0.5	  mL,	  1.5	  mL,	  2	  mL)	   Eppendorf	  AG,	  Hamburg,	  Germany	  
Falcon®	  tubes	  (15	  mL,	  50	  mL)	  	   	   Corning	  Inc.,	  Kaiserlautern,	  Germany	  
Glass	  bottom	  dish	  (1.7	  cm2)	   LabTek,	   Nalge	   Nunc.	   International,	  
Rochester,	  NY,	  USA	  
Microscope	  slides	   Carl	   Roth	   GmbH	   &Co.	   KG,	   Karlsruhe,	  
Germany	  
Molecular	  sieves	  (3Å)	   Carl	   Roth	   GmbH	   &Co.	   KG,	   Karlsruhe,	  
Germany	  
Multi-­‐well	  plates	  (6-­‐well,	  96-­‐well)	   Greiner	   CELLSTAR®,	   Sigma	   Aldrich,	  
Munich,	  Germany	  
Petri	  dishes	  (10,	  20,	  60	  cm2)	   	   	   Corning	  Inc.,	  Kaiserlautern,	  Germany	  
Plastic	  pipettes	  (2	  mL,	  5	  mL,	  10	  mL)	   Greiner	   CELLSTAR®,	   Sigma	   Aldrich,	  
Munich,	  Germany	  






Image	  J	  1.51f	  




4.2.1	  Vector	  design	  	  
	  
For	   mammalian	   expression	   of	   proteins	   on	   the	   cell	   surface,	   pDisplay	   vector	   was	  
chosen.	   pDisplay	   includes	   an	   N-­‐terminal	   murine	   Igκ-­‐chain	   leader	   sequence	   for	  
secretion	  of	   the	  protein	   to	   the	  extracellular	  side	  of	   the	  plasma	  membrane	  and	  a	  C-­‐
terminal	   platelet	   derived	   growth	   factor	   receptor	   (PDFR)	   transmembrane	   (TM)	  
domain,	  which	  anchors	   the	  protein	  to	  the	  plasma	  membrane.	  There	   is	  also	  a	  c-­‐myc	  
epitope	  expressed	  together	  with	  the	  recombinant	  proteins	  in	  pDisplay,	  which	  allows	  
detection	  by	  immunofluorescence.	  For	  purification	  of	  proteins	  from	  bacteria,	  pET21b	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vector	  was	  used.	  pET21b	  carries	  a	  C-­‐terminal	  His6-­‐tag	   for	  protein	  purification	  and	  a	  
lac	  operator	  for	  IPTG	  inducible	  protein	  expression.	  
	  
All	   purchased	  plasmids	  were	   delivered	   in	   transformed	  E.	   coli.	   For	   plasmid	   isolation	  
from	   bacteria,	   the	   cells	   were	   streaked	   on	   an	   LB	   agar	   plate	   containing	   50	   μg/ml	  
ampicillin	   (for	   pAL149,	   pAL175,	   pDisplay	   and	   pET21b)	   or	   35	   μg/ml	   kanamycin	   (for	  
pCRY2FL(deltaNLS)-­‐mCherryN1	   and	   pCIBN(deltaNLS)-­‐pmGFP)	   and	   grown	   at	   37oC	  
overnight.	   The	   colonies	   were	   grown	   in	   LB	   medium	   containing	   the	   corresponding	  
antibiotics	  and	  plasmid	  DNAs	  were	  isolated	  with	  MiniPrep	  kit	  following	  the	  provider’s	  
instructions.	  	  
	  
4.2.2	  Polymerase	  chain	  reaction	  (PCR)	  
CRY2,	  CIBN,	  PhyB	  and	  PIF6	  were	  PCR	  amplified	  with	  gene	  specific	  primers	  (Table	  4.1)	  
and	   inserted	   in	   pDisplay	   or	   in	   pET21b	   either	   by	   restriction	   enzyme	   digestion	   and	  
following	  ligation	  or	  by	  Gibson	  assembly.	  	  
	  
A	  general	  PCR	  protocol	  was	  as	  follows:	  
PCR	  mix	  (1x):	  total	  volume	  =	  100	  μl	   	   	   	  
Template	  (100	  ng/μL)	  	   	  	  	  	  	  	  	  	  	  	  0.5	  μl	   	   	  
dNTPs	  (10	  mM	  stock)	   	   	  	  	  	  	   2	  μl	   	   	   	  
Forwards	  primer	  (10	  μM)	   	  	  	  	  	   5	  μl	   	   	   	  
Reverse	  primer	  (10	  μM)	   	  	  	  	  	   5	  μl	   	   	   	  
HF	  phusion	  polymerase	  buffer	  (5x)	  	  20	  μl	   	   	  
HF	  phusion	  polymerase	   	  	  	  	  	   1	  μl	   	   	   	  	  
Distilled	  water	  	   	   	  	  	  	  	  	  	  	  66.5	  μl	  
	  
PCR	  conditions:	  
Step	  1)	  95oC,	  1	  min	  
Step	  2)	  95oC,	  30	  sec	  
Step	  3)	  60oC,	  30	  sec	  
Step	  4)	  72oC,	  30	  sec-­‐4	  min	  (depending	  of	  the	  length	  of	  the	  insert,	  1	  min/kb)	  
Step	  5)	  Go	  to	  step	  2	  (34	  cycles)	  
Step	  6)	  72oC,	  10	  min	  
Step	  7)	  4oC,	  forever	  
	  
All	   PCR	   mixtures	   were	   digested	   with	   1	   μl	   Dpn1	   at	   37oC	   for	   1	   hr	   to	   degrade	   the	  
template	  DNA	  and	  the	  PCR	  products	  were	  verified	  with	  agarose	  gel	  electrophoresis.	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For	  this,	  1%	  (w/v)	  agarose	  was	  prepared	  in	  TRIS-­‐acetate-­‐EDTA	  buffer	  (TAE	  buffer	  (1x):	  
40	  mM	  TRIS	  base,	  40	  mM	  acetic	  acid,	  1	  mM	  EDTA,	  pH	  8.3)	  and	  mixed	  with	  4	  μl	  of	  
DNA	  stain	  G.	  Gel	  was	  run	  for	  20	  min	  at	  120	  volts.	  	  
	  
Table	  4.1	  List	  of	  gene	  specific	  primers.	  




FWD:	  5'-­‐	  CAGATCTCCCGCGATCCGCGGAATGAAGATGGACAAAAA	  







FWD:	  5'-­‐	  GATATACCCGGGATGAATGGAGCTATAGGAGG	  -­‐	  3'	   pDisplay-­‐
FLIPE-­‐600n	  REV:	  	  5'-­‐	  GATATAGTCGACCATAATTACACACTTTGTC	  -­‐	  3'	  
PhyB	  
(~3	  kb)	  
FWD:	  5'-­‐	  CGGCCAGATCTCCCGGGATGGTTTCCGGAGTC	  -­‐	  3'	   pDisplay	  
REV:	  5'-­‐	  CGACCTGCAGCCGCGGGCTCGGGATTTGCAAG	  -­‐	  3'	  
YFP	  
(~0.5	  kb)	  
FWD:	  5'-­‐ATCCCGAGCCCGCGGCAGTGCTGGTGTGAGCAAGGGCG	  -­‐	  3'	   pDisplay	  	  
REV:	  5'-­‐GTTCGTCGACCTGCAGCAGCTCGTCCATGCCGAG	  -­‐	  3’	  
PIF6	  
(~0.5	  kb)	  
Forward:	  5'-­‐	  GATATAAGATCTATGATGTTCTTACCAACCG	  -­‐	  3'	   pDisplay-­‐





Forward:	  5'-­‐	  CACACACATATGATGAATGGAGCTATAG	  -­‐	  3'	   	   pET21b	  
Reverse:	  5'-­‐	  GGTGGTGGTGCTCGAGCGACATAATTACACACTTTG	  -­‐	  3'	  
Forward:	  5'-­‐CAAAGTGTGTAATTATGTCGCTCGAGCACCACCACC	  -­‐	  3'	   Mutation	  
primers	  Reverse:	  5'-­‐	  GGTGGTGGTGCTCGAGCGACATAATTACACACTTTG	  -­‐	  3'	  
PIF6	  
(~0.5	  kb)	  
Forward:	  5'-­‐	  CACACACATATGATGTTCTTACCAACCG	  -­‐	  3'	   pET21b	  
Reverse:	  5'-­‐	  CACACACTCGAGCTTGTACAGCTCGTC	  -­‐	  3'	  
	  
Site	  directed	  mutagenesis	  was	  done	   to	   remove	   the	   stop	   codon	  CIBN-­‐GFP	  and	  His6-­‐
tag.	  The	  PCR	  condition	  for	  mutagenesis	  was	  as	  follows:	  
PCR	  mix	  (1X):	  total	  volume	  =	  50	  μl	   	   	   PCR	  conditions:	  
Template	  (100	  ng/μL)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  0.5	  μl	   	   Step	  1)	  95oC,	  1	  min	  
dNTPs	  (10	  mM	  stock)	   	   	  	  	  	  1	  μl	   	   	   Step	  2)	  95oC,	  50	  sec	  
Forwards	  primer	  (10	  μM)	   	  	  	  	  1	  μl	   	   	   Step	  3)	  60oC,	  50	  sec	  
Reverse	  primer	  (10	  μM)	   	  	  	  	  1	  μl	   	   	   Step	  4)	  68oC,	  7	  min	  
PFU	  buffer	  	  (10x)	   	   	  	  	  	  5	  μl	   	   	  	  	  	  	   Step	  5)	  Go	  to	  step	  2	  (18	  cycles)	  
PFU	   	  	  	  	  	  	  	  	  	  	  	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  μl	   	   	   Step	  6)	  68oC,	  10	  min	  	  
Quick	  change	  solution	  	   	  	  	  	  3	  μl	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  Step	  7)	  4oC,	  forever	  




4.2.3	  Restriction	  enzyme	  digestion	  and	  ligation	   	   	  
PCR	  products	  and	  vectors	  were	  double-­‐digested	  with	  the	  restriction	  enzymes	  (Table	  
4.2),	   then	  purified	  with	  PCR	  purification	  kit.	  For	  each	  digestion,	  200	  ng/μl	  substrate	  
(PCR	  product	  or	  vector)	  was	  mixed	  with	  1	  μl	  of	  each	  enzyme	  and	   final	  volume	  was	  
adjusted	  50	  μl	  with	  miliQ	  water.	  	  
	  
Table	  4.2	  Restriction	  enzymes	  and	  digestion	  conditions	  
Substrates	  (insert/vector)	   Enzymes	   Conditions	  
CRY2-­‐mCherry/pDisplay	   SalI/SacII	   1x	  Cut	  smart	  buffer,	  37oC,	  overnight	  
CIBN-­‐GFP/pDisplay-­‐FLIPE-­‐600n	   SalI/XmaI	   1x	  Cut	  smart	  buffer,	  37oC,	  overnight	  
CIBN-­‐GFP/pET21b	   NdeI/XhoI	   1x	  Cut	  smart	  buffer,	  37oC,	  overnight	  
PhyB/pDisplay	   XmaI/SacII	   1x	  Cut	  smart	  buffer,	  37oC,	  overnight	  
YFP/pDisplay-­‐PhyB	   SacII/PstI	   1x	  Cut	  smart	  buffer,	  37oC,	  overnight	  
PIF6/pDisplay-­‐AP-­‐CFP-­‐TM	   BglII/AscI	   1)	  1x	  NEB	  Buffer	  3.1	  for	  BglII	  digestion,	  37oC,	  
overnight	  
2)	  1x	  Cut	  smart	  buffer,	  37oC,	  overnight	  
PIF6/pET21b	   NdeI/XhoI	   Cut	  smart	  buffer,	  37oC,	  overnight	  
	  
After	  digestions,	  agarose	  gels	  were	  done	  to	  verify	  the	  products.	  The	  vectors	  pDisplay-­‐
FLIPE-­‐600n	   and	   pDisplay-­‐AP-­‐CFP-­‐TM	  were	   purified	  with	   gel	   extraction	   kit	   following	  
the	  provider’s	  instructions.	  The	  other	  digestion	  products	  were	  purified	  by	  using	  PCR	  
purification	  kit	  due	   to	   the	  small	   size	  of	   the	   removed	  nucleotides.	  To	  determine	   the	  
concentrations	   of	   digested	   products,	   absorbance	   was	  measured	   at	   260	   nm	  with	   a	  
Nanodrop	  spectrometer.	  	  
	  
CRY2-­‐mCherry,	   PhyB	   and	   YFP	  were	   ligated	   into	   pDisplay	   plasmids	   following	  Gibson	  
assembly	   protocol.	   For	   this,	   the	   purified	   digested	   vector	   and	   PCR	   products	   were	  
mixed	  in	  a	  1:2	  (vector:insert)	  molar	  ratio	  with	  5	  μl	  Gibson	  assembly	  Master	  mix	  (2x)	  
and	   incubated	   at	   50oC	   for	   1	   hr.	   A	   mixture	   without	   a	   PCR	   product	   was	   used	   as	   a	  
negative	   control.	   CIBN-­‐GFP	   and	   PIF6	   were	   ligated	   into	   pDisplay	   and	   pET21b	   by	  
following	  a	  general	  ligation	  protocol	  as	  follows.	  The	  digested	  vector	  and	  insert	  were	  
mixed	  in	  a	  1:3	  and	  1:5	  (vector:insert)	  molar	  ratio	  with	  0.5	  μl	  and	  1	  μl	  T4	  DNA	  ligase	  
buffer	  (10x),	  and	  incubated	  4oC	  overnight.	  In	  both	  cases,	  final	  volume	  was	  adjusted	  to	  




4.2.4	  Transformation	  into	  E.coli	  by	  electroporation	  
After	  all	  cloning	  steps	  were	  completed,	  the	  final	   ligated	  plasmids	  were	  transformed	  
into	   E.	   coli	   DH5α	   by	   electroporation.	   For	   electroporation,	   2	   μl	   ligation	   or	   Gibson	  
product	  was	  mixed	  with	  48	  μl	  electrocompetent	  E.	  coli	  DH5α	  on	  ice.	  This	  mixture	  was	  
placed	  in	  the	  electroporation	  cuvettes	  and	  a	  pulse	  was	  given	  (1800	  V,	  25	  μF,	  200	  Ω).	  
Immediately	   after	   pulsing,	   450	  μl	   LB	  was	   added	   to	   the	   cells	   and	   the	   transformants	  
were	  placed	  in	  a	  clean	  1.5	  ml	  tube.	  The	  cultures	  were	  incubated	  on	  a	  heating	  block	  
for	  1	  h	  at	  37	  oC	  at	  200	  rpm.	  The	  transformants	  were	  plated	  on	  an	  LB	  agar	  plate	  with	  
50	  μg/ml	  ampicillin	  at	  37oC	  overnight.	  The	   following	  day,	   colonies	  were	  picked	  and	  
grown	  in	  10	  mL	  LB	  with	  50	  μg/ml	  ampicillin	  at	  37	  oC	  overnight.	  The	  next	  day,	  plasmids	  
were	   isolated	  with	  miniprep	  kit	   and	   sent	   for	   sequencing	  with	  a	  T7	   forward	  primer.	  
The	  sequences	  of	  these	  constructs	  are	  shown	  in	  Section	  6.1.	  
	  
4.3	  Cell	  Culture	   	  
4.3.1	  Culturing	  and	  freezing	  medium	  
Complete	   medium	   was	   prepared	   by	   filtering	   Dulbecco’s	   Modified	   Eagle	   Medium	  
(DMEM)/F12	   (1:1)	   with	   10%	   FBS	   through	   0.2	   μm	   sterile	   cellulose	   filters	   and	   1%	  
penicillin/streptomycin	   was	   added	   after	   filtration.	   All	   cells	   were	   cultured	   in	   the	  
complete	  medium	  and	  incubated	  at	  37oC	  and	  under	  5%	  CO2.	  For	  stable	  cell	  lines,	  0.9	  
mg/ml	   Geneticin	   (G418)	   was	   added	   to	   the	   complete	   medium.	   For	   illumination	  
experiments	  phenol-­‐red	  free	  medium	  was	  used	  and	  200	  mM	  L-­‐glutamine	  was	  added.	  
FBS	   was	   excluded	   for	   the	   illumination	   experiments	   to	   control	   cell-­‐material	  
interactions.	   Cells	   were	   frozen	   for	   storage	   in	   liquid	   nitrogen	   in	   a	   1:1	   mixture	   of	  
DMEM:FBS-­‐DMSO	  (80%FBS	  and	  20%	  DMSO)	  was	  used.	  	  
	  
4.3.2	  Generation	  of	  stable	  cell	  lines	  
To	   generate	   the	   stable	   cells	   lines,	   the	   cells	   were	   transfected	   with	   pDisplay-­‐CRY2-­‐
mCherry,	   pDisplay-­‐CIBN-­‐GFP	   and	   pDisplay-­‐PhyB-­‐YFP	   plasmids	   by	   using	  
LipofectamineTM	   LTX	   reagent	   following	   the	   instructions	   provided	   by	   the	  
manufacturers	   as	   follows.	   MDA-­‐MB-­‐231	   cells	   were	   seeded	   on	   6-­‐well	   polystyrene	  
plates	  at	  a	  density	  of	  6.25	  x	  104	   cells/cm2	  and	  grown	  overnight.	   	   The	  next	  day,	   the	  
cells	  were	  washed	  twice	  with	  warm	  PBS	  and	  fresh	  medium	  is	  added.	  For	  transfection,	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2.5	   µg	   DNA	  was	  mixed	  with	   500	   µl	   OPTI-­‐MEM	   and	   2.5	   µl	   PLUS	   reagent.	   This	   DNA	  
solution	  was	  incubated	  at	  room	  temperature	  for	  15	  min.	  8.75	  µl	  of	  LTX	  reagent	  was	  
added	   to	   the	   solution	   and	   the	   mixture	   was	   incubated	   for	   30	   min	   at	   room	  
temperature.	   Finally,	   500	   µl	   DNA-­‐Lipofectamine	   solution	   was	   added	   to	   the	   cell	  
medium	  drop-­‐wise.	   After	   24	   hours,	   cells	  were	   cultured	   in	  medium	  with	   0.9	  mg/ml	  
Geneticin	   (G418)	   for	   selection	   over	   2	   weeks	   and	   subsequently	   cell	   stocks	   were	  
prepared.	  The	  resulting	  cell	  lines	  were	  named	  as	  MDA-­‐CRY2-­‐mCherry,	  MDA-­‐CIBN-­‐GFP	  
and	  MDA-­‐PhyB-­‐YFP.	  These	  cell	  lines	  were	  used	  for	  illumination	  experiments	  up	  to	  the	  
passage	  number	  11.	  	  
	  
4.3.3	  Fixation,	  actin	  and	  nuclear	  staining	  
	  
For	   fixation,	   the	  medium	  was	  removed,	  cells	  were	  washed	  twice	  with	  PBS	  and	  cells	  
were	   incubated	   with	   1	   ml	   4%	   paraformaldehyde	   (PFA)	   for	   15	   min	   at	   room	  
temperature.	  Then,	  PFA	  was	  removed	  and	  the	  cells	  were	  washed	  twice	  with	  PBS.	  For	  
actin	  staining,	  cells	  were	  permeabilized	  with	  0.1	  %	  Triton	  X-­‐100	   in	  PBS	   for	  5	  min	  at	  
room	  temperature,	  stained	  with	  0.5	  µg/ml	  Phalloidin-­‐TRITC	  in	  PBS	  for	  30	  min	  in	  dark	  
to	   prevent	   bleaching.	   Finally,	   the	   samples	   were	   mounted	   with	   mowiole-­‐488	  
containing	  1	  µg/ml	  DAPI	   for	  nuclear	  staining.	  For	  the	  unmounted	  samples,	   the	  cells	  




MDA-­‐CRY2-­‐mCherry	   and	  MDA-­‐CIBN-­‐GFP	   cells	   were	   seeded	   24	  mm	   x	   24	  mm	   cover	  
slips,	   which	   were	   cleaned	   with	   70%	   ethanol,	   at	   a	   density	   of	   15000	   cells/cm2	   and	  
grown	  overnight.	   The	  next	  day,	   the	   cells	  were	   fixed	  with	  PFA.	  One	   set	  of	   cells	  was	  
permeabilized	  whereas	   one	   set	  was	   kept	   impermeable	   for	   the	   primary	   antibody	   in	  
order	  to	  stain	  only	  the	  proteins	  at	  the	  plasma	  membrane.	  The	  samples	  were	  blocked	  
with	   1%	   BSA	   in	   PBS	   for	   10	   min	   at	   room	   temperature.	   Meanwhile,	   the	   primary	  
antibody,	  mouse	  anti-­‐c-­‐myc,	  was	  diluted	  1:200	   in	  1%	  BSA-­‐PBS.	   The	   coverslips	  were	  
placed	  in	  a	  humid	  chamber	  and	  150	  μL	  of	  primary	  antibody	  solution	  was	  added	  drop-­‐
wise	  on	  the	  cells.	  The	  samples	  were	  incubated	  with	  the	  primary	  antibody	  for	  1	  hour	  
at	  room	  temperature	  and	  then,	  the	  cells	  were	  washed	  three	  times	  with	  1%	  BSA-­‐PBS	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solution	   for	   2	   min.	   The	   secondary	   antibody,	   goat	   anti-­‐mouse	   AlexaFluor	   488,	   was	  
prepared	  with	  at	  1:1000	  dilution	  in	  1%	  BSA-­‐PBS	  and	  150	  μL	  of	  it	  was	  added	  drop-­‐wise	  
on	  the	  cells.	  The	  samples	  were	  incubated	  with	  the	  secondary	  antibody	  for	  1	  hour	  at	  
room	   temperature	   in	   dark	   to	   prevent	   bleaching	   of	   the	   AlexaFluor488.	   After	   the	  
secondary	   antibody	   staining,	   the	   cells	   were	   washed	   three	   times	   with	   1%	   BSA-­‐PBS	  
solution	  for	  2	  min.	  The	  impermeable	  set	  of	  cells	  was	  permeabilized	  for	  actin	  staining	  
after	   the	   secondary	   antibody	   staining.	   The	   cells	   were	   stained	   for	   actin	   with	  
phalloidin-­‐TRITC	  and	  mounted	  with	  mowiole:DAPI	  as	  described	  above.	  The	  samples	  
were	  imaged	  with	  a	  Zeiss	  LSM	  880	  confocal	  microscope.	  
	  
4.4	  Isolation	  of	  PCB	  
Following	  the	  protocol	  from	  Müller	  et	  al.,	  PCB	  was	  isolated	  from	  Spirulina	  extract	  by	  
methanolysis	   and	  organic	   extraction.112	   25	   g	  Spirulina	   extract	  was	  boiled	   in	   250	  ml	  
methanol	  for	  2	  min	  under	  reflux.	  The	  green	  liquid	  was	  removed	  by	  vacuum	  filtration	  
and	  the	  reflux	  and	  filtration	  steps	  were	  repeated	  6-­‐8	  times	  until	  the	  flow	  through	  was	  
colorless.	  At	  this	  step	  the	  powder	  could	  be	  stored	  overnight	  at	  4oC.	  The	  next	  day,	  the	  
washed	  powder	  was	  boiled	  in	  methanol	  for	  4	  hours	  in	  reflux	  under	  the	  dim	  light.	  The	  
liquid	  was	  vacuum	  filtrated	  and	  it	  was	  reduced	  to	  15	  ml	  with	  a	  rotary	  evaporator.	  The	  
dark	  green	  solution	  was	  transferred	  into	  a	  thin	  separatory	  funnel	  and	  mixed	  with	  35	  
ml	   diethyl	   ether	   and	   50	   ml	   of	   1%	   (w/v)	   citric	   acid	   solution	   in	   water.	   The	   bottom	  
aqueous	  phase	  was	  collected	  into	  a	  clean	  flask	  for	  re-­‐extraction.	  The	  organic	  phase	  in	  
the	   separatory	   funnel	   was	   mixed	   with	   25	   ml	   of	   1%	   (w/v)	   NaHCO3	   and	   PCB	   was	  
extracted	   from	   the	   newly	   formed	   organic	   phase.	   The	   aqueous	   phase	   from	   this	  
extraction	  was	  transferred	  into	  a	  second	  separatory	  funnel,	  acidified	  by	  adding	  5	  ml,	  
1	   M	   HCl.	   Protonated	   PCB	   was	   extracted	   with	   25	   ml	   chloroform.	   Chloroform	   was	  
evaporated	   in	   vacuo	   and	   the	  product	  was	  dried	  on	   the	  vacuum	   line	  overnight.	   The	  
dried	   PCB	   was	   dissolved	   in	   1.5	   ml	   DMSO	   and	   aliquots	   were	   stored	   at	   -­‐20oC.	   To	  
determine	  the	  concentration	  of	  PCB,	  it	  was	  diluted	  1:800	  in	  methanol:HCl	  (95:5	  (v/v))	  
and	  absorbance	  spectrum	  was	  measured	  between	  300-­‐800	  nm	  (ε680	  =	  37900	  M-­‐1.cm-­‐
1;	  molecular	  weight:	  586.7	  g/mol):	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The	  concentration	  obtained	  from	  this	  purification	  was	  36	  mM.	  5	  μM	  PCB	  was	  added	  
to	  the	  cell	  culture	  medium	  for	  illumination	  experiments	  with	  red	  light.	  
	  
4.5	  Protein	  purification	  and	  characterization	  
4.5.1	  Protein	  expression	  
PIF6-­‐CFP-­‐His6	  and	  CIBN-­‐GFP-­‐His6	  were	  transformed	  chemically	  into	  E.	  coli	  BL21	  using	  
a	  standard	  protocol.	  In	  short,	  2	  μl	  plasmid	  was	  mixed	  with	  48	  μl	  chemicompetent	  E.	  
coli	   BL21	  on	   ice	   for	  30	  min.	   This	  mixture	  was	  placed	   in	  heating	  block	   for	  45	   sec	   at	  
42oC	   and	   subsequently	   placed	  back	   on	   ice	   for	   a	   few	  minutes.	   Then,	   450	  μl	   LB	  was	  
added	  and	  the	  cells	  were	   incubated	  on	  a	  heating	  block	  for	  1	  h	  at	  37	  oC	  at	  200	  rpm.	  
The	  transformants	  were	  placed	  on	  an	  LB	  agar	  plate	  with	  50	  μg/ml	  ampicillin	  at	  37oC	  
and	  grown	  overnight.	  The	  next	  day,	  a	  colony	  from	  each	  plate	  was	  selected	  and	  grown	  
in	  10	  mL	  LB	  with	  50	  µg/ml	  ampicillin	  overnight	  at	  37	  oC	  at	  200	   rpm.	   	  The	   following	  
day,	  the	  bacterial	  cultures	  were	  transferred	  into	  1	  l	  LB	  with	  50	  µg/ml	  ampicillin	  and	  
were	   grown	   at	   37	   oC	   at	   200	   rpm	   until	   they	   reached	   a	   density	   of	   OD600	   =	   0.4-­‐0.6.	  
Protein	   expression	   was	   induced	   with	   0.5	   mM	   IPTG	   and	   the	   bacterial	   culture	   was	  
incubated	  at	  16oC	  at	  200	   rpm	  overnight	   following	   the	   induction.	  The	  bacteria	  were	  
harvested	  by	  centrifugation	  (6000	  g,	  8	  min).	  
	  
4.5.2	  Affinity	  chromatography	  
For	  protein	  purification	  all	  the	  steps	  were	  performed	  on	  ice	  or	  at	  4oC.	  The	  bacterial	  
pellet	  was	  resuspended	  in	  20	  ml	  Buffer	  A	  (50	  mM	  TRIS	  at	  pH	  7.4	  and	  300	  mM	  NaCl)	  
containing	  1.25	  mM	  PMSF	  (stock	  solution	  100	  mM	  in	  methanol)	  and	  1.25	  mM	  DTT.	  
The	   bacterial	   suspension	   was	   homogenized	   using	   a	   rupture	   sonicator	   at	   50%	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frequency,	   40%	   power	   for	   10	   min.	   The	   homogenized	   solution	   was	   centrifuged	   at	  
12000	   rpm	   at	   4oC	   for	   30	   min.	   The	   supernatant	   was	   filtered	   through	   a	   0.45	   μm	  
cellulose	  filter	  twice.	  His-­‐trapTM	  HP	  column	  (column	  volume	  is	  5	  ml)	  was	  equilibrated	  
with	  20	  ml	  Buffer	  A	  containing	  1.25	  mM	  DTT.	  The	  filtered	  protein	  solution	  was	  passed	  
over	  the	  column	  and	  the	  column	  was	  washed	  first	  with	  10	  ml	  Buffer	  A	  and	  then,	  with	  
50	  ml	  Buffer	  A	  containing	  12.5	  mM	  imidazole.	  Finally,	  the	  protein	  was	  eluted	  with	  the	  
elution	   buffer	   (Buffer	   A	   containing	   250	   mM	   imidazole).	   After	   the	   elution	   was	  
completed,	  the	  His-­‐Trap	  column	  was	  cleaned	  first	  with	  50	  ml	  elution	  buffer	  and	  then	  
with	  50	  ml	  Buffer	  A.	  For	  long	  term	  storage,	  the	  column	  was	  washed	  with	  20	  ml	  water	  
followed	  by	  20	  ml	  20%	  ethanol	  and	  was	  left	  in	  ethanol	  to	  prevent	  bacterial	  growth.	  
	  
4.5.3	  Size	  exclusion	  chromatography	  
The	   His-­‐trap	   purified	   proteins	   were	   further	   purified	   with	   size	   exclusion	  
chromatography	   on	   an	   ÄKTA	   Pure	   system.	   For	   this,	   first	   the	   protein	   solution	   was	  
concentrated	   to	   a	   final	   volume	   of	   2	  mL	   by	   50	  mL	   centrifugal	   filter	   units.	   The	   size	  
exclusion	  column	  was	  equilibrated	  with	  Buffer	  A	  containing	  1	  mM	  DTT	  at	  a	  flow	  rate	  
of	   1	  ml/min.	   The	   concentrated	  protein	   solution	  was	   injected	   into	   the	   sample	   loop,	  
the	  column	  was	  run	  for	  120	  ml	  (1	  column	  volume)	  and	  1	  ml	  fractions	  were	  collected.	  
The	  purified	  protein	  was	  characterized	  with	  SDS-­‐PAGE.	  The	  retention	  times	  for	  CIBN-­‐
GFP	  and	  PIF6-­‐CFP	  were	  50	  min	  and	  75	  min,	  respectively.	  After	  the	  fractionation	  was	  
complete,	  the	  column	  was	  cleaned	  first	  with	  120	  ml	  Buffer	  A,	  then	  120	  ml	  water	  and	  
finally	  120	  ml	  20	  %	  ethanol	  for	  storage	  to	  prevent	  bacterial	  growth.	  
	  
4.5.4	  SDS-­‐PAGE	  
20	  µl	  from	  each	  fraction	  was	  mixed	  with	  5	  µl	  SDS	  sample	  buffer	  (4x)	  and	  incubated	  at	  
90oC	  for	  10	  min	  for	  protein	  denaturation.	  Then,	  the	  denatured	  proteins	  were	  loaded	  
in	   the	   SDS	   gels	   along	  with	   a	   pre-­‐stained	  protein	  marker.	   The	   gel	  was	   run	   in	  MOPS	  
buffer	  (50	  mM	  MOPS,	  50	  mM	  TRIS-­‐base,	  0.1	  (w/v)	  SDS,	  1	  mM	  EDTA,	  pH	  7.7)	   for	  50	  
min,	  at	  220	  volts	  and	  120	  mA.	  After	   the	  gel	   run	  was	  complete,	   the	  gel	  was	  stained	  
with	  comassie	  for	  1	  hr	  at	  room	  temperature	  on	  roller.	  Then,	  the	  gel	  was	  placed	  in	  de-­‐
staining	   buffer	   (20%	   (v/v)	  methanol	   and	   10	  %	   (v/v)	   acetic	   acid	   in	  miliQ	  water)	   and	  
imaged	  with	  Amersham	  600	   imager.	   The	   fractions	  with	   right	   sizes	  were	   combined,	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concentrated	   in	   the	   centrifugal	   filter	   units	   and	   the	   final	   concentrations	   of	   proteins	  
were	   determined	   by	   measuring	   the	   absorbance	   at	   280	   nm	   with	   a	   nanodrop	  
spectrometer.	   The	   molecular	   masses	   and	   the	   molar	   extinction	   coefficients	   were	  
theoretically	  calculated	  from	  an	  online	  tool	  (http://web.expasy.org/protparam/)	  and	  
were	  as	  follows:	  
	   PIF6-­‐CFP:	  38.8	  kDa,	  ε280	  =	  29300	  M-­‐1.cm-­‐1	  
	   CIBN-­‐GFP:	  48.9	  kDa,	  ε280	  =	  24890	  M-­‐1.cm-­‐1	  
The	  concentrations	  were	  as	  follows:	  [CIBN-­‐GFP-­‐His6]	  =	  0.24	  mM	  and	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  [PIF6-­‐CFP-­‐His6]	  =	  0.4	  mM	  
	  
4.6	  Surface	  functionalization	  and	  protein	  immobilization	  
The	  surface	  modification	  scheme	  was	  adapted	  from	  Schenk	  et	  al.132	  In	  short,	  20	  mm	  x	  
20	  mm	  cover	  slips	  were	  cleaned	  in	  piranha	  solution	  (3:1	  H2SO4:H2O2)	  for	  1	  hr	  at	  room	  
temperature,	  rinsed	  thoroughly	  with	  water	  and	  dried	  with	  N2	  stream.	  The	  substrates	  
were	  immersed	  in	  a	  solution	  of	  0.25	  mM	  PEG-­‐N3	  (PEG	  3000	  with	  a	  terminal	  azide	  and	  
a	  terminal	  triethoxysilane	  group)	  and	  25	  µM	  triethylamine	  in	  dry	  toluene	  (dried	  over	  
molecular	   sieves	   (3Å))	   and	   held	   at	   78oC	   overnight	   under	   a	   nitrogen	   atmosphere	  
(Section	   6.2).	   The	   substrates	   were	   sonicated	   in	   ethylacetate	   for	   5	   min	   and	   then,	  
sonicated	   in	   methanol	   for	   5	   min	   and	   dried	   in	   a	   stream	   of	   nitrogen.	   For	   copper	  
catalyzed	   azide	   alkyne	   cycloaddition	   (CuAAC),	   the	   PEGylated	   substrates	   were	  
incubated	  with	   a	   freshly	   prepared	   aqueous	   solution	   of	   100	  mM	  TRIS	   (pH	   9.5),	   100	  
mM	  L-­‐ascorbic	  acid,	  150	  µM	  NTA-­‐alkyne	  (synthesized	  by	  Julia	  Ricken)134,135	  and	  1	  mM	  
CuSO4	  for	  2	  hours	  in	  a	  moisture	  chamber.	  Substrates	  were	  washed	  twice	  with	  a	  buffer	  
(Buffer	  A),	  once	  with	  50	  mM	  EDTA	  and	  twice	  with	  Buffer	  A.	  The	  substrates	  were	  then	  
incubated	   with	   100	   mM	   NiCl2	   for	   5	   min	   for	   Ni2+	   coordination	   with	   NTA	   and	   then	  
washed	   once	   with	   Buffer	   A.	   	   Finally,	   the	   Ni2+-­‐NTA	   functionalized	   surfaces	   were	  
incubated	  with	  10	  µM	  His6-­‐tagged	  protein	  for	  30	  min	  at	  room	  temperature.	  
	  
4.7	  Quartz	  Crystal	  Microbalance	  with	  dissipation	  monitoring	  (QCM-­‐D)	  
SiO2	   sensors	   were	   immersed	   in	   an	   aqueous	   solution	   of	   2%	   (w/v)	   SDS	   overnight,	  
washed	  with	  water	  thoroughly	  and	  dried	  in	  a	  nitrogen	  stream.	  The	  SiO2	  sensors	  were	  
then	  cleaned	  and	  activated	  in	  an	  O2	  plasma	  (0.4	  mbar,	  150	  W,	  45	  min).	  Subsequently,	  
	  80	  
the	  QCM-­‐D	   crystals	  were	   functionalized	  with	   a	   PEG	   layer	  with	   a	   terminal	   Ni2+-­‐NTA	  
group	   as	   described	   above.	   Then,	   the	   crystals	   were	   placed	   in	   the	   QCM-­‐D	   closed	  
module	   and	   a	   flow	   rate	   of	   100	   µl/min	   was	   used	   for	   all	   measurements.	   First,	   the	  
crystals	  were	  washed	  with	   the	   same	  buffer	   (Buffer	  A)	  until	   a	  baseline	  was	   reached	  
and	   then	   10	   µM	   His6-­‐tagged	   proteins	   were	   washed	   over	   the	   crystals,	   where	   the	  
binding	   of	   proteins	   to	   the	   Ni2+-­‐NTA-­‐functionalized	   surface	   was	   observed	   as	   a	  
decrease	  in	  frequency.	  The	  crystals	  were	  washed	  once	  again	  with	  Buffer	  A	  to	  remove	  
unspecifically	   bound	  proteins.	   Finally,	   they	  were	  washed	  with	   the	  elution	  buffer	   to	  
remove	   all	   proteins,	   which	   are	   bound	   to	   the	   crystals	   through	   His6-­‐Ni2+-­‐NTA	  
coordination.	  
	  
4.8	  Blue	  -­‐	  light	  induced	  cell-­‐cell	  contacts	  	  
4.8.1	  Cell-­‐cell	  contact	  formation	  and	  quantification	  
For	   illumination	  experiments,	  MDA-­‐CRY2-­‐mCherry	  and	  MDA-­‐CIBN-­‐GFP	  were	  seeded	  
on	   24	   mm	   x	   24	   mm	   cover	   slips	   (cleaned	   with	   70%	   ethanol)	   at	   a	   density	   of	   5000	  
cells/cm2	  each	  in	  the	  presence	  of	  0.5	  µM	  FAD	  and	  kept	  in	  dark	  and	  under	  blue	  light	  
(471	  nm,	  80	  µW/cm2)	  for	  4	  hours.	  After	  incubation,	  cells	  were	  fixed	  in	  dark	  and	  under	  
blue	   light	   and	   stained	   for	   actin	   and	  nucleus.	   Fluorescence	   images	   in	   the	  TRITC	  and	  
DAPI	   channels	   were	   acquired	   with	   a	   tile	   scan	   of	   an	   area	   of	   1	   cm2	   on	   an	   upright	  
fluorescence	  microscope	  (Leica	  DM6000B)	  through	  a	  10x	  air	  lens	  objective.	  All	  images	  
were	  analyzed	  in	  ImageJ.	  The	  number	  of	  cells	  (nuclei	  as	  objects	  of	  50-­‐5000	  µm2)	  was	  
determined	   with	   the	   analyze	   particles	   tool	   using	   images	   in	   the	   DAPI	   channel.	   The	  
total	  area,	  the	  area	  of	  each	  object	  and	  the	  number	  of	  objects	  were	  determined	  for	  all	  
cells	  (objects	  >	  300	  µm2),	  single	  cells	  (objects	  of	  300-­‐3000	  µm2)	  and	  clusters	  (objects	  
>	  10000	  µm2)	  with	  the	  analyze	  particles	  tool	  using	  images	  in	  the	  TRITC	  channel.	  The	  %	  
area	  that	  single	  cells	  or	  cell	  clusters	  occupy	  was	  calculated	  as	  the	  total	  area	  of	  single	  
cells	  or	  clusters	  divided	  by	  the	  total	  area	  of	  all	  cells.	  All	  clustering	  experiments	  were	  
done	   in	   technical	   duplicates	   with	   2	   replicates	   in	   each.	   Statistical	   analysis	   was	  
performed	  using	  the	  unpaired	  t-­‐test	  in	  GraphPad	  Prism	  and	  statistical	  significance	  is	  




4.8.2	  Reversible	  cell-­‐cell	  contacts	  
MDA-­‐CRY2-­‐mCherry	   cells	   were	   seeded	   on	   adhesive	   circular	   micropatterns	   (Cytoo	  
chips)	  with	  20	  µm	  in	  diameter	  at	  a	  density	  of	  10000	  cells/cm2	  and	  cultured	  overnight.	  
For	  live	  cell	  imaging	  an	  Olympus	  IX	  inverted	  microscope	  equipped	  with	  an	  incubation	  
chamber	  (37oC,	  under	  5%	  CO2)	  and	  a	  20x	  air	  objective	  was	  used.	  A	  time	  lapse-­‐movie	  
was	   recorded	   at	   1	   frame/minute	   and	   illumination	  was	   done	  with	   a	   blue	   LED	   lamp	  
(471	  nm,	  15	  Watts)	  from	  the	  top	  of	  the	  cells.	  First	  images	  of	  MDA-­‐CRY2-­‐mCherry	  cells	  
were	  acquired	   in	   the	  dark	   for	  5	  min,	   then	  under	  blue	   light	   for	  5	  min	  before	  adding	  
MDA-­‐CIBN-­‐GFP	  cells.	  After	  the	  addition	  of	  MDA-­‐CIBN-­‐GFP	  cells	  (100	  µl	  from	  200	  000	  
cells/ml),	  the	  imaging	  continued	  for	  30	  min	  under	  blue	  light	  and	  subsequently	  images	  
were	  acquired	  in	  repeated	  dark/light	  for	  20	  min/cycle.	  Interacting	  cells	  were	  marked	  
and	  the	  distance	  over	  time	  is	  measured	  in	  ImageJ.	  
	  
4.8.3	  Layer-­‐by-­‐layer	  tissue	  formation	  
MDA-­‐CIBN-­‐GFP	   and	   MDA-­‐CRY2-­‐mCherry	   cells	   were	   pre-­‐stained	   with	   lipophilic	  
tracers,	   DiO	   (3,3'	   -­‐	   Dioctadecyloxacarbocyanine	   Perchlorate)	   and	   DiI	   (1,1'	   -­‐	  
dioctadecyl-­‐3,3,3'3'-­‐tetramethylindocarbocyanine	   perchlorate),	   respectively,	   by	  
adding	  these	  dyes	  in	  the	  culture	  medium	  at	  final	  concentration	  of	  6	  µM	  DiO	  and	  3	  µM	  
DiI.	  MDA-­‐CIBN-­‐GFP	  cells	  were	  then	  seeded	  on	  a	  glass	  bottom	  dish	  at	  a	  density	  of	  300	  
cells/cm2	   and	   cultured	   overnight	   to	   confluency.	   The	   next	   day,	  MDA-­‐CRY2-­‐mCherry	  
cells	  were	   added	  on	   top	  of	   CIBN	  expressing	   cells	   at	   a	   density	   of	   300	   cells/cm2	   and	  
cultured	  in	  dark	  or	  under	  blue	  light	  illumination	  for	  8	  hours.	  After	  the	  incubation	  cells	  
were	  washed,	  fixed	  and	  stained	  with	  DAPI.	  Confocal	  imaging	  was	  done	  to	  observe	  the	  
tissue	  formation	  under	  blue	  light	  illumination.	  
	  
4.9	  Blue	  and	  red	  light	  induced	  cell	  –	  surface	  contacts	  
4.9.1	  Blue	  and	  red	  light	  induced	  cell	  adhesion	  
PIF6-­‐CFP-­‐His6	   and	  CIBN-­‐GFP-­‐His6	  were	   immobilized	  on	  Ni2+-­‐NTA-­‐functionalized	  glass	  
substrates	  separately.	  MDA-­‐CRY2-­‐mCherry	  and	  MDA-­‐PhyB-­‐YFP	  cells	  were	  seeded	  on	  
their	   complementary	   substrates	   at	   a	   density	   of	   5000	   cells/cm2.	   The	   samples	   were	  
incubated	   in	   dark,	   under	   blue	   light	   (471	   nm,	   80	   µW/cm2)	   or	   red	   light	   (673	   nm,	   55	  
µW/cm2)	   for	  2	  hours	   in	   the	  presence	  of	  0.5	  µM	  FAD	  and	  5	  µM	  PCB	  for	  MDA-­‐CRY2-­‐
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mCherry	  and	  MDA-­‐PhyB-­‐YFP	  cells,	  respectively.	  After	  incubation,	  cells	  were	  fixed	  and	  
mounted	  with	  mowiole:DAPI.	  Fluorescence	  images	  in	  the	  DAPI	  channel	  was	  acquired	  
with	   a	   tile	   scan	   of	   an	   area	   of	   1	   cm2	   on	   an	   upright	   fluorescence	  microscope	   (Leica	  
DM6000B)	  through	  a	  10x	  air	  lens	  objective.	  The	  number	  of	  cells	  (nuclei	  as	  objects	  of	  
50-­‐5000	  µm2)	  was	  determined	  with	  the	  analyze	  particles	  tool	  on	  ImageJ.	  
	  
4.9.2	  Cell	  spreading	  by	  photoswitchable	  interactions	  
MDA-­‐CRY2-­‐mCherry	   and	  MDA-­‐PhyB-­‐YFP	   cells	  were	   seeded	  on	   substrates	  with	   their	  
complementary	  partner	  proteins	  and	  on	  a	  bare	  glass	  surface	  (control)	  and	  incubated	  
for	  2	  hours.	  Fixation,	  staining	  for	  actin	  and	  mounting	  were	  done	  as	  described	  above.	  
Fluorescence	  images	  in	  the	  TRITC	  and	  DAPI	  channels	  were	  acquired	  with	  a	  tile	  scan	  of	  
an	  area	  of	  1	  cm2	  on	  an	  upright	  fluorescence	  microscope	  (Leica	  DM6000B)	  through	  a	  
10x	  air	  lens	  objective.	  All	  images	  were	  analyzed	  in	  ImageJ.	  The	  spreading	  area	  of	  the	  
cells	   on	   the	   protein	   functionalized	   substrates	   and	   on	   the	   glass	   surfaces	   was	  
calculated	  using	  the	  Cell	  outliner	  tool	   in	   ImageJ.	  For	  comparison	  of	  cell	  morphology	  
when	  they	  were	  on	  protein	  and	  on	  the	  glass	  substrates,	  confocal	   imaging	  was	  done	  
with	  Zeiss	  LSM	  880	  microscope.	  The	  cells	  were	  fixed	  and	  stained	  for	  actin;	  however,	  
they	  were	  not	  mounted.	  In	  order	  to	  detect	  mCherry	  signal	  from	  MDA-­‐CRY2-­‐mCherry	  
stable	  cell	  line,	  a	  Phalloidin-­‐FITC	  conjugate	  was	  used	  for	  actin	  staining.	  
	  
4.9.3	  Adhesion	  and	  reversion	  kinetics	  
For	   the	   adhesion	   kinetics,	   cells	   were	   incubated	   on	   substrates	   with	   their	  
complementary	   interaction	   partners	   under	   blue	   light	   for	   MDA-­‐CRY2-­‐mCherry	   cells	  
and	  under	  red	  light	  for	  MDA-­‐PhyB-­‐YFP	  cells	  for	  30,	  60,	  90	  and	  120	  min	  and	  in	  dark	  for	  
120	   min.	   At	   each	   time	   point	   a	   triplicate	   set	   of	   samples	   were	   fixed.	   For	   reversion	  
kinetics	  cells	  were	  first	  incubated	  on	  substrates	  with	  their	  complementary	  interaction	  
partners	  under	   light	   for	  60	  min	  as	  described	  above,	  and	  then	  placed	   in	  dark	  for	  30,	  
60,	   90	   and	   120	  min.	   At	   each	   time	  point	   a	   triplicate	   set	   of	   samples	  were	   fixed.	   For	  
MDA-­‐PhyB-­‐YFP	   cells	   on	   PIF6	   immobilized	   substrates,	   the	   samples	   were	   also	  
incubated	  under	  far-­‐red	  light	  (750	  nm,	  50	  µW/cm2)	  for	  5,	  15	  and	  30	  min	  following	  1	  h	  
red	   light	   illumination.	   At	   each	   time	   point	   a	   triplicate	   set	   of	   samples	   were	   fixed.	  
Fluorescence	  images	  in	  the	  DAPI	  channel	  was	  acquired	  with	  a	  tile	  scan	  of	  an	  area	  of	  1	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cm2	  on	  an	  upright	  fluorescence	  microscope	  (Leica	  DM6000B)	  through	  a	  10x	  air	   lens	  
objective.	  All	  images	  were	  analyzed	  in	  ImageJ.	  The	  number	  of	  cells	  (nuclei	  as	  objects	  
of	  50-­‐5000	  µm2)	  was	  determined	  with	  the	  analyze	  particles	  tool.	  	  
	  
4.9.4	  Orthogonal	  switching	  of	  cell	  adhesion	  
PhyB	  and	  CRY2	  expressing	  cells	  were	  pre-­‐stained	  with	  lipophilic	  tracers,	  DiO	  and	  DiI,	  
respectively,	  as	  described	  above.	  10	  µM	  PIF6-­‐CFP-­‐His6	  and	  10	  µM	  CIBN-­‐GFP-­‐His6	  were	  
incubated	   with	   Ni2+-­‐NTA-­‐functionalized	   glass	   surfaces	   to	   co-­‐immobilize	   the	   two	  
proteins.	   The	   pre-­‐stained	   PhyB	   and	   CRY2	   expressing	   cells	   were	   seeded	   at	   5000	  
cells/cm2	  each	  as	  described.	  The	  cells	  were	  incubated	  in	  dark,	  just	  under	  red	  or	  blue	  
light	  or	  under	  co-­‐illumination	  of	  blue	  and	  red	  light	  for	  2	  hours,	  fixed	  and	  mounted	  as	  
described	  above.	  Fluorescence	  images	  in	  the	  FITC	  (MDA-­‐PhyB-­‐YFP	  cells),	  TRITC	  (MDA-­‐
CRY2-­‐mCherry	  cells)	  and	  DAPI	  channels	  were	  acquired	  with	  a	  tile	  scan	  of	  an	  area	  of	  1	  
cm2	  on	  an	  upright	  fluorescence	  microscope	  (Leica	  DM6000B)	  through	  a	  10x	  air	   lens	  
objective.	  The	  number	  of	  PhyB	  and	  CRY2	  expressing	  cells	  was	  determined	  with	   the	  
analyze	  particles	  tool	  using	  images	  in	  the	  FITC	  and	  TRITC	  channel,	  respectively.	  	  
	  
4.10	  Cell	  viability	  assay	  
MTT	   (3-­‐(4,5-­‐dimethylthiazol-­‐2-­‐yl)-­‐2,5-­‐diphenyltetrazolium	   bromide)	   assay	   was	   used	  
to	  measure	  phototoxicity	  under	  blue	  light	  illumination.	  5	  mg	  MTT	  was	  dissolved	  in	  1	  
ml	  PBS	  to	  obtain	  12	  mM	  MTT.	  MDA-­‐MB-­‐231	  cells	  were	  seeded	   in	  a	   flat-­‐bottom	  96-­‐
well	  plate	  at	  a	  density	  of	  150	  000	  cells/cm2	  in	  duplicates.	  Cells	  were	  incubated	  in	  dark	  
and	  under	  80	  μW/cm2,	  800	  μW/cm2	  and	  8000	  μW/cm2	  blue	   light	  for	  4	  hours.	  Then,	  
10	  μl	  of	  12	  mM	  MTT	  was	  added	  and	  cells	  were	  incubated	  4	  hours	  in	  dark.	  Finally,	  50	  
μl	  DMSO	  was	  added	  and	   incubated	   for	  10	  min	   in	  dark.	  Absorbance	  at	  540	  nm	  was	  
measured	  using	  a	  microplate	  reader	  Infinite	  200M	  controlled	  by	  i-­‐control	  1.9.	  All	  the	  
absorbance	  values	  were	  normalized	  to	  the	  absorbance	  values	  of	  the	  dark	  samples.	  
	  
4.11	  Confocal	  imaging	  
Confocal	   images	  were	   acquired	   on	   a	   LSM	   880	   Zeiss	   confocal	  microscope	   equipped	  
with	   a	   UV	   diode	   (405	   nm),	   Ar	   laser	   (488	   nm),	   HeNe	   laser	   (633	   nm)	   and	   a	   63x	   oil-­‐
immersion	  objective	  to	  detect	  mCherry	  and	  GFP	  signals	  from	  the	  stable	  cell	  lines,	  for	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immunostainings	   and	   for	   the	   microtissue	   formed	   layer-­‐by-­‐layer.	   z-­‐stacks	   were	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6.1	  DNA	  and	  aminoacid	  sequences	  of	  cloned	  constructs	  
6.1.1	  pDisplay-­‐CRY2-­‐mCherry	  
DNA	  sequence:	  	  


















































	   	  	   	   	   	   	  
Aminoacid	   sequence:	   Ig-­‐ĸ	   leader	   sequence-­‐HA-­‐CRY2-­‐mCherry-­‐myc	   epitope-­‐TM	  
domain	  
Met	  E	  T	  D	  T	  L	  L	  L	  W	  V	  L	  L	  L	  W	  V	  P	  G	  S	  T	  G	  D	  Y	  P	  Y	  D	  V	  P	  D	  Y	  A	  G	  A	  Q	  P	  A	  R	  S	  P	  G	  I	  R	  G	  M	  
K	  M	  D	  K	  K	  T	  I	  V	  W	  F	  R	  R	  D	  L	  R	  I	  E	  D	  N	  P	  A	  L	  A	  A	  A	  A	  H	  E	  G	  S	  V	  F	  P	  V	  F	  I	  W	  C	  P	  E	  E	  E	  G	  Q	  F	  
Y	  P	  G	  R	  A	  S	  R	  W	  W	  M	  K	  Q	  S	  L	  A	  H	  L	  S	  Q	  S	  L	  K	  A	  L	  G	  S	  D	  L	  T	  L	  I	  K	  T	  H	  N	  T	  I	  S	  A	  I	  L	  D	  C	  I	  R	  V	  
T	  G	  A	  T	  K	  V	  V	  F	  N	  H	  L	  Y	  D	  P	  V	  S	  L	  V	  R	  D	  H	  T	  V	  K	  E	  K	  L	  V	  E	  R	  G	  I	  S	  V	  Q	  S	  Y	  N	  G	  D	  L	  L	  Y	  E	  P	  W	  
E	  I	  Y	  C	  E	  K	  G	  K	  P	  F	  T	  S	  F	  N	  S	  Y	  W	  K	  K	  C	  L	  D	  M	  S	  I	  E	  S	  V	  M	  L	  P	  P	  P	  W	  R	  L	  M	  P	  I	  T	  A	  A	  A	  E	  A	  I	  
W	  A	  C	  S	  I	  E	  E	  L	  G	  L	  E	  N	  E	  A	  E	  K	  P	  S	  N	  A	  L	  L	  T	  R	  A	  W	  S	  P	  G	  W	  S	  N	  A	  D	  K	  L	  L	  N	  E	  F	  I	  E	  K	  Q	  L	  I	  
D	  Y	  A	  K	  N	  S	  K	  K	  V	  V	  G	  N	  S	  T	  S	  L	  L	  S	  P	  Y	  L	  H	  F	  G	  E	  I	  S	  V	  R	  H	  V	  F	  Q	  C	  A	  R	  M	  K	  Q	  I	  I	  W	  A	  R	  D	  K	  
	  96	  
N	  S	  E	  G	  E	  E	  S	  A	  D	  L	  F	  L	  R	  G	  I	  G	  L	  R	  E	  Y	  S	  R	  Y	  I	  C	  F	  N	  F	  P	  F	  T	  H	  E	  Q	  S	  L	  L	  S	  H	  L	  R	  F	  F	  P	  W	  D	  A	  
D	  V	  D	  K	  F	  K	  A	  W	  R	  Q	  G	  R	  T	  G	  Y	  P	  L	  V	  D	  A	  G	  M	  R	  E	  L	  W	  A	  T	  G	  W	  M	  H	  N	  R	  I	  R	  V	  I	  V	  S	  S	  F	  A	  
V	  K	  F	  L	  L	  L	  P	  W	  K	  W	  G	  M	  K	  Y	  F	  W	  D	  T	  L	  L	  D	  A	  D	  L	  E	  C	  D	  I	  L	  G	  W	  Q	  Y	  I	  S	  G	  S	  I	  P	  D	  G	  H	  E	  L	  D	  
R	  L	  D	  N	  P	  A	  L	  Q	  G	  A	  K	  Y	  D	  P	  E	  G	  E	  Y	  I	  R	  Q	  W	  L	  P	  E	  L	  A	  R	  L	  P	  T	  E	  W	  I	  H	  H	  P	  W	  D	  A	  P	  L	  T	  V	  L	  
K	  A	  S	  G	  V	  E	  L	  G	  T	  N	  Y	  A	  K	  P	  I	  V	  D	  I	  D	  T	  A	  R	  E	  L	  L	  A	  K	  A	  I	  S	  R	  T	  R	  E	  A	  Q	  I	  M	  I	  G	  A	  A	  P	  D	  E	  I	  V	  
A	  D	  S	  F	  E	  A	  L	  G	  A	  N	  T	  I	  K	  E	  P	  G	  L	  C	  P	  S	  V	  S	  S	  N	  D	  Q	  Q	  V	  P	  S	  A	  V	  R	  Y	  N	  G	  S	  A	  A	  V	  K	  P	  E	  E	  E	  E	  
E	  R	  D	  M	  K	  K	  S	  R	  G	  F	  D	  E	  R	  E	  L	  F	  S	  T	  A	  E	  S	  S	  S	  S	  S	  S	  V	  F	  F	  V	  S	  Q	  S	  C	  S	  L	  A	  S	  E	  G	  K	  N	  L	  E	  G	  I	  Q	  
D	  S	  S	  D	  Q	  I	  T	  T	  S	  L	  G	  K	  N	  G	  C	  K	  A	  R	  D	  P	  P	  V	  A	  T	  M	  V	  S	  K	  G	  E	  E	  D	  N	  M	  A	  I	  I	  K	  E	  F	  M	  R	  F	  K	  V	  
H	  M	  E	  G	  S	  V	  N	  G	  H	  E	  F	  E	  I	  E	  G	  E	  G	  E	  G	  R	  P	  Y	  E	  G	  T	  Q	  T	  A	  K	  L	  K	  V	  T	  K	  G	  G	  P	  L	  P	  F	  A	  W	  D	  I	  L	  
S	  P	  Q	  F	  M	  Y	  G	  S	  K	  A	  Y	  V	  K	  H	  P	  A	  D	  I	  P	  D	  Y	  L	  K	  L	  S	  F	  P	  E	  G	  F	  K	  W	  E	  R	  V	  M	  N	  F	  E	  D	  G	  G	  V	  V	  T	  
V	  T	  Q	  D	  S	  S	  L	  Q	  D	  G	  E	  F	  I	  Y	  K	  V	  K	  L	  R	  G	  T	  N	  F	  P	  S	  D	  G	  P	  V	  M	  Q	  K	  K	  T	  M	  G	  W	  E	  A	  S	  S	  E	  R	  M	  
Y	  P	  E	  D	  G	  A	  L	  K	  G	  E	  I	  K	  Q	  R	  L	  K	  L	  K	  D	  G	  G	  H	  Y	  D	  A	  E	  V	  K	  T	  T	  Y	  K	  A	  K	  K	  P	  V	  Q	  L	  P	  G	  A	  Y	  N	  V	  
N	  I	  K	  L	  D	  I	  T	  S	  H	  N	  E	  D	  Y	  T	  I	  V	  E	  Q	  Y	  E	  R	  A	  E	  G	  R	  H	  S	  T	  G	  G	  M	  D	  E	  L	  Y	  K	  V	  D	  E	  Q	  K	  L	  I	  S	  E	  E	  
D	  L	  N	  A	  V	  G	  Q	  D	  T	  Q	  E	  V	  I	  V	  V	  P	  H	  S	  L	  P	  F	  K	  V	  V	  V	  I	  S	  A	  I	  L	  A	  L	  V	  V	  L	  T	  I	  I	  S	  L	  I	  I	  L	  I	  M	  L	  W	  Q	  
K	  K	  P	  R	  –	  
	  
6.1.2	  pDisplay-­‐CIBN-­‐GFP	  
DNA	  sequence:	  	  






























Aminoacid	  sequence:	  Ig-­‐ĸ	  leader	  sequence-­‐HA-­‐CIBN-­‐GFP-­‐myc	  epitope-­‐TM	  domain	  
M	  E	  T	  D	  T	  L	  L	  L	  W	  V	  L	  L	  L	  W	  V	  P	  G	  S	  T	  G	  D	  Y	  P	  Y	  D	  V	  P	  D	  Y	  A	  G	  A	  Q	  P	  A	  R	  S	  P	  G	  M	  N	  G	  A	  I	  
G	  G	  D	  L	  L	  L	  N	  F	  P	  D	  M	  S	  V	  L	  E	  R	  Q	  R	  A	  H	  L	  K	  Y	  L	  N	  P	  T	  F	  D	  S	  P	  L	  A	  G	  F	  F	  A	  D	  S	  S	  M	  I	  T	  G	  G	  
E	  M	  D	  S	  Y	  L	  S	  T	  A	  G	  L	  N	  L	  P	  M	  M	  Y	  G	  E	  T	  T	  V	  E	  G	  D	  S	  R	  L	  S	  I	  S	  P	  E	  T	  T	  L	  G	  T	  G	  N	  F	  K	  A	  A	  K	  F	  
D	  T	  E	  T	  K	  D	  C	  N	  E	  A	  A	  K	  K	  M	  T	  M	  N	  R	  D	  D	  L	  V	  E	  E	  G	  E	  E	  E	  K	  S	  K	  I	  T	  E	  Q	  N	  N	  G	  S	  T	  K	  S	  I	  K	  K	  
M	  K	  H	  K	  A	  K	  K	  E	  E	  N	  N	  F	  S	  N	  D	  S	  S	  K	  V	  T	  K	  E	  L	  E	  K	  T	  D	  Y	  I	  H	  V	  P	  V	  A	  T	  M	  V	  S	  K	  G	  E	  E	  L	  F	  T	  
G	  V	  V	  P	  I	  L	  V	  E	  L	  D	  G	  D	  V	  N	  G	  H	  K	  F	  S	  V	  S	  G	  E	  G	  E	  G	  D	  A	  T	  Y	  G	  K	  L	  T	  L	  K	  F	  I	  C	  T	  T	  G	  K	  L	  P	  V	  
P	  W	  P	  T	  L	  V	  T	  T	  L	  T	  Y	  G	  V	  Q	  C	  F	  S	  R	  Y	  P	  D	  H	  M	  K	  Q	  H	  D	  F	  F	  K	  S	  A	  M	  P	  E	  G	  Y	  V	  Q	  E	  R	  T	  I	  F	  F	  
K	  D	  D	  G	  N	  Y	  K	  T	  R	  A	  E	  V	  K	  F	  E	  G	  D	  T	  L	  V	  N	  R	  I	  E	  L	  K	  G	  I	  D	  F	  K	  E	  D	  G	  N	  I	  L	  G	  H	  K	  L	  E	  Y	  N	  Y	  N	  
S	  H	  N	  V	  Y	  I	  MA	  D	  K	  Q	  K	  N	  G	  I	  K	  V	  N	  F	  K	  I	  R	  H	  N	  I	  E	  D	  G	  S	  V	  Q	  L	  A	  D	  H	  Y	  Q	  Q	  N	  T	  P	  I	  G	  D	  G	  
P	  V	  L	  L	  P	  D	  N	  H	  Y	  L	  S	  T	  Q	  S	  A	  L	  S	  K	  D	  P	  N	  E	  K	  R	  D	  H	  M	  V	  L	  L	  E	  F	  V	  T	  A	  A	  G	  I	  T	  L	  G	  M	  D	  E	  L	  Y	  
K	  G	  K	  K	  K	  K	  K	  K	  S	  K	  T	  K	  C	  V	  I	  M	  V	  D	  E	  Q	  K	  L	  I	  S	  E	  E	  D	  L	  N	  A	  V	  G	  Q	  D	  T	  Q	  E	  V	  I	  V	  V	  P	  H	  S	  L	  P	  
F	  K	  V	  V	  V	  I	  S	  A	  I	  L	  A	  L	  V	  V	  L	  T	  I	  I	  S	  L	  I	  I	  L	  I	  M	  L	  W	  Q	  K	  K	  P	  R	  -­‐	  
	  
	   	  
	  98	  
6.1.3	  pDisplay-­‐PhyB-­‐YFP	  
DNA	  sequence:	  	  






























































Aminoacid	  sequence:	  Ig-­‐ĸ	  leader	  sequence-­‐PhyB-­‐YFP-­‐myc	  epitope-­‐TM	  domain	  
M	  E	  T	  D	  T	  L	  L	  L	  W	  V	  L	  L	  L	  W	  V	  P	  G	  S	  T	  G	  D	  Y	  P	  Y	  D	  V	  P	  D	  Y	  A	  G	  A	  Q	  P	  A	  R	  S	  P	  G	  M	  V	  S	  G	  V	  
G	  G	  S	  G	  G	  G	  R	  G	  G	  G	  R	  G	  G	  E	  E	  E	  P	  S	  S	  S	  H	  T	  P	  N	  N	  R	  R	  G	  G	  E	  Q	  A	  Q	  S	  S	  G	  T	  K	  S	  L	  R	  P	  R	  S	  
N	  T	  E	  S	  M	  S	  K	  A	  I	  Q	  Q	  Y	  T	  V	  D	  A	  R	  L	  H	  A	  V	  F	  E	  Q	  S	  G	  E	  S	  G	  K	  S	  F	  D	  Y	  S	  Q	  S	  L	  K	  T	  T	  T	  Y	  G	  S	  S	  
	  100	  
V	  P	  E	  Q	  Q	  I	  T	  A	  Y	  L	  S	  R	  I	  Q	  R	  G	  G	  Y	  I	  Q	  P	  F	  G	  C	  M	  I	  A	  V	  D	  E	  S	  S	  F	  R	  I	  I	  G	  Y	  S	  E	  N	  A	  R	  E	  M	  L	  G	  
I	  M	  P	  Q	  S	  V	  P	  T	  L	  E	  K	  P	  E	  I	  L	  A	  M	  G	  T	  D	  V	  R	  S	  L	  F	  T	  S	  S	  S	  S	  I	  L	  L	  E	  R	  A	  F	  V	  A	  R	  E	  I	  T	  L	  L	  N	  P	  V	  
W	  I	  H	  S	  K	  N	  T	  G	  K	  P	  F	  Y	  A	  I	  L	  H	  R	  I	  D	  V	  G	  V	  V	  I	  D	  L	  E	  P	  A	  R	  T	  E	  D	  P	  A	  L	  S	  I	  A	  G	  A	  V	  Q	  S	  Q	  K	  L	  
A	  V	  R	  A	  I	  S	  Q	  L	  Q	  A	  L	  P	  G	  G	  D	  I	  K	  L	  L	  C	  D	  T	  V	  V	  E	  S	  V	  R	  D	  L	  T	  G	  Y	  D	  R	  V	  M	  V	  Y	  K	  F	  H	  E	  D	  E	  H	  
G	  E	  V	  V	  A	  E	  S	  K	  R	  D	  D	  L	  E	  P	  Y	  I	  G	  L	  H	  Y	  P	  A	  T	  D	  I	  P	  Q	  A	  S	  R	  F	  L	  F	  K	  Q	  N	  R	  V	  R	  M	  I	  V	  D	  C	  N	  A	  
T	  P	  V	  L	  V	  V	  Q	  D	  D	  R	  L	  T	  Q	  S	  M	  C	  L	  V	  G	  S	  T	  L	  R	  A	  P	  H	  G	  C	  H	  S	  Q	  Y	  M	  A	  N	  M	  G	  S	  I	  A	  S	  L	  A	  M	  
A	  V	  I	  I	  N	  G	  N	  E	  D	  D	  G	  S	  N	  V	  A	  S	  G	  R	  S	  S	  M	  R	  L	  W	  G	  L	  V	  V	  C	  H	  H	  T	  S	  S	  R	  C	  I	  P	  F	  P	  L	  R	  Y	  A	  C	  
E	  F	  L	  M	  Q	  A	  F	  G	  L	  Q	  L	  N	  M	  E	  L	  Q	  L	  A	  L	  Q	  M	  S	  E	  K	  R	  V	  L	  R	  T	  Q	  T	  L	  L	  C	  D	  M	  L	  L	  R	  D	  S	  P	  A	  G	  I	  
V	  T	  Q	  S	  P	  S	  I	  M	  D	  L	  V	  K	  C	  D	  G	  A	  A	  F	  L	  Y	  H	  G	  K	  Y	  Y	  P	  L	  G	  V	  A	  P	  S	  E	  V	  Q	  I	  K	  D	  V	  V	  E	  W	  L	  L	  A	  
N	  H	  A	  D	  S	  T	  G	  L	  S	  T	  D	  S	  L	  G	  D	  A	  G	  Y	  P	  G	  A	  A	  A	  L	  G	  D	  A	  V	  C	  G	  M	  A	  V	  A	  Y	  I	  T	  K	  R	  D	  F	  L	  F	  W	  F	  
R	  S	  H	  T	  A	  K	  E	  I	  K	  W	  G	  G	  A	  K	  H	  H	  P	  E	  D	  K	  D	  D	  G	  Q	  R	  M	  H	  P	  R	  S	  S	  F	  Q	  A	  F	  L	  E	  V	  V	  K	  S	  R	  S	  Q	  
P	  W	  E	  T	  A	  E	  M	  D	  A	  I	  H	  S	  L	  Q	  L	  I	  L	  R	  D	  S	  F	  K	  E	  S	  E	  A	  A	  M	  N	  S	  K	  V	  V	  D	  G	  V	  V	  Q	  P	  C	  R	  D	  M	  A	  
G	  E	  Q	  G	  I	  D	  E	  L	  G	  A	  V	  A	  R	  E	  M	  V	  R	  L	  I	  E	  T	  A	  T	  V	  P	  I	  F	  A	  V	  D	  A	  G	  G	  C	  I	  N	  G	  W	  N	  A	  K	  I	  A	  E	  L	  T	  
G	  L	  S	  V	  E	  E	  A	  M	  G	  K	  S	  L	  V	  S	  D	  L	  I	  Y	  K	  E	  N	  E	  A	  T	  V	  N	  K	  L	  L	  S	  R	  A	  L	  R	  G	  D	  E	  E	  K	  N	  V	  E	  V	  K	  L	  K	  
T	  F	  S	  P	  E	  L	  Q	  G	  K	  A	  V	  F	  V	  V	  V	  N	  A	  C	  S	  S	  K	  D	  Y	  L	  N	  N	  I	  V	  G	  V	  C	  F	  V	  G	  Q	  D	  V	  T	  S	  Q	  K	  I	  V	  M	  D	  
K	  F	  I	  N	  I	  Q	  G	  D	  Y	  K	  A	  I	  V	  H	  S	  P	  N	  P	  L	  I	  P	  P	  I	  F	  A	  A	  D	  E	  N	  T	  C	  C	  L	  E	  W	  N	  M	  A	  M	  E	  K	  L	  T	  G	  W	  
S	  R	  S	  E	  V	  I	  G	  K	  M	  I	  V	  G	  E	  V	  F	  G	  S	  C	  C	  M	  L	  K	  G	  P	  D	  A	  L	  T	  K	  F	  M	  I	  V	  L	  H	  N	  A	  I	  G	  G	  Q	  D	  T	  D	  K	  
F	  P	  F	  P	  F	  F	  D	  R	  N	  G	  K	  F	  V	  Q	  A	  L	  L	  T	  A	  N	  K	  R	  V	  S	  L	  E	  G	  K	  V	  I	  G	  A	  F	  C	  F	  L	  Q	  I	  P	  S	  P	  R	  S	  A	  G	  A	  
V	  S	  K	  G	  E	  E	  L	  F	  T	  G	  V	  V	  P	  I	  L	  V	  E	  L	  D	  G	  D	  V	  N	  G	  H	  K	  F	  S	  V	  S	  G	  E	  G	  E	  G	  D	  A	  T	  Y	  G	  K	  L	  T	  L	  K	  F	  
I	  C	  T	  T	  G	  K	  L	  P	  V	  P	  W	  P	  T	  L	  V	  T	  T	  F	  G	  Y	  G	  L	  Q	  C	  F	  A	  R	  Y	  P	  D	  H	  M	  K	  Q	  H	  D	  F	  F	  K	  S	  A	  M	  P	  E	  G	  
Y	  V	  Q	  E	  R	  T	  I	  F	  F	  K	  D	  D	  G	  N	  Y	  K	  T	  R	  A	  E	  V	  K	  F	  E	  G	  D	  T	  L	  V	  N	  R	  I	  E	  L	  K	  G	  I	  D	  F	  K	  E	  D	  G	  N	  I	  L	  G	  
H	  K	  L	  E	  Y	  N	  Y	  N	  S	  H	  N	  V	  Y	  I	  M	  A	  D	  K	  Q	  K	  N	  G	  I	  K	  V	  N	  F	  K	  I	  R	  H	  N	  I	  E	  D	  G	  S	  V	  Q	  L	  A	  D	  H	  Y	  Q	  
Q	  N	  T	  P	  I	  G	  D	  G	  P	  V	  L	  L	  P	  D	  N	  H	  Y	  L	  S	  Y	  Q	  S	  A	  L	  S	  K	  D	  P	  N	  E	  K	  R	  D	  H	  M	  V	  L	  L	  E	  F	  V	  T	  A	  A	  G	  I	  
T	  L	  G	  M	  D	  E	  L	  L	  Q	  V	  D	  E	  Q	  K	  L	  I	  S	  E	  E	  D	  L	  N	  A	  V	  G	  Q	  D	  T	  Q	  E	  V	  I	  V	  V	  P	  H	  S	  L	  P	  F	  K	  V	  V	  V	  I	  S	  
A	  I	  L	  A	  L	  V	  V	  L	  T	  I	  I	  S	  L	  I	  I	  L	  I	  M	  L	  W	  Q	  K	  K	  P	  R	  –	  
	   	  
	  101	  
6.1.4	  pDisplay-­‐PIF6-­‐CFP	  
DNA	  sequence:	  	  



























































AATTATGCTCGAGCACCACCACCACCACCACTGA	  	  	  	  	  	  	  
	  
Aminoacid	  sequence:	  NdeI-­‐CIBN-­‐GFP-­‐XhoI-­‐His6	  
	  
	  103	  
H	  M	  M	  N	  G	  A	  I	  G	  G	  D	  L	  L	  L	  N	  F	  P	  D	  M	  S	  V	  L	  E	  R	  Q	  R	  A	  H	  L	  K	  Y	  L	  N	  P	  T	  F	  D	  S	  P	  L	  A	  G	  F	  F	  A	  D	  
S	  S	  M	  I	  T	  G	  G	  E	  M	  D	  S	  Y	  L	  S	  T	  A	  G	  L	  N	  L	  P	  M	  M	  Y	  G	  E	  T	  T	  V	  E	  G	  D	  S	  R	  L	  S	  I	  S	  P	  E	  T	  T	  L	  G	  T	  G	  
N	  F	  K	  A	  A	  K	  F	  D	  T	  E	  T	  K	  D	  C	  N	  E	  A	  A	  K	  K	  M	  T	  M	  N	  R	  D	  D	  L	  V	  E	  E	  G	  E	  E	  E	  K	  S	  K	  I	  T	  E	  Q	  N	  N	  G	  
S	  T	  K	  S	  I	  K	  K	  M	  K	  H	  K	  A	  K	  K	  E	  E	  N	  N	  F	  S	  N	  D	  S	  S	  K	  V	  T	  K	  E	  L	  E	  K	  T	  D	  Y	  I	  H	  V	  P	  V	  A	  T	  M	  V	  S	  K	  
G	  E	  E	  L	  F	  T	  G	  V	  V	  P	  I	  L	  V	  E	  L	  D	  G	  D	  V	  N	  G	  H	  K	  F	  S	  V	  S	  G	  E	  G	  E	  G	  D	  A	  T	  Y	  G	  K	  L	  T	  L	  K	  F	  I	  C	  T	  
T	  G	  K	  L	  P	  V	  P	  W	  P	  T	  L	  V	  T	  T	  L	  T	  Y	  G	  V	  Q	  C	  F	  S	  R	  Y	  P	  D	  H	  M	  K	  Q	  H	  D	  F	  F	  K	  S	  A	  M	  P	  E	  G	  Y	  V	  
Q	  E	  R	  T	  I	  F	  F	  K	  D	  D	  G	  N	  Y	  K	  T	  R	  A	  E	  V	  K	  F	  E	  G	  D	  T	  L	  V	  N	  R	  I	  E	  L	  K	  G	  I	  D	  F	  K	  E	  D	  G	  N	  I	  L	  G	  H	  K	  
L	  E	  Y	  N	  Y	  N	  S	  H	  N	  V	  Y	  I	  MA	  D	  K	  Q	  K	  N	  G	  I	  K	  V	  N	  F	  K	  I	  R	  H	  N	  I	  E	  D	  G	  S	  V	  Q	  L	  A	  D	  H	  Y	  Q	  Q	  N	  
T	  P	  I	  G	  D	  G	  P	  V	  L	  L	  P	  D	  N	  H	  Y	  L	  S	  T	  Q	  S	  A	  L	  S	  K	  D	  P	  N	  E	  K	  R	  D	  H	  M	  V	  L	  L	  E	  F	  V	  T	  A	  A	  G	  I	  T	  L	  
G	  M	  D	  E	  L	  Y	  K	  G	  K	  K	  K	  K	  K	  K	  S	  K	  T	  K	  C	  V	  I	  L	  E	  H	  H	  H	  H	  H	  H	  –	  
	  
6.1.6	  pET21b-­‐PIF6-­‐CFP	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